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ABBREVIATIONS	
ADCC	 	 Antibody-dependent	cell-mediated	cytotoxicity	
ALL	 	 Acute	lymphoblastic	leukemia	
AML	 	 Acute	myeloid	leukemia	
APC	 	 Antigen	presenting	cell	
BLT	 	 Bone	marrow−liver−thymus	
BRG	 	 BALB/c	RAG2−/−	γc−/−	
cDC	 	 Conventional	dendritic	cell	
CLP	 	 Common	lymphoid	progenitor	
CMV	 	 Cytomegalovirus	
γc	 	 Common	gamma	chain	
DAMP	 	 Danger	associated	molecular	pattern	
DC	 	 Dendritic	cell	
DZ	 	 Dendritische	Zellen	
EAT2	 	 EWS/FLI1-activated	transcript	2	
EBV	 	 Epstein	Barr	virus	
EVT	 	 Extravillous	trophoblast	
f-actin	 	 Filamentous	actin	
FcεRIγ		 High-affinity	IgE	receptor	subunit-γ	
GM-CSF	 Granulocyte	macrophage	colony-stimulating	factor	
GvHD	 	 Graft-versus-host	disease	
GvL	 	 Graft-versus-leukemia	
HLA		 	 Human	leukocyte	antigen	
HCV	 	 Hepatitis	C	virus	
HFL	 	 Human	 fetal	 liver	
HPC	 	 Hematopoietic	progenitor	cell	
HSC	 	 Hematopoietic	stem	cell	
huMice	 Humanized	mice	
huNSG		 Humanized	mice	on	NSG	background	
IFN	 	 Interferon	
Ig	 	 Immunoglobulin	
IL	 	 Interleukin	
ILC	 	 Innate	lymphoid	cells	
IM	 	 Infectious	mononucleosis	
IS	 	 Immunological	synapse	
Abbrevations	
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ITAM	 	 Immunoreceptor	tyrosine-based	activation	motif	
ITIM	 	 Immunoreceptor	tyrosine-based	inhibition	motif	
KIR	 	 Killer	cell	immunoglobulin-like	receptor	
KLRG1		 Killer	cell	lectin-like	receptor	G1	
LIR	 	 Leukocyte	immunoglobulin-like	receptor	
LRC	 	 Leukocyte	receptor	complex	
MHC	 	 Major	histocompatibility	complex	
MTOC	 	 Microtubule-organizing	center	
NCR	 	 Natural	cytotoxicity	receptor	
NK	 	 Natural	Killer,	Natürliche	Killer	
NOD	 	 Non-obese	diabetic	
NSG	 	 NOD-scid	γc−/−	
ODN	 	 Oligodeoxynucleotide	
PAMP	 	 Pathogen	associated	molecular	pattern	
PBMC	 	 Peripheral	blood	mononuclear	cell	
pDC	 	 Plasmacytoid	dendritic	cell	
PILR	 	 Paired	Ig-like	2	receptor	
PLZF	 	 Pro-myelocytic	leukemia	zinc	finger	
PRR	 	 Pattern	recognition	receptor	
PTLD	 	 Post-transplant	lymphoproliferative	disease	
Rag	 	 Recombination-activating	gene	
RIU	 	 Raji-infecting	unit	
SLO	 	 Secondary	lymphoid	organ	
SMAC	 	 Supramolecular	activation	cluster	
TCR	 	 T	cell	receptor	
TLR	 	 Toll-like	receptor	
TNF	 	 Tumor	necrosis	factor	
VLP	 	 Virus	like	particle	
YFV	 	 Yellow	fever	vaccine	
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1.1	Zusammenfassung		Natürliche	 Killer	 (NK)	 Zellen	 spielen	 eine	 wesentliche	 Rolle	 bei	 der	 angeborenen	Immunantwort	 des	Menschen.	 Dank	 ihres	 frühzeitigen	 Eingreifens	 bei	 viralen	 Infekten	sowie	 ihrer	 Fähigkeit	 transformierte	 Zellen	 zu	 erkennen,	 sind	 sie	 eine	 effiziente	 erste	Instanz	 in	 der	 Immunabwehr.	 Zudem	 unterstreichen	 aktuelle	 Studien	 immer	 häufiger	nicht	 nur	 ihren	 Stellenwert	 während	 der	 prompten	 Immunantwort,	 sondern	 auch	 als	Bestandteil	des	 langlebigen	 immunologischen	Gedächtnisses.	Dementsprechend	wird	es	immer	wichtiger,	die	Einzelheiten	zu	verstehen,	welche	die	NK	Zell	Biologie	steuern.	In	 unserer	 ersten	 Studie	 haben	 wir	 ein	 neues	 humanisiertes	 Maus	 Modell	entwickelt,	 anhand	 dessen	 wir	 den	 Einfluss	 von	 HLA	 Klasse	 I	 Molekülen	 in	 der	Entwicklung	 von	 NK	 Zellen	 beobachten	 konnten.	 Für	 eine	 Gruppe	 von	 NK	 Zell	Rezeptoren,	den	sogenannten	killer	cell	immunoglobulin-like	receptors	(KIRs),	fungieren	bestimmte	HLA	Klasse	I	Moleküle	als	Liganden	(KIR-Liganden).	Diese	Interaktionen	sind	für	 einen	 als	 NK	 Zell	 Erziehung	 genannten	 Reifungsprozess	 unerlässlich.	 Für	 unsere	Studie	 haben	 wir	 zwei	 Spender,	 welche	 ungleich	 waren	 bezüglich	 ihrer	 KIR-Liganden	Ausstattung,	 in	 einzelne	 Empfängermäuse	 transplantiert.	 Immunzellen	 beider	 Spender	wuchsen	 in	 ähnlichen	 Frequenzen	 in	 den	 Tieren	 an	 und	 konnten	 über	 den	 gewählten		Beobachtungszeitraum	 miteinander	 koexistieren.	 Das	 KIR	 Repertoire	 der	rekonstituierten	NK	Zellen	veränderte	sich	weder	im	Normalzustand	noch	während	einer	experimentellen	Epstein	Barr	Virus	(EBV)-Infektion	im	Vergleich	zum	KIR	Repertoire	der	NK	Zellen	des	Spenders,	sondern	blieb	sehr	divers,	wie	es	in	Neugeborenen	zu	finden	ist.	Des	Weiteren	konnten	wir	 eindeutig	belegen,	dass	 in	unserem	Modell	die	Anwesenheit	von	fremden	HLA	Liganden	den	Prozess	der	NK	Zell	Erziehung	aufhebt.	Dies	würde	gegen	das	 sogenannte	Bewaffnungsmodel	 sprechen	und	 für	 eine	 als	Entwaffnung	bezeichnete	Hypothese.	Weiterhin	konnten	wir	beobachten,	dass	NK	Zellen,	welche	nicht	durch	den	Erziehungsprozess	gegangen	sind,	trotzdem	noch	körpereigene	Zellen	erkennen	konnten	und	 diese	 entsprechend	 nicht	 angreifen.	 Ferner	 konnten	 wir	 feststellen,	 dass	 EBV	infizierte	Tiere,	welche	mit	zwei	Spendern	transplantiert	waren,	niedrigere	virale	Lasten	hatten.	Dies	könnte	darauf	hinweisen,	dass	die	nicht-erzogenen	NK	Zellen	wesentlich	an	der	Immunantwort	gegen	EBV	beteiligt	sind,	ähnlich	wie	es	bereits	für	die	Infektion	mit	murinem	 Zytomegalovirus	 gezeigt	 wurde.	 Nachdem	 wir	 die	 NK	 Zellen	 in	 den	 Tieren	depletiert	haben,	hob	sich	der	beobachtete	Effekt	der	doppelten	Transplantation,	vor	EBV	zu	schützen,	wieder	auf,	was	unsere	Theorie	bekräftigt.	Diese	Studie	hat	demzufolge	neue	
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Erkenntnisse	 dazu	 erbracht,	 wie	 sich	 NK	 Zellen	 in	 einem	 veränderten	 HLA	 Umfeld	entwickeln	und	welche	funktionellen	Konsequenzen	dies	ergibt.	Im	 Mittelpunkt	 des	 zweiten	 Projekt	 stand	 die	 Beihilfe	 der	 plasmazytoiden	dendritischen	 Zelle	 (DZ)	 für	 NK	 Zellen.	 Vorangehende	 Daten	 haben	 gezeigt,	 dass	konventionelle	 DZs	 eine	 sogenannte	 regulatorische	 Synapse	 mit	 NK	 Zellen	 eingehen,	weshalb	wir	 in	 dieser	 Studie	nun	 auch	die	Rolle	 und	 Strukturen	der	 Synapse	 zwischen	plasmazytoiden	 DZs	 und	 NK	 Zellen	 besser	 verstehen	 lernen	 wollten.	Wir	 fanden,	 dass	Rezeptoren	 und	 Aktin	 zur	 Synapse	 hin	 polarisieren	 und	 die	 Interaktion	 zwischen	 den	Zellen	 stabilisieren.	 Zudem	 konnten	 wir	 zeigen,	 dass	 phosphorylierte	 STAT	 Proteine	ebenfalls	an	der	Synapse	angereichert	waren,	was	darauf	hinweist,	dass	es	sich	um	eine	aktivierende	 Synapse	 handelt.	 Ferner	 konnten	 wir	 bestätigen,	 dass	 eine	 Interaktion	zwischen	 den	 beiden	 Zellpopulationen	 zur	 Aktivierung	 und	 Hochregulation	 von	Zytotoxizität	 in	 den	 NK	 Zellen	 führte.	 Obwohl	 die	 Synapse	 alle	 Kennzeichen	 einer	zytotoxischen	 Synapse	 vorwies,	 wurden	 die	 plasmazytoiden	 DZs	 interessanterweise	nicht	 angegriffen.	 	 NK	 Zellen	 scheinen	 also	 imstande	 zu	 sein	 eine	 einzigartige	immunologische	Synapse	mit	plasmazytoiden	DZs	einzugehen.	
Summary	
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1.2	Summary		Natural	killer	(NK)	cells	are	an	instrumental	part	of	the	human	innate	immune	response.	Their	intervention	at	the	primary	stages	of	viral	infections	as	well	as	detection	of	altered-self	makes	them	an	efficient	first	line	of	defense.	Moreover,	current	studies	have	started	to	highlight	their	contribution	not	only	as	early	responders	but	also	as	long-lived	memory	cells.	 Therefore,	 understanding	 the	details	 of	NK	 cell	 biology	 is	 of	 growing	 importance.	One	 of	 the	 poorly	 understood	 developmental	 aspects	 in	 human	 NK	 cell	 biology	 is	 the	impact	and	manner	of	the	interaction	of	killer	cell	immunoglobulin-like	receptors	(KIRs)	with	 their	 ligands,	 HLA	 class	 I	molecules,	 in	 shaping	 the	 KIR	 repertoire	 itself	 and	 also	during	the	process	of	NK	cell	education.	In	a	first	study	that	aimed	to	understand	the	influence	of	HLA	haplotypes	on	NK	cell	development	and	repertoire	diversity	we	fashioned	a	novel	humanized	mouse	model	by	 co-reconstituting	 two	 KIR-ligand	mismatched	 donors	 into	 a	 single	mouse	 recipient.	We	 found	 that	 both	 compartments	 were	 adept	 at	 engrafting	 the	 animals	 at	 equal	frequencies	and	persisted	side-by-side.	Furthermore,	as	compared	to	the	KIR	repertoire	found	in	the	donor(s),	neither	in	steady	state	nor	under	Epstein	Barr	virus	(EBV)-induced	inflammatory	 conditions	 were	 there	 any	 alterations	 to	 the	 KIR	 repertoire	 which	remained	 extremely	 diverse,	 as	 found	 in	 human	 neonates.	 Moreover,	 we	 were	 able	 to	show	that	 the	presence	of	non-cognate	HLA	completely	abolishes	education	of	NK	cells,	thus	 arguing	 in	 favor	 of	 the	 disarming	 hypothesis.	 Additionally,	 we	 demonstrated	 that	loss	 of	 education	 does	 not	 impair	 the	 NK	 cell’s	 ability	 to	 discriminate	 self,	 i.e.	 non-educated	 NK	 cells	 downregulate	 cytotoxicity	 when	 KIRs	 get	 engaged	 by	 self	 HLA.		Interestingly,	we	observed	lower	viral	burdens	in	co-reconstituted	animals,	which	could	point	towards	a	possible	involvement	of	non-educated	human	NK	cells	in	controlling	EBV	infection,	 as	 has	 been	 shown	 for	 murine	 cytomegalovirus	 (MCMV).	 This	 theory	 was	further	 supported	by	data	 from	co-reconstituted	animals	 that	had	been	depleted	of	NK	cells	 and	 concomitantly	 lost	 their	 protection	 from	 EBV.	 Thus,	 this	 study	 has	 provided	novel	 insights	 into	 the	 development	 and	 function	 of	 NK	 cells	 under	 the	 influence	 of	mismatched	HLA.	The	 second	project	 focused	on	 the	 role	 of	 plasmacytoid	dendritic	 cells	 (DCs)	 as	accessory	 cells	 in	NK	 cell-mediated	 immune	 response.	 	 As	NK	 cells	 had	been	 shown	 to	form	 distinct	 regulatory	 synapses	with	 conventional	 DCs,	 we	 investigated	 the	 function	and	structure	of	the	synapse	between	plasmacytoid	DCs	and	NK	cells.	Our	results	showed	
Summary	
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that	polarization	of	receptors	as	well	as	actin	takes	place,	thus	stabilizing	the	interaction	between	 the	 cells.	 In	 addition	 we	 were	 able	 to	 demonstrate	 accumulation	 of	phosphorylated	STAT	proteins	at	the	synapse,	which	points	toward	an	activating	nature	of	 the	 synapse.	 We	 confirmed	 that	 the	 interaction	 leads	 to	 activation	 as	 well	 as	upregulation	of	cytotoxicity	in	NK	cells.	Intriguingly,	although	the	synapse	showed	all	the	hallmarks	of	a	cytotoxic	synapse,	plasmacytoid	DCs	were	not	killed.	Hence,	NK	cells	seem	capable	of	forming	a	unique	type	of	immunological	synapse	with	plasmacytoid	DCs.	
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PART	I–	HUMAN	IMMUNE	SYSTEM		The	 human	 immune	 system	 is	 made	 up	 of	 various	 cell	 populations	 that	 in	 a	 complex	interplay	 jointly	protect	us	 from	pathogens	and	 transformed	cells.	The	 two	branches	of	the	 immune	 system	 are	 separated	 into	 innate	 and	 adaptive	 arms.	 The	 innate	 immune	system	encompasses	defense	mechanisms	 that	 are	 broadly	 specific	 and	 encoded	 in	 the	host’s	germ	line.	These	are	for	instance	physical	barriers	such	as	the	mucosal	tissue	lining	our	airways	and	gut,	or	secreted	bioactive	small	molecules.	In	addition,	the	first	response	is	 aided	 by	 a	 number	 of	 innate	 leukocytes,	which	 include	macrophages,	 dendritic	 cells,	granulocytes	 and	 innate	 lymphoid	 cells.	 These	 cells	 possess	 receptors	 on	 their	 surface,	which	are	able	to	recognize	specific	molecular	patterns	in	their	environment.	In	contrast,	T-	and	B-lymphocytes,	which	comprise	 the	adaptive	 immune	system,	express	 receptors	highly	 specific	 toward	 the	 antigen	 they	 recognize.	 This	 collection	 of	 receptors	 is	generated	by	somatic	gene	rearrangement	and	hypermutation,	permitting	the	formation	of	millions	of	different	antigen	receptors,	each	with	a	unique	specificity.	Furthermore,	it	has	been	well	established	that	the	lymphocytes	of	the	adaptive	immune	system	are	able	to	 form	 a	 durable	 pool	 of	memory	 cells,	 which	 allow	 for	 improved	 response	 time	 and	magnitude	when	antigens	are	encountered	repeatedly.	Although	the	innate	and	adaptive	immune	systems	are	often	described	as	two	separate	arms	of	the	host	response,	in	reality	they	 work	 together	 to	 achieve	 a	 comprehensive	 immune	 response	 with	 the	 innate	immune	system	in	charge	of	the	initial	defense	as	well	as	guiding	the	adaptive	response	which	catches	on	 later	after	 the	antigen-specific	cells	have	undergone	clonal	expansion.	Thus,	a	synergy	between	them	is	essential	for	the	host	to	mount	a	fully	effective	immune	response	(Chaplin,	2010).		
PART	II–	NATURAL	KILLER	CELLS	
	Natural	 Killer	 (NK)	 cells	 are	 the	 prototypic	 innate	 lymphoid	 cell,	 and	 were	 first	discovered	 in	 the	 mouse	 as	 lymphocytes	 that	 were	 able	 to	 spontaneously	 lyse	transformed	cells	 (Kiessling	et	al.,	1975).	Soon	after	 the	same	observation	was	made	 in	humans,	 where	 the	 T	 cell-depleted	 fraction	 of	 lymphocytes	 isolated	 from	 peripheral	blood	was	incubated	with	human	and	xenogeneic	cell	 lines.	Lysis	of	the	target	cells	was	observed,	and	the	process	was	termed	spontaneous	lymphocyte-mediated	cytotoxicity	at	
Introduction	
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the	 time	 (Jondal	 &	 Pross,	 1975;	 Pross	 &	 Jondal,	 1975).	 At	 this	 point,	 it	 was	 already	apparent	that	 the	human	cell	 line	K562,	originally	 isolated	from	a	chronic	myelogenous	leukemia	patient,	constituted	a	good	NK	cell	target	(Lozzio	and	Lozzio,	1975).	Only	later	though	would	it	become	clear,	that	the	lack	of	MHC	class	I	expression	and	upregulation	of	stress	 ligands	 on	 their	 cell	 surface,	was	what	made	 them	 such	 highly	 sensitive	 in	vitro	targets	 (Drew	 et	 al.,	 1977;	 Saksela	 et	 al.,	 1979).	 In	 an	 effort	 to	 characterize	 these	mysterious	 cytotoxicity-mediating	 lymphocytes,	 a	 number	 of	 isolation	 methods	 and	culturing	 techniques	 were	 tested.	 With	 the	 results	 obtained	 from	 these	 trials,	 it	 was	evident	that	these	lymphocytes	did	not	match	any	of	the	populations	known	at	the	time	and	 they	 were	 termed	 N-cells	 (Herberman	 et	 al.,	 1975b).	 Further	 work	 demonstrated	their	involvement	not	only	in	targeting	transformed	cells,	but	also	in	responding	to	viral	infections	(Trinchieri	and	Santoli,	1978).	This	ability	to	rapidly	counter	viral	infections	as	well	 as	 efficiently	 eradicate	 transformed	 cells,	 in	 short	 to	 naturally	 kill	 targets,	 is	what	finally	gave	them	their	name	as	natural	killer	cells.	Several	 ligand-receptor	 interactions	 can	 trigger	 NK	 cell	 activation,	 mostly	combinations	 thereof	 (Long	 et	 al.,	 2013),	 such	 as	 lack	 of	 MHC	 class	 I	 interaction	 with	inhibitory	receptors,	binding	of	NKG2D	to	its	various	ligands,	DNAM-1	recognition	of	PVR	and	Nectin-2	or	antibody-dependent	cell-mediated	cytotoxicity	 (ADCC).	 In	 fact,	NK	cells	are	the	main	mediators	of	ADCC,	a	process	where	infected	cells	are	opsonized	by	specific	antibodies	that	bind	to	the	antigens	expressed	on	their	surface.		The	CD16	receptor	on	NK	cells	is	subsequently	able	to	recognize	the	Fc	part	of	these	antibodies	and	initiate	killing.	To	induce	target	cell	lysis,	NK	cells	take	advantage	of	cytotoxic	proteins,	which	are	stored	within	 specialized	 secretory	 lysosomes	 also	 termed	 lytic	 granules.	 The	 abundantly	present	 cytotoxic	proteins	within	 secretory	 lysosomes	are	 the	 granzymes	and	perforin.	Once	 the	 NK	 cell	 receives	 the	 signal	 to	 kill,	 it	 initiates	 exocytosis	 and	 release	 of	 the	cytotoxic	 granules	 across	 the	 immunologic	 synapse,	 thus	 limiting	 the	 spread	 of	 the	cytotoxic	 effector	 proteins.	 In	 this	 process	 the	 cytotoxic	 proteins	 work	 together	 to	facilitate	killing	of	the	target.	Perforin	mediates	the	formation	of	pores	thus	enabling	the	entry	of	granzymes	 that	cleave	a	variety	of	 targets	 in	 the	cytoplasm,	 finally	 resulting	 in	cell	death	(Topham	&	Hewitt,	2009).	However,	in	order	to	be	able	to	elicit	their	effector	functions,	NK	 cells	 need	 to	 undergo	 the	 additional	 developmental	 process	 of	 education	allowing	 them	 to	 tune	 their	 reactivity	 in	 a	 way	 that	 they	 are	 non-reactive	 to	 self	 and	specifically	detect	transformed	cells.	
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2.1	Receptors	Shaping	NK	Cell	Biology		For	NK	cells,	diversity	and	specificity	does	not	arise	from	a	single	polymorphic	receptor	but	rather	emerges	 from	the	 large	variety	of	receptors	many	of	which	are	differentially	expressed	 on	 individual	 NK	 cells	 (Figure	 1).	 Since	 NK	 cells	 lack	 the	 degree	 of	 antigen	specificity	other	 lymphocytes	possess,	 they	 rely	on	a	 series	of	 activating	and	 inhibitory	receptors	to	regulate	their	immune	responses	towards	targets.	Unlike	T	and	B	cells,	they	are	 unable	 to	 achieve	 diversity	 of	 their	 receptors	 by	 somatic	 gene	 rearrangement.	However,	some	level	of	flexibility	has	been	achieved	through	the	rapid	genetic	evolution	of	 the	 NK	 cell	 recognition	 receptor	 families	 as	 well	 as	 promiscuity	 of	 ligand	 binding	(McQueen	 &	 Parham,	 2002).	 There	 are	 three	major	 families	 of	 NK	 cell	 receptors	 -	 the	KIRs,	NKG2s	and	NCRs.	Together	with	other	receptors	on	the	surface	of	NK	cells,	they	all	contribute	to	balance	the	immune	response	of	NK	cells.			
		
	
	
Figure	1.	Adapted	from	key	receptors	on	human	NK	cells	(“NK	cells:	receptors	and	functions,”	2010)			
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2.1.1	Killer	Immunoglobulin-like	Receptors		Killer	 immunoglobulin-like	 receptors	 (KIRs)	 evolved	 from	 the	 immunoglobulin-superfamily	 (Ig-superfamily)	 and	 are	 built-up	 of	 type	 1	 transmembrane	 glycoproteins	with	two	or	three	Ig-like	domains	(Colonna	&	Samaridis,	1995;	Wagtmann	et	al.,	1995).	Their	 nomenclature	 is	 based	 on	 the	 number	 of	 extracellular	 Ig-domains	 (KIR2D	 or	KIR3D)	 and	 on	 an	 either	 long	 (L)	 or	 short	 (S)	 cytoplasmic	 tail	 (E.	 O.	 Long,	 Colonna,	 &	Lanier,	 1996).	 The	 KIR	 family	 comprises	 both	 activating	 (short	 cytoplasmic	 tail)	 and	inhibitory	 (long)	 receptors	 that	 signal	 through	 association	 with	 DAP-12	 via	 its	immunoreceptor	 tyrosine-based	 activation	 motif	 (ITAM)	 or	 through	 their	 own	immunoreceptor	 tyrosine-based	 inhibition	 motif	 (ITIM),	 respectively	 (Burshtyn	 et	 al.,	1996;	Campbell,	Dessing,	López-Botet,	Cella,	&	Colonna,	1996;	Lanier,	1998).	As	the	KIR	repertoire	 for	 each	 individual	 is	 unique,	 the	 interplay	 of	 activating	 and	 inhibitory	KIRs	can	 be	 of	 importance	 in	 a	 person’s	 immune	 response.	 Thus,	 KIR	 activating	 genes	 are	commonly	 associated	 with	 increased	 susceptibility	 to	 autoimmunity	 and	 protection	against	infection	while	inhibitory	genes	have	been	mainly	implicated	in	the	opposite,	i.e.	susceptibility	 to	 infection	 and	 protection	 against	 autoimmunity	 (Augusto,	 Lobo-Alves,	Melo,	 Pereira,	 &	 Petzl-Erler,	 2012).	 Moreover,	 the	 KIR	 haplotype	 of	 an	 individual	 can	contribute	 beneficially	 to	NK	 cell	 immunity	 or	 reproductive	 fitness	 as	 discussed	 below	(Khakoo	et	al.,	2004;	Parham	&	Moffett,	2013).		
	
Figure	2.	Humans	KIRs	recognize	four	epitopes	of	HLA-A,	HLA-B	and	HLA-C	(Parham	&	Moffett,	2013)		KIRs,	like	their	classic	MHC	class	I	ligands	which	are	also	called	human	leukocyte	antigens	 (HLAs),	are	encoded	by	a	genetic	complex	 located	on	chromosome	19,	 termed	leukocyte	receptor	complex	(LRC)	(Kelley,	Walter,	&	Trowsdale,	2005;	M.	J.	Wilson	et	al.,	2000).	 There	 are	 13	 expressed	 KIR	 genes	 and	 two	 KIR	 pseudogenes	 encoding	 for	dedicated	 activating	 receptors	 KIR2DS1,	 2,	 3,	 4,	 5	 and	 inhibitory	 receptors	 KIR2DL1,	
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2DL2/3	and	2DL5	 (Figure	2).	 In	addition,	 exceptional	 receptors,	 such	as	KIR2DL4	have	the	potential	 to	be	both	 activating	 and	 inhibitory,	while	KIR3DL1/S1	has	 two	mutually	exclusive	 subsets	 of	 allotypes	 that	 allows	 it	 to	 have	 either	 activating	 or	 inhibitory	functions	(Campbell	&	Purdy,	2011).	The	 repertoire	 of	 KIR	 genes	 expressed	 within	 one	 individual	 defines	 a	 KIR	haplotype	which	differs	on	the	basis	of	KIR	gene	content	at	the	KIR	locus	(Pyo	et	al.,	2010;	Uhrberg	et	al.,	1997).	Three	conserved	genes	(KIR3DL3,	2DL4	and	3DL2)	are	common	to	all	haplotypes	and	pinpoint	two	regions	of	gene-content	diversity	in	the	centromeric	and	telomeric	part	of	the	locus	(A.	M.	Martin	et	al.,	2004).	KIR	haplotypes	are	divided	into	two	groups;	the	A	haplotype	which	is	enriched	for	 inhibitory	KIRs	that	bind	HLA	class	I	and	only	expresses	one	activating	gene	(KIR2DS4)	and	the	B	haplotype	that	is	characterized	by	 activating	 and	 inhibitory	KIRs	 of	which	 some	 have	 lost	 or	 lack	 the	 capacity	 to	 bind	HLA	(Uhrberg,	Parham,	&	Wernet,	2002;	M.	 J.	Wilson	et	 al.,	2000).	Some	receptors	 that	are	common	to	both	haplotypes	show	functional	differences	between	allotypes	of	 the	A	and	 B	 KIR	 haplotypes	 (Bari	 et	 al.,	 2009).	 One	 particularly	 good	 example	 is	 the	KIR3DL1/DS1	gene,	which	 in	 its	 inhibitory	 form	 in	A	haplotype	binds	 the	Bw4	epitope,	whereas	 B	 haplotype	 KIR3DS1	 does	 not	 (Parham,	 Norman,	 Abi-Rached,	 &	 Guethlein,	2011).	 Diversity	 of	KIR	 genes	 is	 achieved	by	unusual	 presence/absence	polymorphism	and	reciprocal	combination	between	the	central	region	of	the	KIR	locus	3DP1	and	2DL4	(Figure	 2)	 (Uhrberg	 et	 al.,	 1997).	 This	 recombination	 allows	 re-shuffling	 of	 the	centromeric	and	telomeric	gene-content	motifs	resulting	in	haplotypes	that	combine	an	A	haplotype	with	 a	 B	 haplotype.	 	 Conventionally	 any	 such	 recombinant	 haplotypes	 have	been	 termed	 B	 haplotypes,	 reserving	 the	 term	 A	 haplotype	 for	 haplotypes	 entirely	consisting	of	A	motifs	(Hsu	et	al.,	2002;	Pyo	et	al.,	2010).	Moreover,	allelic	variants	of	KIR	genes	influence	the	expression	levels	and	patterns	of	KIRs,	giving	rise	to	different	NK	cell	populations	 that	 express	 multiple	 different	 assortments	 of	 KIRs	 (Gardiner,	 2008).	Surprisingly,	the	mechanism	by	which	NK	cells	decide	what	KIRs	are	expressed	on	their	surface	 is	 still	 elusive.	However,	 it	has	been	observed	 that	 the	overall	KIR	repertoire	 is	determined	by	the	KIR	genotype	and	expression	is	regulated	by	methylation	of	KIR	gene	loci	 (Chan	 et	 al.,	 2003;	 Yawata	 et	 al.,	 2006).	 	 Furthermore,	 some	 studies	 have	 found	evidence	that	expression	of	HLA	class	I	is	able	to	subtly	modulate	KIR	expression	as	well	(Shilling	 et	 al.,	 2002;	 Sleiman	 et	 al.,	 2014).	 In	 addition,	 evidence	 suggests	 that	 the	 KIR	repertoire	 can	 be	 significantly	 skewed	 by	 exposure	 to	 pathogens,	 as	 in	 HCMV-seropositive	 donors	 compared	 to	 HCMV-negative	 individuals	 (Béziat	 et	 al.,	 2013;	
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Schönberg	et	al.,	2011).	Thus	several	mechanisms	ensure	the	formation	of	a	diverse	NK	cell	pool	that	can	interact	with	its	environment. MHC	class	I	binding	is	one	way	that	NK	cells	can	survey	their	surroundings.	The	genetic	 complex	 encoding	 MHC	 class	 I	 members,	 called	 HLA	 complex	 and	 located	 on	chromosome	 6,	 is	 the	 most	 highly	 polymorphic	 segment	 of	 the	 human	 genome	 (1000	Genomes	Project	Consortium	et	al.,	2010;	Robinson,	Mistry,	McWilliam,	Lopez,	&	Marsh,	2010).	 	Classical	HLA	class	I	 ligands	are	expressed	on	the	surface	of	nucleated	cells	and	consist	 of	 an	 alpha	 chain	with	 three	 extracellular	 domains	 (α1,	 α2	 and	 α3)	 and	 beta-2	microglobulin		(Figure	3).	Their	key	function	is	to	present	peptide	fragments	to	immune	cells,	 which	 they	 bind	 in	 a	 groove	 formed	 by	 the	 α1	 and	 α2	 domains	{Rammensee:1993eo}.	Within	 the	 family	 of	 HLA	 class	 I	 genes,	 HLA-A,	 -B,	 -C	 are	 highly	polymorphic	while	HLA-E,	-F,	-G	are	more	conserved.	Some	KIRs	bind	to	members	of	the	first	group,	and	HLA-E	interacts	with	the	NKG2A/C	receptors	(see	below),	while	HLA-G	is	implicated	in	mediating	NK	cell	functions	during	early	pregnancy	by	binding	to	KIR2DL4	(Lash,	 Robson,	 &	 Bulmer,	 2010).	 Only	 HLA-F	 remains	 enigmatic,	 possibly	 acting	 as	 a	chaperone	that	retrieves	unfolded	HLA	class	I	molecules	from	the	plasma	membrane	and	escorts	them	inside	the	cell	(Goodridge,	Burian,	Lee,	&	Geraghty,	2010). 
 
	
Figure	3.	Interaction	of	KIR	with	their	known	HLA	ligands	(Augusto	&	Petzl-Erler,	2015)	
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Structural	studies	have	shown	that	KIRs	which	bind	to	HLA	do	so	at	the	peptide-binding	 region,	 and	 thus	have	 an	 overlapping	binding	 site	with	 the	 αβ	T	 cell	 receptors	(TCR)	 (Boyington	&	 Sun,	 2002).	 Competition	between	KIR	 and	αβ	TCR	 could	 therefore	influence	the	selection	pressure	on	HLA	class	I;	i.e.	HLA	class	I	variants	selected	for	their	beneficial	T	cell	 response	against	one	 infection	might	 induce	unfavorable	consequences	for	the	NK	cell	response	towards	another	pathogen,	and	vice	versa.	However	this	issue	is	likely	overcome	since	KIRs	only	bind	a	fraction	of	the	HLA-A,	-B	and	-C	variants.	Hence,	while	all	HLA-C	allotypes	have	either	 the	C1	or	C2	epitope	and	are	all	KIR	 ligands,	only	30-40%	 of	 the	 HLA-A	 and	 HLA-B	 allotypes	 can	 be	 bound	 by	 KIRs	 (Gonzalez-Galarza,	Christmas,	Middleton,	&	Jones,	2011;	Older	Aguilar	et	al.,	2010;	Older	Aguilar,	Guethlein,	Hermes,	Walter,	&	Parham,	2011).	Therefore,	the	majority	of	HLA-A	and	HLA-B	allotypes	are	not	KIR	ligands	and	are	free	to	evolve	exclusively	under	pressure	from	the	TCRs.	Although	KIR-HLA	interactions	are	one	of	the	central	receptor-ligand	cross-talks	shaping	 NK	 cell	 biology,	 not	 all	 KIRs	 bind	 HLA.	 Only	 some	 of	 the	 13	 KIRs	 actually	recognize	HLA:			
KIR	receptor	 HLA	class	I	ligand	 Reference	
KIR3DL2	 A3/A11	 (Döhring,	Scheidegger,	Samaridis,	Cella,	&	Colonna,	1996)	
KIR3DL1	(but	not	KIR3DS1)	 Bw4	 (Carr	et	al.,	2007;	Cella,	Longo,	Ferrara,	Strominger,	&	Colonna,	1994)	KIR2DL1	and	DS1	 C2	 (Biassoni	et	al.,	1997)	KIR2DL2/3	 C1	and	C2	low	affinity	 (Pende	et	al.,	2009)	KIR2DS4	 C1,	C2	and	A11	 (Graef	et	al.,	2009)	
KIR2DS2	 A11	 (J.	Liu,	Xiao,	Ko,	Shen,	&	Ren,	2014)	
Table	1.	KIR	receptors	and	their	respective	HLA	ligands		For	 the	 remaining	 KIR2DS3,	 2DS5,	 2DL5,	 3DS1,	 3DL3,	 2DP1	 and	 3DP1,	 the	 so-called	 orphan	 receptors,	 no	 ligands	 have	 been	 identified	 yet.	 To	 determine	 the	unexplained	functional	benefits	of	orphan	KIRs,	studies	were	done	assessing	KIR	genes	in	various	 populations	 (Gonzalez-Galarza	 et	 al.,	 2011).	 All	 KIR	 genes	were	 represented	 at	
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significant	 frequencies	 across	 all	 populations,	 implying	 that	 orphan	 KIRs	 must	 serve	some	 purpose	 that	 might	 not	 necessarily	 involve	 interaction	 with	 HLA	 class	 I.	 One	example	of	a	possible	alternative	pathway	for	the	orphan	KIRs	is	KIR3DL2,	which	on	top	of	 binding	 HLA-A3/A11	 can	 also	 recognize	 microbial	 products	 such	 as	 CpG	oligodeoxynucleotides	 (ODN).	 The	 presence	 of	 CpG	 ODN	 leads	 to	 downregulation	 of	KIR3DL2	 from	 the	 cell	 surface	 and	 co-internalization	 of	 the	 bound	 product,	 making	 it	accessible	 to	Toll-like	 receptors	 (TLRs)	 in	 early	 endosomes	 (Sivori	 et	 al.,	 2010a;	 Sivori,	Falco,	Moretta,	&	Moretta,	2010b). For	some	KIR-HLA	interactions,	peptide	sensitivity	additionally	plays	a	role	in	KIR	binding.	KIR3DL2	serves	as	an	example	that	was	so	far	only	found	to	be	able	to	bind	HLA-A3	or	-A11	if	a	peptide	fragment	derived	from	Epstein-Barr	virus	(EBV)	is	present	in	the	peptide-binding	groove	(Hansasuta	et	al.,	2004).	In	comparison,	HLA-C-specific	KIRs	are	less	 selective	 and	 are	 compatible	with	 around	 40%	 of	 all	 peptides	 that	 bind	 to	 HLA-C	(Fadda	 et	 al.,	 2010;	 Mandelboim,	 Wilson,	 Valés-Gómez,	 Reyburn,	 &	 Strominger,	 1997;	Rajagopalan	&	Long,	1997;	Zappacosta,	Borrego,	Brooks,	Parker,	&	Coligan,	1997).		In	an	attempt	to	better	understand	the	evolution	of	KIRs,	several	studies	worked	on	 characterizing	 KIR	 genes	 in	 simian	 primates	 such	 as	 chimpanzees.	 As	 our	 close	ancestor,	many	elements	of	the	KIR	locus	are	similar	to	humans	(Khakoo	et	al.,	2000).	Yet	some	of	the	most	striking	differences	are	that	all	their	variable	gene	content	is	located	in	the	 centromeric	 region	 of	 the	KIR	 gene	 locus	 and	 that	 chimpanzees	 only	 have	 one	KIR	haplotype	 (Abi-Rached,	Moesta,	 Rajalingam,	 Guethlein,	 &	 Parham,	 2010).	 Furthermore,	most	NK	cell	receptors	of	chimpanzees	are	HLA-C	receptors	that	preferentially	bind	HLA-C2	(Moesta,	Abi-Rached,	Norman,	&	Parham,	2009;	Moesta	et	al.,	2010).	This	makes	their	system	more	 robust	 compared	 to	 humans,	where	 only	 half	 of	 the	 receptors	 even	 bind	HLA	 class	 I.	 In	 addition,	 humans	 developed	 two	 haplotypes	 of	 which	 the	 A	 haplotype	resembles	the	one	found	in	their	ancestor	while	the	B	haplotype	has	accumulated	genes	that	encode	KIRs	with	a	reduced	or	lacking	ability	to	bind	HLA	class	I	(Parham,	Norman,	Abi-Rached,	&	Guethlein,	2012). The	discrepancy	found	in	the	human	KIR	haplotypes	in	mediating	immunity	may	well	 be	 ascribed	 to	 the	 role	 that	 NK	 cells	 and	 KIR	 receptors	 play	 during	 pregnancy.	Complications	 during	 pregnancy	 such	 as	 preeclampsia,	 spontaneous	 abortion	 and	 fetal	growth	restriction	are	linked	to	cases	where	the	mother	is	homozygous	for	group	A	KIR	haplotypes	 and	 the	 fetus	 expresses	 HLA-C2	 (Hiby	 et	 al.,	 2008;	 2004).	 Interactions	between	the	fetal	C2	on	extravillous	trophoblast	cells	(EVTs)	and	maternal	KIR2DL1	on	
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uterine	 NK	 cells	 are	 therefore	 the	 likely	 cause	 for	 spontaneous	 abortion.	 Accordingly,	expression	of	the	activating	KIR2DS1	in	maternal	B	KIR	haplotypes	is	protective	against	these	 complications,	 allowing	 EVTs	 to	 successfully	 mediate	 placentation	 (Hiby	 et	 al.,	2010).	 In	 line	 with	 these	 findings,	 the	 frequencies	 of	 C2	 and	 group	 A	 KIR	 haplotypes	within	 a	 population	 are	 inversely	 correlated	 to	 each	 other	 (Parham	 et	 al.,	 2012).	 As	 a	result,	pressure	from	human	reproduction	might	have	driven	the	evolution	of	the	B	KIR	haplotype	 to	attenuate	 such	 interactions	during	 fetal	development.	However,	 the	KIR	A	haplotype	is	still	vitally	important	as	evidence	points	to	it	being	involved	in	the	defense	against	 infections.	This	 is	 exemplified	by	KIR3DL2/3	 interaction	with	HLA-C1	 inferring	protection	during	HCV	infection	or	in	HIV	where	certain	allelic	combinations	of	KIR3DL1	and	HLA-B	can	influence	the	disease	progression	and	outcome	(Khakoo	et	al.,	2004;	M.	P.	Martin	 et	 al.,	 2007).	 Thus	 in	 summary,	 the	 human	 KIR	 system	 has	 evolved	 to	accommodate	immunity	against	pathologies	as	well	as	reproductive	fitness.			
2.1.2	CD94–NKG2	heterodimer	receptors	and	NKG2D		The	CD94-NKG2A/B/C/E	heterodimers	are	part	of	 the	C-type	 lectin	 family	of	receptors.		They	 are	 specialized	 to	 recognize	 the	non-classical	MHC	 class	 I	molecule	HLA-E	on	 the	surface	of	potential	targets	(Borrego,	Ulbrecht,	Weiss,	Coligan,	&	Brooks,	1998;	Braud	et	al.,	1998;	Lieto,	Maasho,	West,	Borrego,	&	Coligan,	2006)	and	their	expression	levels	are	modulated	by	the	secretion	of	cytokines	in	their	surrounding	(Bertone	et	al.,	1999;	Derre	et	 al.,	 2002;	Mingari	 et	 al.,	 1998).	 The	 ubiquitously	 found	 HLA-E	 is	 capable	 of	 binding	peptides	derived	 from	 the	 leader	 sequence	of	 classical	MHC	 class	 I	molecules	 and	 thus	presents	a	reflection	of	classical	MHC	class	I	molecules	expressed	on	the	cell	(Borrego	et	al.,	1998;	N.	Lee,	Goodlett,	Ishitani,	Marquardt,	&	Geraghty,	1998).	Highly	specific	binding	of	 HLA-E	 through	 the	 CD94-NKG2	 heterodimer	 therefore	 allows	 NK	 cells	 to	 indirectly	monitor	 the	 expression	 of	 MHC	 class	 I	 on	 the	 target	 cell	 (Braud,	 Jones,	 &	 McMichael,	1997).	 Similar	 to	 the	 KIRs,	 the	 family	 of	 CD94-NKG2	 receptors	 also	 has	 activating	 and	inhibitory	receptors.	CD94-NKG2C	and	CD94-NKG2E	have	been	shown	to	associate	with	DAP-12	and	are	thought	to	be	activating	receptors	(Borrego	et	al.,	1998;	Lanier,	Corliss,	Wu,	&	Phillips,	1998),	while	 ITIM-containing	CD94–NKG2A	and	CD94–NKG2B	receptors	are	 inhibitory	 (Carretero	 et	 al.,	 1997;	 Lieto	 et	 al.,	 2006;	 Palmieri	 et	 al.,	 1999).	 As	 a	surrogate	 of	 function,	 expression	 of	 NKG2C	 has	 been	 implicated	 in	memory	 formation	(Gumá	 et	 al.,	 2004)	while	 NKG2A	 surface	 expression	 seems	 to	 delineate	 a	 progression	
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from	 early	 differentiation	 to	 late	 differentiation	 (Béziat,	 Descours,	 Parizot,	 Debré,	 &	Vieillard,	2010).	Although	the	NKG2D	receptor	shares	the	same	nomenclature	as	the	CD94-NKG2	heterodimers,	its	function	and	structure	are	distinct.	NKG2D	receptors	recognize	stressed	cells	 and	 are	 therefore	 important	 for	 NK	 cell-mediated	 control	 of	 transformed	 cells	 or	cells	 under	 viral	 pressure	 (Champsaur	 &	 Lanier,	 2010).	 In	 contrast	 to	 the	 rest	 of	 its	family,	 NKG2D	 does	 not	 form	 a	 heterodimer	 with	 CD94,	 but	 rather	 is	 expressed	 as	 a	homodimer,	 which	 signals	 through	 the	 DAP-10	 or	 DAP-12	 molecules	 (S.	 Bauer	 et	 al.,	1999b;	 J.	 Wu	 et	 al.,	 1999).	 In	 humans,	 only	 the	 long	 isoform	 of	 NKG2D	 exists,	 which	associates	with	 four	DAP-10	chains	 to	 induce	both	perforin-dependent	 cytotoxicity	and	cytokine-mediated	responses	(Billadeau,	Upshaw,	Schoon,	Dick,	&	Leibson,	2003;	Garrity,	Call,	Feng,	&	Wucherpfennig,	2005;	Hayakawa	et	al.,	2002;	J.	Wu	et	al.,	1999).	Ligands	of	NKG2D	include	the	MHC	class	I-like	transmembrane	proteins	MIC-A,	MIC-B	and	ULBP4	as	well	as	the	GPI-anchored	proteins	ULBP1-3	(S.	Bauer	et	al.,	1999b;	Chalupny,	Sutherland,	Lawrence,	Rein-Weston,	&	Cosman,	2003;	Cosman	et	al.,	2001).	None	of	these	ligands	are	expressed	 on	 healthy	 cells,	 but	 are	 regulated	 by	 DNA	 damage,	 heat	 shock	 response	pathways	 and	 genotoxic	 or	 cellular	 stress	 which	 are	 typical	 hallmarks	 of	 viral	 and	malignant	 transformation	 (González,	 Groh,	 &	 Spies,	 2006;	 Groh	 et	 al.,	 1996;	 Jolly	 &	Morimoto,	2000).	Thus,	clearance	of	stressed	or	malignant	cells	 is	essentially	 facilitated	by	 NKG2D-mediated	 recognition.	 In	 fact,	 it	 has	 such	 a	 central	 part	 in	 the	 immune	response	 to	 viruses	 and	 tumors	 that	 is	 has	 become	 the	 target	 of	 immune	 evasion	strategies.	For	example	HCMV-infected	cells	produce	the	protein	UL16	which	enables	the	retention	 of	 several	 stress-ligands	 intracellularly	 (Valés-Gómez,	 Browne,	 &	 Reyburn,	2003)	 and	 some	 tumors	 secret	 either	 transforming	 growth	 factor-b1,	 which	 leads	 to	downregulation	 of	 NKG2D	 on	 NK	 cells	 (Castriconi	 et	 al.,	 2003)	 or	 NKG2D	 ligands	 as	decoys	 (Groh,	 Wu,	 Yee,	 &	 Spies,	 2002;	 Salih,	 Rammensee,	 &	 Steinle,	 2002).	 The	 latter	however	is	not	exclusively	immune	evasive	as	a	recent	report	highlighted	the	role	of	shed	NKG2D	ligands	in	mice,	supporting	immunosurveillance	and	tumor	rejection	by	NK	cells	(Deng	et	al.,	2015)	.		
2.1.3	Natural	cytotoxicity	receptors	
 
NKp46,	NKp30	and	NKp44	are	all	part	of	an	additional	group	of	activating	receptors,	the	natural	 cytotoxicity	 receptors	 (NCRs).	 They	 belong	 to	 the	 Ig-superfamily	 and	 mediate	
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tumor	 and	 dendritic	 cell	 recognition	 by	 NK	 cells	 (Ferlazzo	 et	 al.,	 2002;	 Moretta	 et	 al.,	2001).	 All	 NCRs	 except	 for	 NKp44	 are	 expressed	 on	 resting	 and	 activated	 NK	 cells.	NKp44,	which	is	solely	found	in	more	recently	evolved	species,	is	upregulated	only	upon	IL-2	stimulation	of	specific	NK	cells	(De	Maria	et	al.,	2009;	Fuchs,	Cella,	Kondo,	&	Colonna,	2005;	 Vitale	 et	 al.,	 2001).	 Viral	 hemagglutinins	 are	 supposed	 ligands	 for	 NKp46	 and	NKp44,	while	other	cellular	 ligands	have	not	been	defined.	Their	existence,	however,	 is	demonstrated	 by	 the	 fact	 that	 NCR-blocking	 antibodies	 are	 able	 to	 abrogate	 NK	 cell-mediate	 lysis	of	 tumor	cell	 (Höglund	and	Brodin,	2010).	Ligands	 for	NKp30	 include	 the	nuclear	factor	HLA-B-associated	transcript	3,	which	can	be	released	from	tumor	cells,	B7-H6	 and	 heparin	 sulfate	 proteoglycans,	 the	 latter	 also	 being	 a	 ligand	 for	 NKp46	(Bloushtain	 et	 al.,	 2004;	 Brandt	 et	 al.,	 2009;	 Pogge	 von	 Strandmann	 et	 al.,	 2007).	Complementary	to	NKG2D,	NCRs	are	proposed	to	be	one	of	the	main	mediators	of	NK	cell	cytotoxicity	 towards	 tumor	 targets	 (Pende	 et	 al.,	 2009).	 This	 is	 validated	 by	 studies	showing	that	the	ability	of	NK	cells	to	lyse	tumor	targets	in	vivo	is	diminished	by	deletion	of	a	single	NCR	(Halfteck	et	al.,	2009;	Pessino	et	al.,	1998;	Sivori	et	al.,	1999).	Moreover,	NKp30	 is	 also	 associated	 with	 interaction	 between	 NK	 cells	 and	 dendritic	 cells	 (DCs)	causing	apoptosis	and	maturation	of	DCs	(Moretta,	2002;	Pende	et	al.,	2009).	Within	the	same	family	of	receptors,	the	leukocyte	immunoglobulin-like	receptors	(LIRs)	can	be	found,	which	bind	to	MHC	class	I	molecules	(Colonna	et	al.,	1997).	The	exact	role	 of	 LIRs	 in	 the	 regulation	 of	 NK	 cell	 responses	 is	 as	 of	 yet	 unclear,	 since	 they	 act	similarly	 to	 the	more	dominant	 inhibitory	KIR	and	CD94-NKG2A	(Navarro	et	al.,	1999).	However,	the	increased	affinity	of	specific	LIR	receptors	to	certain	antigens	could	suggest	their	relevance	in	NK	cell	biology	(Chapman,	Heikeman,	&	Bjorkman,	1999).			
2.1.4	2B4,	KLRG1	and	co-stimulatory	receptors		The	 functional	 properties	 of	 the	 2B4	 receptor	 (CD244)	 and	 its	 ligand	CD48	 -	 a	 surface	molecule	restricted	to	the	hematopoietic	lineage,	have	so	far	not	clearly	been	defined	(M.	H.	 Brown	 et	 al.,	 1998;	 Garni-Wagner,	 Purohit,	 Mathew,	 Bennett,	 &	 Kumar,	 1993;	Latchman,	 McKay,	 &	 Reiser,	 1998;	 Valiante	 &	 Trinchieri,	 1993).	 Depending	 on	 the	recruited	adapter	proteins,	 the	2B4	receptor	can	relay	an	activating	or	 inhibitory	signal	(Garni-Wagner	 et	 al.,	 1993;	 K.-M.	 Lee	 et	 al.,	 2004;	 McNerney,	 Lee,	 &	 Kumar,	 2005).	Therefore,	 it	 has	 been	 postulated	 that	 the	maturation	 stage	 of	 NK	 cells	 as	 well	 as	 the	
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expressed	isoform	might	influence	the	outcome	when	triggering	the	multi-functional	2B4	receptor	(Lanier,	2005;	S.	O.	Mathew,	Rao,	Kim,	Bambard,	&	Mathew,	2009).	Killer	cell	 lectin-like	receptor	G1	(KLRG1)	is	an	inhibitory	receptor	that	binds	to	the	classical	cadherins,	(E-,	N-	and	R-cadherins)	(M.	Ito	et	al.,	2006;	Robbins	et	al.,	2002).	As	cadherins	are	commonly	expressed	on	normal,	solid	tissue,	KLRG1-mediated	signaling	on	educated	NK	cells	can	prevent	damage	to	healthy	tissue	(M.	Ito	et	al.,	2006).	However,	apart	from	setting	a	threshold	for	NK	cell	activation,	KLRG1	might	also	have	a	role	in	the	missing-self-mediated	 NK	 cell	 response.	 Consequently,	 downregulation	 of	 E-cadherin,	which	 allows	malignant	 epithelial	 tumors	 to	metastasize,	 could	 in	 turn	 also	 serve	 as	 a	strategy	 for	 NK	 cells	 to	 detect	 malignant	 epithelial	 tissue	 (Colonna,	 2006;	 Cowin,	Rowlands,	&	Hatsell,	2005;	Jeanes,	Gottardi,	&	Yap,	2008).	Co-stimulatory	 receptors	 in	 NK	 cells	 are	 not	 sufficient	 to	 trigger	 an	 NK	 cell	response	on	their	own,	but	provide	and	alternate	mechanism	of	activation	that	prevents	an	 attack	 on	 normal,	 healthy	 tissue.	 These	 receptors	 include	 DNAM-1,	 the	 NKR-P1	receptors	and	the	PILR	receptor	as	discussed	hereafter.	The	DNAM-1	receptor	is	another	member	of	 the	 Ig-superfamily	 and	 is	 constitutively	 expressed	by	 roughly	half	 of	 all	NK	cells	 (Shibuya	 et	 al.,	 1996).	 DNAM-1	 acts	 as	 an	 activating	 co-stimulatory	 receptor	 and	binds	to	CD155	and	CD112,	which	can	be	upregulated	on	tumor	cells	(Bottino	et	al.,	2003;	Masson	et	al.,	2001;	Tahara-Hanaoka	et	al.,	2004).		Further	evidence	suggests	that	DNAM-1	can	act	synergistically	with	other	receptors	such	as	2B4	to	mount	a	cytotoxic	immune	response	 independent	 of	 conventional	 activating	 receptors	 (de	 Andrade,	 Smyth,	 &	Martinet,	2014),	 thus	 implying	more	than	 just	a	co-stimulatory	function	for	DNAM-1.	 In	addition,	DNAM-1	might	play	a	role	 in	 the	 formation	of	 the	 immunological	synapse,	but	the	 precise	mechanisms	 have	 yet	 to	 be	 elucidated	 (de	 Andrade	 et	 al.,	 2014).	With	 the	growing	importance	of	DNAM-1,	the	roles	of	the	two	receptors	sharing	common	ligands	with	 DNAM-1;	 CD96	 and	 TIGIT	 have	 also	 been	 scrutinized	 in	 more	 detail.	 CD96,	 for	instance,	 is	able	 to	bind	CD155	with	a	higher	affinity	 than	DNAM-1,	but	although	CD96	has	 an	 ITIM	 motif,	 its	 biology	 is	 poorly	 understood	 and	 it	 is	 unclear	 whether	 the	interaction	improves	or	limits	NK	cell	reactivity	(Fuchs,	Cella,	Giurisato,	Shaw,	&	Colonna,	2004;	 Meyer	 et	 al.,	 2009;	 X.	 Yu	 et	 al.,	 2009).	 On	 the	 other	 hand,	 TIGIT	 has	 a	 clear	inhibitory	 function,	 yet	additional	 in	vivo	 data	are	necessary	 to	determine	 the	potential	role	 of	 TIGIT	 in	 for	 example	 autoimmune	 pathologies	 where	 activating	 signals	 from	DNAM-1	 interactions	 have	 been	described	 to	 be	 involved	 (de	Andrade	 et	 al.,	 2014).	 As	current	 studies	 have	 exemplified	 the	 relevance	 of	 DNAM-1,	 TIGIT	 and	 CD96	 in	NK	 cell	
Introduction	
	 	 	 	 23	
responses,	 studying	 them	 in	 more	 detail	 might	 reveal	 valuable	 insights	 into	 pursuing	these	co-receptors	as	therapeutic	targets.	In	 humans	 only	 one	 non-polymorphic	 gene	 exists	 for	 NKR-P1	 (CD161),	 the	second	co-stimulatory	receptor	addressed	here	(Lanier,	Chang,	&	Phillips,	1994).	NKR-P1	also	belongs	to	the	C-type	lectin	family	and	is	known	in	mice	for	the	prototypical	NK	cell	marker	NK1.1	(Glimcher,	Shen,	&	Cantor,	1977).	In	humans	NKR-P1	together	with	NKp80	and	NKp65	make	up	this	group	of	receptors	that	preferentially	bind	CLEC2	glycoproteins	(Bartel,	Bauer,	&	Steinle,	 2013).	 LLT1,	AICL	and	KACL	are	 the	 respective	 ligands	of	 the	receptors	and	are	encoded	in	proximity	to	their	corresponding	receptors	on	the	NKRP1	gene	 (Aldemir	 et	 al.,	 2005;	 Rosen	 et	 al.,	 2005;	 Spreu	 et	 al.,	 2010;	 Welte,	 Kuttruff,	Waldhauer,	&	Steinle,	2006).	All	three	receptors	have	very	distinct	modes	of	action.	While	NKR-P1	 elicits	 inhibitory	 functions	 when	 bound	 to	 LLT1,	 NKp80	 acts	 as	 an	 activating	receptor	allowing	autonomous	control	of	NK	cells	that	express	its	ligand	AICL	(Aldemir	et	al.,	 2005;	 Klimosch,	 Bartel,	Wiemann,	 &	 Steinle,	 2013;	 Rosen	 et	 al.,	 2005;	 Vitale	 et	 al.,	2001).	Further,	NKp65	which	binds	KACL	-	 the	CLEC2	protein	exclusively	expressed	on	keratinocytes	 -	 is	 thought	 to	 facilitate	 immunosurveillance	of	human	keratinocytes	 and	mount	 an	 activating	 response	 if	 necessary	 (Spreu	 et	 al.,	 2010).	 Hence,	 due	 to	 their	established	 uniqueness,	 NKR-P1	 receptors	 might	 represent	 a	 novel	 mechanism	 for	self/non-self	discrimination	complementary	to	MHC-KIR	dependent	system.	The	 last	 co-stimulatory	 receptor	 covered	 here	 is	 the	 paired	 Ig-like	 2	 receptor	(PILRb)	and	its	isoform	PILRa.	While	the	former	can	associate	with	DAP-12	and	act	as	an	activating	 receptor,	 the	 latter	 carries	 an	 ITIM	 domain	 and	 is	 regarded	 as	 a	 inhibitory	receptor	 (Mousseau,	 Banville,	 L'Abbé,	 Bouchard,	 &	 Shen,	 2000;	 Shiratori,	 Ogasawara,	Saito,	 Lanier,	 &	 Arase,	 2004).	 PILR-L	 (CD99)	 is	 the	 ligand	 for	 these	 receptors	 and	recognition	has	been	 shown	 to	be	dependent	 on	 the	 sialylation	pattern	of	 the	O-linked	sugar	chains	(J.	Wang,	Shiratori,	Satoh,	Lanier,	&	Arase,	2008).	Hence,	PILRs	on	NK	cells	might	 have	 a	 possible	 role	 in	 mediating	 recognition	 of	 carbohydrate	 chains	 on	 target	cells,	thereby	broadening	the	recognition	spectrum	of	NK	cell	surveillance.		
2.2	Developmental	stages	of	Natural	Killer	cells	
	Hematopoiesis	 is	 a	 continuous	 process	 that	 replenishes	 our	 blood	 cells.	 In	 humans,	hematopoiesis	begins	in	the	yolk	sac	during	embryonic	development	before	moving	on	to	the	fetal	liver	and	finally	ending	up	in	the	bone	marrow	(Fernández	&	de	Alarcón,	2013).	
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All	cells	found	in	the	blood	originate	from	one	common	ancestor,	the	hematopoietic	stem	cell	(HSC)	(LORENZ,	UPHOFF,	REID,	&	SHELTON,	1951;	Maximow,	1909).			
	
Figure	4.	Adapted	from	a	model	for	hematopoiesis.	(Sankaran	&	Weiss,	2015)		These	 pluripotent	 stem	 cells	 give	 rise	 to	 daughter	 cells	 that	 are	 committed	 to	producing	multipotent	progenitors	intended	for	long-term	engraftment	and	are	therefore	also	 called	 LT-HSCs	 (Ogawa,	 1993).	 As	 hematopoiesis	 progresses,	 progenitor	 cells	undergo	 a	 gradual	 fate	 restriction	 and	 eventually	 mature	 into	 lineage-committed	 cells	(Figure	 4)	 (Doulatov,	 Notta,	 Laurenti,	 &	 Dick,	 2012).	 The	 identity	 of	 the	 numerous	hematopoietic	 cell	 types	 is	 influenced	 by	 the	 expression	 of	 transcription	 and	 growth	factors	 as	well	 as	 cytokines	 that	 shape	 the	 final	 lineage-specific	 differentiation	 (Zhu	 &	Emerson,	2002).		
2.2.1	Early	development	of	NK	cell	precursors		NK	 cells	 are	 part	 of	 a	 broader	 family	 of	 innate	 lymphoid	 cells	 (ILCs),	 which	 share	 a	common	precursor	 that	gives	 rise	 to	 the	phenotypically	and	 functionally	distinct	 ILC1s,	ILC2s	 and	 ILC3s	 (Spits	 et	 al.,	 2013).	 Despite	 their	 differences	 later	 in	 development,	 all	ILCs	 originate	 from	 bone	marrow-derived	 Lin-CD34+CD38-CD90+CD45RA-	 HSCs	 (Figure	5).	As	these	pluripotent	cells	start	to	be	committed,	their	loss	of	developmental	plasticity	is	 evident	 by	 the	 acquisition	 of	 CD38	 on	 the	 surface	 and	 they	 mature	 into	 Lin-CD34+CD38+CD10+	 common	 lymphoid	 progenitors	 (CLPs)	 In	 mice,	 the	 acquisition	 of	CD122	marks	a	fate	deciding	step	in	NK	cell	differentiation	(Boos,	Ramirez,	&	Kee,	2008).		
LT-HSC ST-HSC
e B  cell T cel l NK cell
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However,	in	humans,	CD122	expression	is	virtually	undetectable	by	flow	cytometry,	thus	enforcing	 the	 necessity	 to	 rely	 on	 alternative	markers	 to	 identify	 early	 developmental	stages	prior	to	CD94	expression	(Freud	and	Caligiuri,	2006).	Some	of	these	markers	were	recently	 used	 to	 identify	 a	 unique	 cell	 population	 that	 was	 found	 to	 be	CD34+CD38+CD123-CD45RA+CD7+CD10+CD127-	 and	 thought	 to	 represent	 the	 first	 NK	lineage	progenitor	subset	(Renoux	et	al.,	2015).	In	secondary	lymphoid	organs	(SLO),	two	populations	of	Lin-CD94-	NK	precursor	can	be	found	in	close	proximity	to	their	putative	progeny:	 Lin-CD34dimCD45RA+α4β7bright	CD117+CD161+/-CD94-	 stage	2	 and	Lin-CD34-α4β7-CD117+CD161+CD94-	stage	3	NK	precursors	(Figure	5)	(Freud	and	Caligiuri,	2006).			
	
Figure	5.	Schematic	representation	of	the	cellular	intermediates	of	human	natural	killer	(NK)	cell	
development.	(Yu	et	al.,	2013)		Both	populations	are	able	 to	 respond	 to	stimulation	with	 interleukin-15	 (IL-15)	and	can	give	rise	to	mature	NK	cells	in	vitro.	Yet	stage	2	cells	clearly	represent	an	earlier	point	 in	development,	 as	 they	are	able	 to	differentiate	 into	T	 cells,	DCs	and	 stage	3	NK	cells	 in	vitro	(Freud	 et	 al.,	 2006).	 In	 contrast,	 stage	3	 cells	 are	neither	 able	 to	 revert	 to	stage	2	cells	nor	give	rise	 to	T	cells	or	DCs	 in	vitro,	 suggesting	that	stage	3	cells	are	the	direct	progeny	of	stage	2	cells.	
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Figure 1. Schematic representation of the cellular intermediates of human natural killer (NK) cell development. Human NK cell development from hematopoietic stem cells
(HSCs) to mature stage 5 CD56dim NK cells is represented as a linear pathway from left to right. Memory NK cells are depicted as a possible terminal stage of maturation
(stage 6), with experimental evidence that memory NK cells may be derived from CD56bright as well as CD56dim NK cells [87]. Of note, memory NK cells are depicted here as
one population, although evidence to date indicates that there are at least three distinct pathways of NK cell memory formation [88]. Shown for each developmental stage is
the expression of each surface antigen useful in distinguishing populations of NK developmental intermediates. Expression is designated as ‘+’ (expression), ‘–’ (no
expression), ‘hi’ (high expression), or ‘lo’ (low expression).
CLP  pre-NKP NKP iNK HSC 
Lin(-)
Scal-1(+)
CD117(+)
Lin(-)
Sca-1(lo)
CD117(lo)
CD127(+)
CD135(+)
Lin(-)
CD117(-)
CD127(+)
CD135(-)
NKG2D(+)
CD244(+)
CD122(-)
NK1.1(-)
Lin(-)
NKG2D(+)
CD244(+)
CD122(+)
NK1.1(-)
CD94(-)
NKp46(-)
Ly49(-)
DX5(-)
NKG2D(+)
CD244(+)
CD122(+)
NK1.1(+)
CD94(+)
NKp46(+)
Ly49(-)
DX5(-)
CD11b(lo)
CD27(hi)
NKG2D(+)
CD244(+)
CD122(+)
NK1.1(+)
CD94(+/-)
NKp46(+)
Ly49(+/-)
DX5(+)
CD11b(hi)
CD27(+/-)
Ly49(?)
CD11b(?)
CD27(?)
KLRG1(?)
Thy1(?)
CXCR6(?)
CD49a(?)
mNK 
Memory NK 
? 
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Figure 2. Schematic representation of the cellular intermediates of mouse natural killer (NK) cell development. Mouse NK cell development from hematopoietic stem cells
(HSCs) to mature CD11bhighDX5+ NK cells is represented as a linear pathway from left to right. Memory NK cells are depicted as a possible terminal stage of maturation, and
memory NK cells are depicted here as one population, although evidence to date indicates that there are at least three distinct pathways of NK cell memory formation [88].
Shown for each developmental stage is the expression of each surface antigen useful in distinguishing populations of NK developmental intermediates. Expression of each
antigen in a particular stage is designated as ‘+’ (expression), ‘–’ (no expression), ‘hi’ (high expression), or ‘lo’ (low expression). Abbreviations: CLP, common lymphoid
progenitor; iNK, immature NK cell; mNK, mature NK cell; NKP, NK cell precursor.
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As	the	NK	precursors	head	towards	the	final	stages	of	development,	they	acquire	a	number	of	functional	receptors	in	a	sequential	fashion.	First	among	them	is	the	C-type	lectin	CD161,	followed	by	CD56,	CD94-NKG2A,	NKp46,	and	NKG2D;	and	completed	by	the	killer	 immunoglobulin-like	 receptors	 (KIRs)	and	CD16	 (Grzywacz	et	 al.,	 2006;	Perussia,	Chen,	&	Loza,	2005).	Some	of	these	surface	receptors	such	as	CD56,	CD117,	NKp46,	CD94-NKG2A,	and	 the	TNF	 family	 receptor	CD27	are	 lost	again	or	downregulated	as	NK	cells	reach	maturity.	These	expression	patterns	found	in	vitro	coincide	with	data	from	clinical	samples	where	neonatal	NK	cells	which	are	mostly	CD94+KIR-	show	the	same	progression	to	CD94-KIR+	NK	cells	in	adults	(Almeida-Oliveira	et	al.,	2011;	Hayhoe,	Henson,	Akbar,	&	Palmer,	2010;	Sundström	et	al.,	2007).			
2.2.2	Late	stages	of	NK	cell	development:	early	vs.	late	differentiation		
	
Figure	6.	Schema	of	human	natural	killer	(NK)-cell	subsets.	(Cooper,	Fehniger,	&	Caligiuri,	2001a)		Mature	NK	cells	are	made	up	of	 two	major	subsets,	 the	CD56bright	 (stage	4)	and	CD56dim	(stage	 5)	 NK	 cells	 (Figure	 5&6).	 The	 CD56bright	 are	 classically	 known	 as	 the	 cytokine-producing	subset	(Fehniger	et	al.,	2003).	They	are	enriched	in	SLO	and	characterized	by	expression	of	NKp30,	NKp46,	DNAM-1,	2B4,	LAIR-1,	and	NKG2D	while	lacking	expression	of	KIRs,	CD16	and	perforin	in	early	developmental	subsets	(Ferlazzo	et	al.,	2004b).	Since	cytokines	produced	by	NK	cells	are	crucial	 in	early	 innate	host	responses,	 the	CD56bright	subset	 plays	 an	 important	 immunoregulatory	 role	 during	 infection.	 Upon	 induction	 by	monokines,	 CD56bright	 NK	 cells	 secrete	 a	 trove	 of	 factors	 such	 as	 interferon-γ	 (IFNγ),	tumor	necrosis	 factor	α/β	(TNFα/β),	granulocyte	macrophage	colony-stimulating	 factor	
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(GM-CSF),	 IL-10	 and	 IL-13	 (Cooper	 et	 al.,	 2001).	 In	 comparison,	 the	 CD56dimCD16+	 NK	cells,	 found	 in	 peripheral	 blood,	 are	 proficient	 at	 eliciting	 cytolytic	 activity	 (Caligiuri,	2008).	For	instance,	using	the	abundantly	expressed	low-affinity	Fc-gamma	receptor	IIIA	(CD16A)	 on	 their	 surface	 CD56dim	 NK	 cells	 are	 able	 to	 bind	 the	 constant	 region	 of	immunoglobulin	 on	 the	 cell	 surface	 of	 opsonized	 tumor	 targets.	 Upon	 receptor-ligand	binding,	CD16	mediates	a	signal	which	results	 in	degranulation	and	perforin-dependent	target	 cell	 lysis,	 a	process	also	 termed	antibody-dependent	 cellular	 cytotoxicity	 (ADCC)	(Lanier,	Ruitenberg,	&	Phillips,	1988;	Perussia,	1998).	In	addition	to	the	aforementioned	pathway,	 NK	 cells	 can	 efficiently	 target	 malignant	 cells	 without	 prior	 simulation	 by	sensing	the	absence	or	loss	of	major	histocompatibility	complex	(MHC)	class	I	on	target	cells	(Ljunggren	&	Kärre,	1990).	Under	normal	conditions,	NK	cell	cytotoxicity	is	averted	by	signaling	through	inhibitory	KIRs	(Thielens,	Vivier,	&	Romagné,	2012).	However,	MHC	class	I-deficient	patients	do	not	show	signs	of	NK	cell-mediated	autoimmunity	despite	the	lack	 of	 inhibition	 through	 HLA-KIR	 signaling.	 Thus,	 in	 the	 absence	 of	 feedback	 from	inhibitory	 KIRs,	 additional	 mechanisms	 ensure	 the	 regulated	 immune	 response	 of	 NK	cells.	This	includes	binding	of	HLA-E	to	its	inhibitory	ligands	to	dampen	NK	cell	responses	as	 well	 as	 a	 process	 termed	 education,	 which	 will	 be	 discussed	 in	 more	 detail	 below.	Suffice	to	say	for	now	that	education	is	key	in	allowing	NK	cells	to	be	functionally	primed	through	MHC	class	 I	 interactions	 (Anfossi	 et	 al.,	 2006).	Accordingly,	NK	cells	which	are	not	primed	are	unable	to	kill	or	lyse	target	cells	that	lack	MHC	class	I	(Vitale	et	al.,	2002).	Additionally,	 when	 the	 dominating	 inhibitory	 signal	 is	 lost	 the	 contribution	 of	 lower	affinity	 activating	 receptors	 such	 as	NKG2D,	NCRs,	 the	nectin	 and	nectin-like	 receptors	and	NKp80	need	to	be	taken	into	consideration	(Valés-Gómez,	Reyburn,	Erskine,	López-Botet,	&	Strominger,	1999)	 (Bryceson,	March,	Ljunggren,	&	Long,	2006).	Although	both	subsets	 have	 functionally	 very	 distinct	 properties,	 it	 is	 thought	 that	 the	 CD56bright	 are	precursors	to	the	CD56dim	subset	and	develop	in	an	IL-15-dependent	fashion	(Huntington	et	 al.,	 2009).	 It	 has	 also	 been	 shown	 that	 upon	 activation	with	 IL-2,	NK	 cells	 from	SLO	significantly	 upregulate	 CD16,	 NCRs	 and	 expression	 of	 KIRs	 (Ferlazzo	 et	 al.,	 2004b).	Further,	in	the	periphery	CD56dim	NK	cells,	expressing	high	levels	of	CD94,	can	be	found,	indicating	an	intermediate	transitional	subset	from	CD56bright	to	CD56dim	NK	cells	(Jianhua	Yu	 et	 al.,	 2010).	However,	 some	 amount	 of	 plasticity	 remains	 allowing	CD56dim	 cells	 to	enter	back	into	a	CD56bright-like	phenotype	upon	stimulation	with	IL-18	(Vukicevic	et	al.,	2010).		Additional	 markers	 have	 been	 described	 that	 define	 further	 steps	 in	 the	 late	differentiation	of	CD56dim	NK	cells.	As	CD56dim	cells	mature,	a	progressive	gain	of	CD57	
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and	KIRs	can	be	observed	which	inversely	correlates	to	the	levels	of	NKG2A,	and	this	 is	associated	with	 reduced	NK	 cell	 proliferative	 capacity	 (Björkström	 et	 al.,	 2010).	 These	changes	 illustrate	 a	 progression	 from	 early-differentiated	 CD56dimNKG2A+KIR-	 to	 late-differentiated	 CD56dimNKG2A-KIR+	 NK	 cells	 (Béziat	 et	 al.,	 2010).	 Interestingly,	 both	developmental	stages	have	been	shown	to	favorably	expand	in	specific	disease	settings.	For	instance,	acute	infectious	mononucleosis	(IM),	which	occurs	in	adolescents	suffering	from	 Epstein-Barr	 Virus	 (EBV),	 is	 preferentially	 controlled	 by	 CD56dimNKG2A+KIR-	 NK	cells	that	target	lytically	replicating	B	cells	(Azzi	et	al.,	2014).	These	CD56dimNKG2A+KIR-	NK	cells	remain	elevated	even	after	viral	loads	drop	below	the	detection	limit	hinting	at	long-term	 persistence	 beyond	 their	 effector	 time	 window	 (Dunmire	 et	 al.,	 2015).	 In	contrast,	acute	viral	 infections	 from	hantavirus,	cytomegalovirus	(CMV)	or	chikungunya	virus	 accumulate	 late-differentiated	 NK	 cells	 manifesting	 increased	 expression	 of	 the	HLA-E	 binding	 activating	 receptor	 CD56dimNKG2C+KIR+	 (Béziat,	 Dalgard,	 et	 al.,	 2011a;	Björkström	et	al.,	2011;	Lopez-Vergès	et	al.,	2011;	Petitdemange	et	al.,	2011).	Likewise,	this	population	did	not	only	expand	upon	infection	but	was	observed	to	persist	over	long	periods	of	time,	suggesting	the	existence	of	a	NK	cell	memory	pool.		
 
2.2.3	Immunological	memory	in	innate	immunity			Traditionally,	 the	 ability	 to	 generate	 an	 immunological	 memory	 was	 considered	 a	hallmark	 of	 the	 adaptive	 immune	 system.	 However,	 an	 increasing	 amount	 of	 evidence	suggests	 that	 also	NK	 cells	 are	 able	 to	mount	 recall	 responses.	 This	 could	 therefore	 be	considered	 the	 final	 step	 in	 NK	 cell	 differentiation.	 The	 first	 evidence	 of	 long	 term	persisting	 NK	 cells	 was	 found	 in	 HCMV	 seropositive	 patients	 who	 retained	 higher	frequencies	 of	 NK	 cells	 expressing	 the	 activating	 CD94–NKG2C	 receptor	 compared	 to	seronegative	 individuals	 (Gumá	 et	 al.,	 2004).	 The	 concept	 of	 actual	 antigen-specific	NK	cell	memory	was	later	reinforced	in	mice	 lacking	T	and	B	cells	yet	these	mice	were	still	able	 to	 develop	 a	 contact	 hypersensitivity	 response	 mediated	 by	 NK	 cells,	 following	sensitization	with	haptens	(O'Leary,	Goodarzi,	Drayton,	&	Andrian,	2006).	Soon	after,	the	role	of	ubiquitously	resident	memory	NK	cells	in	the	context	of	a	viral	infection	–	MCMV	and	immunization	with	virus	like	particles	(VLPs)	could	also	be	demonstrated	(Paust	et	al.,	 2010;	 J.	 C.	 Sun,	 Beilke,	 &	 Lanier,	 2009).	 In	 humans,	 it	 is	 well	 established	 that	 the		CD94-NKG2C+	 NK	 cell	 population,	 which	 preferentially	 expands	 during	 acute	 HCMV	infection,	 can	persist	as	memory	NK	cells	and	constitute	up	 to	70%	of	 the	 total	NK	cell	
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population	 (Foley,	 Cooley,	 Verneris,	 Pitt,	 et	 al.,	 2012b;	 Lopez-Vergès	 et	 al.,	 2011).	Furthermore,	 in	 patients	 that	 have	 undergone	 allogeneic	 hematopoietic	 cell	transplantation,	CD94-NKG2C+	NK	cells	from	HCMV-seropositive	donors	co-cultured	with	K562	 cells	 show	 an	 increase	 in	 the	 frequency	 of	 IFN-gamma+	 cells	 after	 HCMV	reactivation	compared	to	CD94-NKG2C+	NK	cells	reconstituted	 from	HCMV-seropositive	or	-seronegative	donors	in	patients	without	such	a	reactivation	of	HCMV.	Thus,	these	data	further	strengthen	the	suggestion	that	a	long-lived	memory	NK	cell	response	exists	that	is	induced	 by	 HCMV	 infection	 (Foley,	 Cooley,	 Verneris,	 Curtsinger,	 et	 al.,	 2012a).	 The	expansion	 of	 NKG2C+	 NK	 cells	 in	 HCMV	 infection	 itself	 has	 been	 postulated	 to	 be	mediated	by	the	interaction	of	the	CD94-NKG2C	receptor	with	its	ligand	HLA-E	as	well	as	IL-12	produced	by	CD14+	monocytes	(Figure	7a)	(Rölle	et	al.,	2014).		
	
Figure	7.	NK	cell	memory	in	HCMV-seropositive	donors.	(Cerwenka	&	Lanier,	2016)		Yet,	 the	 incidence	 of	 congenital	 HCMV	 infection	 remained	 unchanged	 in	individuals	 that	 have	 a	 null	 allele	 for	 the	 gene	 encoding	 NKG2C	 compared	 to	 controls	(Noyola	 et	 al.,	 2012).	 Therefore,	 NK	 cell	 memory	 formation,	 if	 at	 all	 protective	 in	 the	context	 of	 HCMV,	 is	 not	 an	 NKG2C-specific	 process	 but	 rather	 reflects	 the	 selective,	pathogen-specific	 expansion	 and	 persistence	 of	 a	 particularly	 potent	 subpopulation.	 A	supporting	role	of	activating	KIRs	in	memory	NK	cell	formation	in	response	to	HCMV	has	been	 implied	 by	 the	 observation	 of	 a	 specific	 expansion	 of	 KIR2DS2-,	 KIR2DS4-	 and	KIR3DS1-expressing	 NK	 cells,	 (Béziat	 et	 al.,	 2013).	 However,	 it	 is	 still	 unclear	 which	specific	factors	drive	memory	formation	of	NK	cells.	A	lot	of	the	work	so	far	promoting	the	idea	of	memory	NK	cell	formation	has	been	done	 in	 the	 infectious	 setting	 of	HCMV.	However,	 expansion	 of	 CD94–NKG2C+	NK	 cells	has	 also	 been	 observed	 after	 infection	with	 other	 viruses	 such	 as	 hantavirus,	 HIV	 and	hepatitis	C	virus	(HCV)	(Béziat,	Dalgard,	et	al.,	2011a;	Björkström	et	al.,	2011;	Brunetta	et	
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al.,	 2010),	 albeit	 only	 in	 individuals	 who	 are	 persistently	 infected	 with	 HCMV.	Furthermore	 an	 exciting	 new	 study	 described	 the	 role	 of	 antigen-specific	 memory	 NK	cells	in	SIV	infected	rhesus	macaques.	Both	after	infection	and	vaccination,	the	formation	of	a	 robust	antigen-specific	memory	NK	cell	population	was	 induced,	which	specifically	targeted	 dendritic	 cells	 pulsed	 with	 the	 major	 structural	 (Gag)	 and	 envelope	 (Env)	proteins	of	SIV	in	an	NKG2-dependent	fashion	(Reeves	et	al.,	2015).		As	 the	 ability	 for	 cytokines	 to	 induce	 memory	 in	 mice	 had	 been	 shown,	 the	possibility	was	also	 investigated	 in	humans	 (Cooper	et	al.,	2009).	Similar	 to	 the	murine	studies,	NK	 cells	 that	were	 briefly	 exposed	 to	 IL-12,	 IL-15	 and	 IL-18,	washed	 and	 then	cultured	in	IL-15	for	up	to	21	additional	days,	produced	highly	elevated	amounts	of	IFNγ	upon	 re-stimulation	 with	 K562	 or	 IL-12	 and	 IL-15	 (Cooper	 et	 al.,	 2009;	 Romee	 et	 al.,	2012).	In	addition,	a	key	role	for	IL-12	in	the	expansion	of	CD94–NKG2C+	NK	cell	subset	was	also	described	(Rölle	et	al.,	2014).	Both	HCMV-driven	memory	as	well	as	exposure	to	IL-12,	IL-15	and	IL-18	results	in	stable	demethylation	of	the	IFNG	locus	(Luetke-Eversloh	et	 al.,	 2014).	 This	 allows	NK	 cells	 to	 remember	 prior	 exposure	 to	 polarizing	 cytokines	even	 in	 the	absence	of	a	specific	antigenic	stimulus,	 thus	bestowing	them	with	memory	capabilities.		Phenotypically,	memory	NK	cells	have	been	mainly	characterized	in	the	context	of	HCMV	infection.	NK	cells	from	HCMV-seropositive	donors	typically	express	high	levels	of	the	CD94-NKG2C	in	conjunction	with	CD57,	and	lack	NKG2A	(Lopez-Vergès	et	al.,	2011).	In	 addition,	 as	 mentioned	 above,	 the	 expression	 of	 specific	 activating	 KIRs	 such	 as	KIR2DS2,	KIR2DS4	or	KIR3DS1	can	be	observed	(Béziat	et	al.,	2013).	Two	recent	back-to-back	 studies	 defined	 the	 genetic	 and	 epigenetic	 changes	 in	 NK	 cells	 from	 HCMV-seropositive	individuals	in	more	detail.	They	found	that	so-called	‘adaptive	NK	cells’	are	characterized	by	a	 lack	of	high-affinity	 IgE	 receptor	 subunit-γ	 (FcεRIγ),	 variable	 loss	of	the	tyrosine	kinase	SYK	and	transcription	factor	EWS/FLI1-activated	transcript	2	(EAT2)	as	well	as	downregulation	of	the	transcription	factor	pro-myelocytic	leukemia	zinc	finger	(PLZF)	(Lee	et	al.,	2015;	Schlums	et	al.,	2015).	 Interestingly,	both	the	CD94-NKG2C-	and	CD94-NKG2C+	 NK	 cells	 contained	 a	 FcεRIγ-deficient	 subset,	 potentially	 implicating	 the	FcεRI	 in	 shaping	 NK	 cell	 memory	 subsets	 which	 exhibit	 elevated	 CD16-mediated	responses	 against	 HCMV-infected	 target	 cells	 coated	 with	 HCMV-specific	 antibodies	(Figure	7b)	(Lee	et	al.,	2015).	The	 apparent	 existence	 of	 a	 memory	 NK	 cell	 compartment	 poses	 the	 obvious	question	 of	 the	 functional	 relevance	 of	 this	 population.	 Contrary	 to	 what	 one	 might	
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expect,	 CD94-NKG2C+	 NK	 cells	 detected	 in	 HCMV-seropositive	 individuals	 display	 a	reduced	response	to	inflammatory	cytokines	such	as	IL-12	and	IL-18	(Béziat	et	al.,	2013).		Moreover,	 upon	 re-activation	with	pertussis	 or	H1N1	 influenza	vaccine	 antigens,	 lower	levels	 of	 IFNγ	production	 and	degranulation	were	 observed	 (Nielsen	 et	 al.,	 2015).	 This	observation	 that	 HCMV-expanded	 CD94-NKG2C+	 cells	 have	 diminished	 responses	 to	heterologous	 challenges	 could	be	highly	 relevant	 for	designing	vaccines	against	viruses	other	than	HCMV	and	needs	to	be	dissected	in	more	detail	in	future	studies.  	
2.3	Education	and	Disarming	of	NK	cells		As	mentioned	above,	since	KIRs	separate	with	great	diversity	and	stochastic	distribution,	nearly	 every	 differentiated	NK	 cell	 expresses	 at	 least	 one	 self-specific	 KIR	 (Andersson,	Malmberg,	&	Malmberg,	2010;	Uhrberg	et	al.,	1997).	Yet	around	10%	of	NK	cells	do	not	express	 any	 self-specific	KIR	 at	 all,	 posing	 the	 question	what	 prevents	 these	 cells	 from	becoming	autoreactive	(Anfossi	et	al.,	2006).		Currently	it	is	known	that	engagement	of	inhibitory	receptors	on	NK	cells	by	self-MHC	class	 I	molecules	 is	necessary	to	 functionally	prime	NK	cells	 to	recognize	missing-self,	a	process	termed	education	or	licensing	(Kim	et	al.,	2005;	2006).	In	situations	where	self-MHC	 class	 I	 ligands	 are	 not	 available,	NK	 cells	 become	hyporesponsive	 and	 are	 no	longer	able	to	secrete	cytokines	or	mediate	cytotoxicity	upon	stimulation	(Fauriat	et	al.,	2008).	Accordingly,	NK	cells	that	develop	in	the	absence	of	MHC	class	I	are	unable	to	kill	MHC	class	I-deficient	tumor	cells	and	fail	to	reject	hematopoietic	bone	marrow	grafts	 in	
vivo	 (Fernandez	 et	 al.,	 2005;	 Kim	 et	 al.,	 2005;	 2006).	 Still,	 in	 the	 absence	 of	 KIR-MHC-mediated	education,	NK	cell	receptors	that	recognize	ligands	other	than	MHC	class	I	are	able	 to	 compensate	 for	 the	 lack	 of	 self-MHC	 class	 I	 recognition.	 The	 most	 prominent	example	 for	 this	 is	 NKG2A,	 which	 can	 bind	 HLA-E	 and	 elicit	 NK	 cell	 function	 of	 KIR-negative	 NK	 cells,	 thus	 acting	 complementary	 to	 KIR-mediated	 education	 (Yu	 et	 al.,	2007).	The	models	which	explain	how	NK	cell	 education	 is	mediated	 through	KIR-MHC	interaction,	are	summarized	below	and	in	Figure	8:	
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Arming		The	arming	model	proposes	the	requirement	of	 inhibitory	receptors	to	bind	NK	cells	 in	order	to	mediate	functional	competence	(Raulet	&	Vance,	2006).	Thus	in	the	absence	of	self-MHC	class	 I	specific	 inhibitory	receptors,	NK	cells	remain	 functionally	 incompetent.	This	 would	 however	 imply	 an	 instructive	 role	 of	 the	 inhibitory	 receptors,	 actively	promoting	 functional	 maturity	 of	 NK	 cells.	 As	 the	 inhibitory	 receptors	 of	 NK	 cells	customarily	do	not	mediate	developmental	signals	but	rather	immunological	stimuli	the	validity	of	this	model	has	yet	to	be	proven	(Goodridge	et	al.,	2015).	
Disarming		In	contrast,	the	disarming	model	postulates	that	NK	cells	which	lack	inhibitory	receptors	for	self-MHC	class	I,	become	hyporesponsive	due	to	constant	activating	stimuli	(Raulet	&	Vance,	2006).	 	This	model	might	best	be	described	as	mediating	a	form	of	NK	anergy	to	ensure	self-tolerance.	Thus	when	self-MHC	class	I	molecules	are	available	 for	 inhibitory	receptors	to	interact	with,	NK	cells	are	not	prompted	to	become	anergic	and	develop	into	fully	functional	and	reactive	NK	cells.	Compared	to	the	arming	model,	this	means	that	NK	cells	 are	 initially	 responsive	 and	 their	 environment	makes	 them	hyporesponsive,	while	the	 arming	 model	 suggests	 that	 NK	 cells	 are	 constitutively	 hyporesponsive.	 Several	studies	have	been	done	which	support	 the	disarming	model	 for	education.	For	 instance	NKG2D	 ligand	 transgenic	 mice	 have	 been	 shown	 to	 foster	 development	 of	 an	 entirely	hypofunctional	NK	cell	compartment	(Oppenheim	et	al.,	2005;	K.	Wiemann	et	al.,	2005).	Furthermore,	in	humans	NK	cells	expressing	the	activating	KIR2DS1	are	hyporesponsive	when	 derived	 from	 donors	 that	 express	 the	 cognate	 ligand	 HLA-C2,	 backing	 the	observations	 made	 in	 mice	 (Fauriat,	 Ivarsson,	 Ljunggren,	 Malmberg,	 &	 Michaëlsson,	2010).	Together,	these	data	suggest	that	the	constant	presence	of	activating	ligands	leads	to	anergy	in	NK	cell	subsets	that	express	the	corresponding	activating	receptor	(Höglund	and	Brodin,	2010).	
Cis-interaction		The	cis-interaction	model	is	rooted	in	the	observation	that	NK	cell	inhibitory	receptors	in	mice	are	able	to	bind	MHC	class	I	 in	cis	on	the	same	cell	(Chalifour	et	al.,	2009).	Murine	inhibitory	receptors	are	able	to	transmit	inhibitory	signals	despite	the	lack	of	 ligands	in	trans.	 These	 so	 called	 ‘unengaged‘	 receptors	prevent	NK	 cells	 from	efficiently	 engaging	their	 targets	 leading	 to	 a	 hyporesponsive	 phenotype.	However,	 inhibitory	 receptors	 on	murine	 NK	 cells	 can	 bind	 their	 ligands	 in	 cis,	 which	 sequesters	 them	 away	 from	 the	interaction	 site	 and	 allows	 engagement	 of	 the	 target.	 Thus	 cis-interactions	 counteract	‘unengaged’	 receptors	 by	 blocking	 inhibitory	 receptors	 and	 enabling	 interaction	 of	
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activating	receptors,	which	leads	to	improved	responsiveness	of	NK	cells	(Chalifour	et	al.,	2009).	Experiments	where	a	truncated	version	of	the	inhibitory	receptor	was	introduced	into	mice,	further	elucidated	the	role	of	cis-interactions	during	NK	cell	education.	As	the	truncated	inhibitory	receptor	was	no	longer	able	to	interact	with	its	ligand	in	cis,	NK	cells	were	not	educated.	However,	the	truncation	did	not	effect	engagement	of	ligands	in	trans	or	 inhibitory	 signaling	 (Bessoles	 et	 al.,	 2013).	 Thus	 underlining	 the	 importance	 of	 cis-interactions	for	NK	cell	education.	
Rheostat		The	rheostat	model	suggests	that	the	process	of	NK	cell	education	 is	 fluid	rather	than	a	rigid	all	or	nothing	response,	allowing	NK	cells	to	adapt	their	response	to	changes	in	the	environment.	This	idea	is	supported	by	evidence	showing	that	NK	cell	responsiveness	is	dependent	 on	 the	 strength	 of	 the	 inhibitory	 signal	 it	 encounters	 (Brodin,	 Kärre,	 &	Höglund,	 2009;	 Johansson	 et	 al.,	 2005).	 For	 instance,	 NK	 cells	 that	 express	 multiple	inhibitory	 receptors	 for	 self-MHC	 class	 I	 respond	 in	 an	 almost	 additive	 fashion	 more	frequently	 with	 boosted	 effector	 functions	 (Brodin	 et	 al.,	 2009;	 Joncker,	 Fernandez,	Treiner,	Vivier,	&	Raulet,	2009).	As	such,	the	affinity	of	the	inhibitory	receptor	to	its	MHC	class	 I	 ligand	 can	 also	 influence	 the	 NK	 cell	 educational	 process	 (Jonsson,	 Yang,	 Kim,	Taffner,	&	Yokoyama,	2010).	NK	cells	would	therefore	be	able	to	‘tune-up’	or	‘tune-down’	their	 responsiveness	 in	 a	 quantitative	manner	 depending	 on	 the	 inhibitory	 signal	 they	receive	 (Brodin	 et	 al.,	 2009;	 Joncker	 et	 al.,	 2009).	 Hence,	 the	 rheostat	model	 does	 not	claim	exclusiveness,	but	rather	goes	hand-in-hand	with	the	arming	and	disarming	models	(Brodin	&	Höglund,	2008).	
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Figure	8.	Models	for	NK	cell	education.	(Höglund	and	Brodin,	2010)	Importantly,	it	needs	to	be	noted	that	NK	cell	education	is	not	static	and	can	adapt	rapidly	 to	changes	 in	 the	environment	 (Pradeu	et	al.,	2013).	 In	 fact,	when	educated	NK	cells	 are	 adoptively	 transferred	 to	 MHC	 class	 I-deficient	 hosts,	 they	 become	hyporesponsive	 within	 a	 matter	 of	 days	 (Joncker	 et	 al.,	 2010).	 Inversely,	 when	hyporesponsive	 NK	 cells	 are	 transferred	 to	 an	 educating	MHC	 environment	 it	 leads	 to	uptuning	of	their	functionality	(Joncker	et	al.,	2010).	All	so-called	‘hyporesponsive’	NK	cells	are	effectively	non-educated.	Interestingly,	a	protective	 function	during	viral	 infection	has	been	attributed	 to	non-educated	NK	cells.	During	 the	 primary	 response	 to	 MCMV	 infection,	 they	 dominate	 the	 reactive	 NK	 cell	population,	 efficiently	 clearing	 viral	 infection	 in	 the	 host	 independent	 of	 cognate	activating	 receptor	 engagement	 (Orr	 et	 al.,	 2010).	 Also,	 upon	 infection	 with	 Listeria	monocytogenes,	 non-educated	 NK	 cells	 are	 able	 to	 respond	 by	 secreting	 IFN-γ,	demonstrating	that	their	 lack	of	response	in	terms	of	education	was	not	due	to	a	global	defect	 in	NK	cell	 function	(Fernandez	et	al.,	2005).	Moreover,	cytokine	stimulation	with	
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IL-2	 or	 IL-12	 and	 IL-18	 likewise	 induces	 an	 effector	 phenotype	 in	 (self-)	 receptor	negative	 NK	 cells,	 suggesting	 that	 given	 sufficient	 stimulation,	 NK	 cells	 can	 reach	 a	cytolytic	 phenotype	 in	 the	 absence	 of	 any	 educating	 input	 (Björkström	 et	 al.,	 2010).	Collectively,	these	findings	reveal	that	NK	cell	tolerance	or	anergy	is	reversible	and	that	functionality	of	non-educated	or	disarmed	NK	cells	can	be	restored.	Although	 the	 current	 consensus	 is	 that	 education	 is	 important	 for	 the	functionality	 of	 NK	 cells,	 its	 specific	 role	 for	 instance	 during	 the	 acute	 phase	 of	 a	 viral	infection	is	still	poorly	understood.	Our	own	data	as	well	as	a	study	using	a	yellow	fever	vaccine	(YFV	17D)	to	model	viral	infections	suggest	that	educated	and	non-educated	NK	cells	 both	 respond	 to	 a	 similar	 degree	 to	 acute	 viral	 infection	 (Marquardt	 et	 al.,	 2015).	Furthermore,	 researchers	were	able	 to	 show	 that	 the	 response	 to	YFV	17D	was	mainly	mediated	 by	 early-differentiated	 NK	 cells,	 indicating	 that	 differentiation	 but	 not	education	 seems	 to	 be	 central	 in	 the	 response	 to	 vaccination.	 Hence,	 dissecting	 the	function	of	 education	 in	NK	cell	 responses	may	help	 to	better	understand	and	 tune	NK	cell-targeted	vaccination	and	therapies.	
 
2.4	The	NK	cell	immunological	synapse		As	outlined	 in	 the	previous	chapters,	 ligand-receptor	 interactions	are	key	 in	controlling	NK	 cell	 biology.	 Therefore,	 the	 mechanisms	 which	 facilitate	 an	 efficient	 cross-talk	between	NK	cells	and	other	leukocytes	or	transformed	cells	have	been	studied	with	great	interest.	NK	cells	are	described	to	form	three	different	types	of	immunological	synapses	(IS)	 -	 inhibitory,	 cytotoxic	 and	 regulatory	 (Barreira	 da	 Silva	 and	Münz,	 2011).	 Each	 of	these	 interactions	 is	characterized	by	a	set	of	molecules,	which	 interact	at	 the	 interface	between	the	NK	cell	and	the	target	cell.	The	formation	of	the	IS	begins	with	the	initiation	stage,	 during	 which	 primary	 contact	 between	 the	 NK	 cell	 and	 the	 putative	 target	 is	established	 through	 binding	 of	 integrins,	 such	 as	 LFA-1	 and	 ICAM-1.	 While	 integrins	gather	at	the	periphery	of	the	synapse,	receptors	accumulate	in	the	center	(Orange	et	al.,	2003).	 At	 this	 point,	 the	 fate	 of	 the	 synapse	 is	 decided	 by	 whether	 the	 majority	 of	receptors	are	activating	or	inhibitory,	thus	defining	the	dominant	signal.	Accumulation	of	inhibitory	KIRs	and	HLA	molecules	determine	an	inhibitory	outcome	for	the	IS,	and	after	a	transient	interaction	between	the	NK	cell	and	the	putative	target,	the	NK	cell	moves	on	(Davis	et	al.,	1999).		
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However,	if	activating	signals	prevail,	then	the	formation	of	a	long-lived	cytotoxic	synapse	is	initiated.	This	includes	the	accumulation	of	molecules	in	distinct	regions	of	the	IS,	thus	creating	a	so	called	supramolecular	activation	cluster	(SMAC)	that	is	divided	into	a	central	and	a	peripheral	zone	(cSMAC	and	pSMAC)	(Figure	9)	(Orange,	2008).	As	a	first	step,	 actin	 reorganizes	 and	 polarizes	 to	 the	 cytotoxic	 IS,	 supporting	 clustering	 of	 the	receptors.	 Following	 this,	 lytic	 granules	 start	 moving	 along	 microtubules	 to	 the	microtubule-organizing	 center	 (MTOC),	 which	 itself	 begins	 to	 polarize	 towards	 the	 IS.	Once	 the	MTOC	has	 reached	 the	 IS,	 the	 actin	network	 starts	 to	disassemble	 in	 spots	 in	order	 to	 create	 channels	 that	will	 allow	 the	 lytic	 granules	 to	 gain	 access	 to	 the	plasma	membrane.	With	 the	 help	 of	 myosin	 IIA,	 lytic	 granules	 are	 able	 to	 traverse	 the	 acting	network	and	fuse	with	the	plasma	membrane,	subsequently	releasing	their	content,	such	as	perforin	or	granzyme	into	the	synaptic	cleft	(D.	Liu	et	al.,	2005;	Sanborn	et	al.,	2009).	In	the	final	stages	of	the	formation	of	the	IS,	actin	reorganization	is	likely	to	facilitate	NK	cell	 detachment	 from	 the	 target	 cell	 (Burshtyn,	 Shin,	 Stebbins,	 &	 Long,	 2000).	Furthermore,	 after	 completion,	 NK	 cells	 are	 able	 to	 rapidly	 restore	 their	 cytotoxic	potential	by	regenerating	lytic	granules	giving	the	potential	of	‘serial	killing’	targets	(Bhat	&	Watzl,	 2007;	Merrill,	 Ullberg,	 &	 Jondal,	 1981).	 Thus,	 the	 cytotoxic	 synapse	 serves	 to	concentrate	 lytic	 effector	 molecules	 at	 the	 synapse	 while	 protecting	 neighboring	 cells	from	 exposure	 to	 these	 detrimental	molecules,	 enabling	 efficient	 and	 specific	 killing	 of	multiple	subsequent	targets	(Orange,	2008).			
 
Figure	9.	Adapted	from	the	prototypical	mature	NK	cell	lytic	synapse.	(Orange,	2008)		The	third	type	of	synapse	which	is	 formed	by	NK	cells	 is	the	regulatory	synapse	and	its	function	is	related	to	NK	cell	priming	by	myeloid	APCs	(Ferlazzo	et	al.,	2002;	Lucas	et	al.,	2007).	Although	DCs	are	able	to	activate	NK	cells	solely	via	soluble	cytokines,	cell	
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contact	 can	 be	 important	 for	 increased	 transmission	 efficiency	 of	 certain	 signaling	molecules	 (Barreira	 da	 Silva	 and	 Münz,	 2011).	 Interestingly,	 mature	 DCs	 are	 able	 to	mediate	 activation	of	 resting	NK	 cells	 via	 the	 regulatory	 synapse,	while	 simultaneously	preventing	 themselves	 from	 being	 killed	 (Brilot	 et	 al.,	 2007;	 Ferlazzo	 et	 al.,	 2002).	 NK	cells	need	the	cross-talk	with	DCs	to	release	cytokines,	increase	their	cytotoxic	potential,	survive	 and	 proliferate	 (Brilot	 et	 al.,	 2007;	 Strowig	 et	 al.,	 2008).	 In	 parallel,	 the	accumulation	 of	 MHC	 class	 I	 expression	 on	 mature	 DCs	 represses	 NK	 cell	 cytotoxicity	through	inhibitory	receptor	signaling	(Ferlazzo	et	al.,	2002).	Furthermore,	expression	of	the	 protease	 inhibitor	 9	 (PI9)	 in	 DCs	 helps	 to	 inhibit	 granzyme	 B-mediated	 apoptosis	(Hirst	et	 al.,	 2003).	An	 in-depth	 study	of	 the	 regulatory	 synapse	 showed	 that	 the	actin-dependent	 stabilization	 of	 MHC	 class	 I	 molecules	 at	 the	 IS	 is	 essential	 to	 DC	 survival.	Likewise,	 maturation	 of	 the	 regulatory	 synapse	 is	 associated	 with	 an	 accumulation	 of	filamentous	 actin	 (f-actin)	 at	 the	 IS	 (Barreira	 da	 Silva	 et	 al.,	 2011).	 Recruitment	 of	inhibitory	KIRs	and	CD94-NKG2	receptors	as	well	as	IL-15	receptor	components	to	the	IS	happens	 rapidly.	 Thus,	 activating	 and	 inhibitory	 receptors	 find	 themselves	 at	 the	 same	spot	at	same	time.	Segregation	into	separate	domains	at	the	center	of	the	IS	seems	to	be	the	 key	 to	 making	 signaling	 of	 both	 a	 stimulatory	 and	 inhibitory	 nature	 possible	 in	parallel	 (Brilot	 et	 al.,	 2007).	As	maturation	of	 the	 regulatory	 synapse	progresses,	more	signals	emerge	such	as	IL-12,	mediating	IFN-γ	secretion	by	NK	cells	(“NK	cell	activation	by	dendritic	cells	(DCs)	requires	the	formation	of	a	synapse	leading	to	IL-12	polarization	in	 DCs.,”	 2004a).	 Thus,	 stabilization	 of	 the	 KIR-HLA	 interaction	 through	 f-actin	accumulation	allows	for	efficient	priming	of	NK	cells	without	jeopardizing	the	DC.  
 
PART	III	–	DENDRITIC	CELLS		Dendritic	 cells	 are	 prototypic	 antigen	 presenting	 cells	 (APCs)	 that	 express	MHC	 class	 I	and	 II	 and	 are	 adapted	 to	 processing	 and	 presenting	 peptide	 fragments	 to	 cells	 of	 the	innate	 and	 adaptive	 immune	 system.	 Accordingly,	 DCs	 are	 constantly	 patrolling	 their	environment	in	search	of	pathogen	and/or	stress	signals	(“Dendritic	cells	and	the	control	of	immunity.,”	1998).		
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2.1	Dendritic	cell	subsets		The	 different	 types	 of	 DCs	 are	 categorized	 into	 preDCs,	 conventional	 DCs	 and	inflammatory	DCs	(Figure	10).	Pre-DCs	are	defined	by	their	lack	of	dendrites	and	classical	DC	 function	 in	 steady	 state	 and	 include	 plasmacytoid	 DCs	 and	 monocytes	 (“IPC:	Professional	 Type	 1	 Interferon-Producing	 Cells	 and	 Plasmacytoid	 Dendritic	 Cell	Precursors,”	2005).	All	subset	are	uniquely	defined	by	the	expression	of	specific	surface	markers,	 localization	 and	 pattern	 recognition	 receptors	 (PRRs).	 These	 PRRs	 allow	DCs	and	other	 innate	 cells	 to	 recognize	pathogen	and	danger	associated	molecular	patterns	(PAMPs	 and	 DAMPs)	 which	 are	 distinctive	 for	 microbial	 pathogens	 and	 damaged	 or	apoptotic	 cells,	 respectively	 (“Pattern	 recognition	 receptors	 and	 inflammation.,”	 2010).	There	are	a	 lot	of	different	kinds	of	PRRs	described	that	mediate	recognition	of	specific	PAMPs	 and	 DAMPs,	 but	 only	 members	 of	 the	 toll-like	 receptor	 (TLR)	 family	 will	 be	discussed	in	more	detail	below.		
	
Figure	10.	Organization	of	the	dendritic	cell	network.	(“Transcriptional	programming	of	the	dendritic	
cell	network.,”	2012)		Plasmacytoid	DCs	 (pDCs)	 are	 found	 throughout	 the	 body	 and	 are	 an	 important	source	 of	 type	 I	 interferons	 upon	 viral	 infection	 (“A	 leukocyte	 subset	 bearing	 HLA-DR	antigens	 is	responsible	 for	 in	vitro	alpha	 interferon	production	 in	response	to	viruses.,”	1985;	“Anti-viral	activity	induced	by	culturing	lymphocytes	with	tumor-derived	or	virus-transformed	 cells.	 Identification	 of	 the	 anti-viral	 activity	 as	 interferon	 and	characterization	 of	 the	 human	 effector	 lymphocyte	 subpopulation.,”	 1978).	 In	 humans	they	 are	 characterized	 by	 BDCA-2	 and	 BDCA-4	 expression	 and	 are	 considered	 poor	antigen	presenters.	Instead,	pDCs	are	able	to	recognize	RNA	as	well	as	unmethylated	DNA	motives	consisting	of	cytosine	and	guanine	nucleotides	linked	by	a	single	phosphate	(CpG	
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motives)	 on	 bacterial	 and	 viral	 genomes	 via	 TLR7	 and	 TLR9	 (“BDCA-2,	 BDCA-3,	 and	BDCA-4:	three	markers	for	distinct	subsets	of	dendritic	cells	in	human	peripheral	blood.,”	2000;	“DNA	activates	human	immune	cells	through	a	CpG	sequence-dependent	manner.,”	1999;	 “Interferon-alpha	 and	 interleukin-12	 are	 induced	 differentially	 by	 Toll-like	receptor	7	ligands	in	human	blood	dendritic	cell	subsets.,”	2002;	“Plasmacytoid	dendritic	cells:	one-trick	ponies	or	workhorses	of	the	immune	system?,”	2011;	“Regulation	of	Toll-like	receptors	in	human	monocytes	and	dendritic	cells.,”	2001).	Both	these	TLR	receptors	are	abundantly	expressed	in	pDCs	and	upon	induction	lead	to	secretion	of	IFN-α	and	IFN-β	which	in	turn	stimulates	NK	cell	cytotoxicity	(Gerosa	et	al.,	2005).	In	addition,	pDCs	are	also	an	important	source	of	IL-12	for	NK	cell	activation	during	MCMV	infection	(“Cross-talk	between	dendritic	cells	and	natural	killer	cells	in	viral	infection.,”	2005;	“Interaction	between	conventional	dendritic	cells	and	natural	killer	cells	is	integral	to	the	activation	of	effective	antiviral	immunity.,”	2005).		In	contrast,	conventional	DCs	(cDCs)	are	specialized	for	antigen	presentation	and	are	further	divided	into	migratory	DCs	and	lymphoid	tissue-resident	DCs	based	on	their	localization	 in	 tissue.	 Migratory	 DCs	 develop	 in	 peripheral	 tissue,	 where	 they	 act	 as	sentinels,	 constantly	 sampling	 their	 surroundings	 and	 then	migrate	 to	 draining	 lymph	nodes	 (“Lymph-migrating,	 tissue-derived	 dendritic	 cells	 are	 minor	 constituents	 within	steady-state	 lymph	 nodes.,”	 2008;	 “Origin	 and	 development	 of	 dendritic	 cells.,”	 2010).	Langerhans	cells,	dermal	DCs	as	well	as	several	subsets	such	as	BDCA-1+	DCs,	CD141+	DCs	and	CD16+	DCs	are	all	part	of	the	migratory	DCs	(“Epidermal	Langerhans	cells--changing	views	 on	 their	 function	 in	 vivo.,”	 2006;	 “Human	 and	 murine	 dermis	 contain	 dendritic	cells.	 Isolation	 by	 means	 of	 a	 novel	 method	 and	 phenotypical	 and	 functional	characterization.,”	1993;	“Review	of	human	DC	subtypes.,”	2010).	The	second	category	of	lymphoid	 tissue-resident	DCs	 can	be	 found	 in	murine	 spleen,	 thymus	and	 lymph	nodes	and	are	further	classified	by	the	expression	of	CD4	and	CD8α	(“CD4	and	CD8	expression	by	 dendritic	 cell	 subtypes	 in	 mouse	 thymus	 and	 spleen.,”	 2000).	 Of	 note,	 the	 murine	CD8α+	DCs	which	 are	 best	 known	 for	 their	 ability	 to	 cross-present	 antigens	 and	 hence	prime	 CD8+	 T	 cells	 are	 also	 part	 of	 this	 family	 (“CD8(+)	 but	 not	 CD8(-)	 dendritic	 cells	cross-prime	 cytotoxic	 T	 cells	 in	 vivo.,”	 2000).	 Unlike	 migratory	 DCs,	 lymphoid	 tissue-resident	DCs	do	not	traffic	at	all	but	develop	from	precursor	in	the	lymphoid	tissue	itself	(“Intrasplenic	 steady-state	 dendritic	 cell	 precursors	 that	 are	 distinct	 from	monocytes.,”	2006).	cDCs	can	sense	bacteria,	virus	and	fungi	through	the	TLR1,	2,	3,	5,	6,	and	8	upon	which	they	produce	IL-12,	TNF	and	IL-6	amongst	others	(“Subsets	of	human	dendritic	cell	precursors	 express	 different	 toll-like	 receptors	 and	 respond	 to	 different	 microbial	
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antigens.,”	 2001a;	 “Toll-like	 receptors	 and	 dendritic	 cells:	 for	 whom	 the	 bug	 tolls.,”	2004a).			The	 last	 category	 of	 DCs	 are	 the	 inflammatory	DCs	 that	 only	 differentiate	 from	precursors	upon	infection	or	stress	signals.	Their	TLR	repertoire	is	similar	to	that	of	cDCs	but	these	cells	can	in	addition	respond	to	LPS	due	to	their	expression	of	TLR4	(“Subsets	of	 human	 dendritic	 cell	 precursors	 express	 different	 toll-like	 receptors	 and	 respond	 to	different	microbial	 antigens.,”	2001b;	 “Toll-like	 receptors	and	dendritic	 cells:	 for	whom	the	bug	tolls.,”	2004b).		
2.2	Cross-talk	between	DCs	and	NK	cells	
2.2.1	NK	cell	priming	by	DCs		NK	 cell-DC	 interactions	 take	 place	 in	 SLOs	 and	 sites	 of	 inflammation,	which	 is	 also	 the	location	 where	 the	 CD56bright	 subset	 is	 enriched	 (Ferlazzo	 et	 al.,	 2004b;	 2004a).	Maturation	of	NK	cells	upregulates	chemokine	receptors	on	their	surface,	rendering	them	more	 efficient	 at	 migrating	 to	 SLOs	 to	 which	 mature	 DCs	 home	 to,	 facilitating	 their	interaction	 at	 these	 sites	 (Fehniger	 et	 al.,	 2003).	 In	 addition,	 a	 number	 of	 secreted	cytokines	are	also	 important	 for	NK	cell	activation.	For	 instance,	 type	 I	 IFNs	 trigger	NK	cytotoxicity	 and	 control	 IL-12	 production	 by	 cDCs,	 which	 in	 turn	 modulates	 IFN-γ	expression	 by	 NK	 cells	 (“Interferon	 alpha/beta	 and	 interleukin	 12	 responses	 to	 viral	infections:	 pathways	 regulating	 dendritic	 cell	 cytokine	 expression	 in	 vivo.,”	 2002).	Together	 with	 IL-18,	 IL-12	 promotes	 IFN-γ	 secretion	 by	 NK	 cells	 in	 response	 to	 EBV,	influenza,	 parasites	 and	bacteria	 (Strowig	 et	 al.,	 2008).	Another	 important	 cytokine	 for	NK	 cell	 biology	 is	 IL-15,	 which	 has	 been	 implicated	 in	 the	 development,	 survival	 and	proliferation	 of	 these	 innate	 lymphocytes	 (Brilot	 et	 al.,	 2007;	 Huntington	 et	 al.,	 2007).	Among	DCs,	a	subset	of	migratory	DCs	found	in	the	skin	called	Langerhans	cells	expresses	especially	 high	 levels	 of	 IL-15	 and	 IL-15Rα,	 which	 gets	 trans-presented	 to	 NK	 cells	expressing	 the	 IL-15Rβ	 and	 γ	 chains	 to	 promote	 survival	 and	 proliferation	 of	 NK	 cells	(“Mature	myeloid	dendritic	cell	subsets	have	distinct	roles	for	activation	and	viability	of	circulating	human	natural	killer	cells.,”	2005a).	However,	although	DCs	activate	NK	cells	primarily	 via	 cytokines	 to	 initiate	 cytokine	 production	 by	 NK	 cells	 and	 increase	 their	cytotoxic	 activity,	 cell	 contact	 can	 be	 important	 sometimes	 to	 ensure	 efficient	 NK	 cell	
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activation,	 thus	emphasizing	 the	potential	necessity	of	 the	regulatory	synapse	(Brilot	et	al.,	2007;	Strowig	et	al.,	2008).		
2.2.2	DC	editing	by	NK	cells		NK	 cells	 are	 primed	 by	 DCs	 and	 inversely	 are	 responsible	 for	 modulating	 the	 DC	population	 to	 ensure	 efficient	 antigen	 presentation,	 a	 process	 termed	 DC	 editing	(Moretta,	2002).	Despite	their	expression	of	MHC	class	I,	NK	cells	are	able	to	lyse	myeloid	cells	due	to	an	abundance	of	activating	 ligands	that	overcome	the	 inhibitory	signal.	The	main	targets	of	DC	editing	are	non-activated	microglia	cells,	TLR-activated	macrophages	and	immature	DCs	(Ferlazzo	et	al.,	2003).	Interestingly,	the	frequency	of	cells	plays	a	role	in	NK	cell-mediated	killing	of	DCs.	When	activated	NK	cells	are	present	in	large	numbers,	they	 competently	 kill	 immature	 DCs	 via	 NKp30,	 NKp46	 and	 the	 co-receptor	 DNAM-1	(“Expression	of	the	DNAM-1	ligands,	Nectin-2	(CD112)	and	poliovirus	receptor	(CD155),	on	dendritic	cells:	relevance	for	natural	killer-dendritic	cell	interaction.,”	2006;	“NK	cell-mediated	 lysis	of	autologous	antigen-presenting	cells	 is	 triggered	by	 the	engagement	of	the	 phosphatidylinositol	 3-kinase	 upon	 ligation	 of	 the	 natural	 cytotoxicity	 receptors	NKp30	and	NKp46.,”	2001)	while	at	low	ratios,	NK	cells	seem	to	promote	DC	maturation	and	survival,	mediated	by	IFN-γ	and	TNF	(“Contact-dependent	stimulation	and	inhibition	of	 dendritic	 cells	 by	 natural	 killer	 cells.,”	 2002).	 As	 soon	 as	 DCs	 start	 maturing,	 they	upregulate	 HLA-E,	 which	 consequently	 protects	 them	 from	 NK	 lysis	 (Ferlazzo	 et	 al.,	2002).	 	
PART	IV	–	EPSTEIN	BARR	VIRUS		
2.1	EBV	life	cycle		Epstein-Barr	virus	(EBV)	is	one	of	eight	human	herpesviruses	and	was	discovered	more	than	fifty	years	ago	as	the	first	human	tumor	virus	(“MORPHOLOGICAL	AND	BIOLOGICAL	STUDIES	ON	A	 VIRUS	 IN	 CULTURED	 LYMPHOBLASTS	 FROM	BURKITT'S	 LYMPHOMA.,”	1965;	 “VIRUS	 PARTICLES	 IN	 CULTURED	 LYMPHOBLASTS	 FROM	 BURKITT'S	
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LYMPHOMA.,”	1964).	It	is	part	of	the	gamma-herpesviridae	subfamily,	which	is	known	to	infect	only	simians	and	has	a	long	history	of	coevolution	with	our	species	(“Epstein	Barr	Virus	 Volume	 2,”	 2015a).	 Similar	 to	 other	 herpesviruses,	 EBV	 is	 oromucosally	transmitted	via	 saliva	exchange	and	persistently	 infects	over	95%	of	adults	 (Cesarman,	2014)	(“Cellular	immune	controls	over	Epstein-Barr	virus	infection:	new	lessons	from	the	clinic	 and	 the	 laboratory.,”	 2014).	 EBV	 was	 found	 to	 be	 highly	 but	 not	 exclusively	 B-lymphotropic	and	has	potent	B	lymphocyte	growth-transforming	abilities,	enabling	it	to	persist	in	B	cells	and	induce	a	number	of	B	cell	malignancies.	The	most	common	disease	associated	with	EBV	is	infectious	mononucleosis	(IM),	the	symptomatic	manifestation	of	acute	primary	infection	(Balfour	et	al.,	2013;	Luzuriaga	and	Sullivan,	2010).	Furthermore,	the	association	between	EBV	and	certain	malignancies	 is	very	well	 established,	 such	as	Burkitt	 lymphoma,	 classical	 Hodgkin	 lymphoma,	 post-transplant	 lymphoproliferative	disease	 and	 nasopharyngeal	 carcinoma	 (“Co-infections,	 inflammation	 and	 oncogenesis:	future	 directions	 for	 EBV	 research.,”	 2014;	 “Spectrum	 of	 Epstein-Barr	 virus-associated	diseases.,”	 2006b).	 Additionally	 in	 recent	 years,	 EBV	 has	 also	 been	 implicated	 in	 some	autoimmune	 conditions	 such	 as	 multiple	 sclerosis	 (“Epstein-barr	 virus	 infection	 and	multiple	sclerosis:	a	review.,”	2010).			
	
Figure	11.	A	schematic	view	of	EBV	infection	and	persistence	in	the	immunocompetent	host.	(Taylor	
et	al.,	2015)	
IY33CH25-RickinsonTaylor ARI 2 March 2015 8:32
Latent
B
Lytic
Primary response (IM)
CD8+ T cell CD4+ T cell
Lytic
Transmitted
virions
8
8
8
8 4
4
Oral
epithelium
Oral
epithelium
Primary infection
Shed
virions
Lat
III
Lat
III
8
8 8
8
48Natural killer cell
8
8 8
4
4
Lytic
NK
NK
8
8
Lat
III
Lat
III
Lat
III
Lat
III
Lytic
Lytic
Lytic Lat
III
Lytic
Lytic
Persistent infection
Lat
0
Lat
0
Recirculating 
memory
B cell pool
Lytic
B
8
8 84 4
Latent Lytic
Memory response 
Lytic
Lat
III
Lytic
NK
? Ag dependent  
? GC dependent
Lat
III
Lat
III
Figure 2
A schematic view of EBV infection and persistence in the immu ocompetent host. Orally transmitted virus establishes a lytic infection
of permissive cells (squamous epithelium and possibly local B cells) within the oropharynx, leading to high levels of virus shedding in the
throat. Thereafter, the virus initiates growth-transforming (Lat III) infections of B cells in local lymphoid tissues, some of which then
downregulate antigen expression, thereby escaping immune recognition and establishing a pool of latently infected antigen-negative
(Lat 0) memory B cells that mainly recirculate between the blood and oropharyngeal lymphoid tissues; whether entry into memory
occurs by a GC-dependent or -independent route is still debated (1, 6). Occasionally, perhaps induced by antigen-driven differentiation
to plasma cells or by local mucosal signals, latently infected memory B cells reactivate into the lytic cycle, producing virions that can
seed low-level foci of replication and shedding in oropharyngeal epithelium, or initiate a new cycle of infection and transformation in
adjacent B cells, some of which may survive to supplement the virus-positive memory B cell pool. In the immunocompetent host, many
of these events are subject to immune controls. Primary EBV infection, as seen in IM patients, induces NK cell activation, large
expansions of virus-specific CD8+ T cells (with lytic-antigen reactivity dominant over latent), and smaller expansions of virus-specific
CD4+ T cells in the blood. These initial expansions are later culled, leaving lower numbers of virus-specific memory T cells in the
blood of long-term virus carriers. Blue arrows denote transfer of infectious virions, black arrows denote movement or transition of
infected cells, and wide gray arrows denote targeting of infected cells by cell-mediated immune responses. Abbreviations: Ag, antigen;
EBV, Epstein-Barr virus; GC, germinal center; IM, infectious mononucleosis; Lat 0, Latency 0; Lat III, Latency III; NK, natural killer.
of the host response to the viral infection; the main effector cell types are superimposed onto the
diagram of infection in Figure 2 and are described in more detail below.
INNATE IMMUNE RESPONSES TO PRIMARY INFECTION
The Natural Killer Cell Response
The NK cell (CD3−CD56+) population as a whole expands in frequency and number in the
circulating mononuclear cells of IM patients (11, 14, 15). The biological significance of this ex-
pansion remained unclear, as it was first reported to correlate inversely with severity of symptoms
790 Taylor et al.
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Primary	 infection	with	EBV	 leads	 to	 initial	 lytic	 replication	 in	 submucosal	B	 cells	and	epithelial	cells	of	the	oropharynx	(Figure	11)	(Taylor	et	al.,	2015).	At	this	point,	EBV	infected	 individuals	 are	 producing	 vast	 amounts	 of	 virions	 and	 are	 highly	 contagious.	Once	EBV	enters	the	next	stage	of	its	life	cycle,	it	no	longer	produces	virions	and	persists	in	one	of	the	four	stages	of	latency	that	are	characterized	by	specific	expression	patterns	of	viral	genes	(Table	2)	(“EBV	gene	expression	and	regulation,”	2007).	This	is	also	when	the	 infection	 spreads	 through	 proliferation	 of	 latently	 infected	 B	 cells.	 These	 virus-carrying	B	 cells	 express	 six	 EBV	nuclear	 antigens	 (EBNA1,	 2,	 3A,	 3B,	 3C,	 and	 -LP),	 two	latent	membrane	proteins	 (LMP1	and	2),	 two	EBV	encoded	RNAs	 (EBERs)	 and	various	microRNAs,	 which	 drive	 Latency	 III	 infection	 (Cesarman,	 2014).	 Subsequent	 down-regulation	of	the	growth-transforming	program	allows	B	cells	to	enter	Latency	0.	In	this	state,	 EBV	 is	 able	 to	 persist	 as	 a	 truly	 latent	 infection	 in	 the	 B	 cell	 memory	 pool	throughout	 the	 host’s	 life.	 Occasionally,	 reactivation	 of	 EBV	 into	 lytic	 replication	 can	occur	 in	 plasma	 cells,	 leading	 to	 virus	 shedding	 in	 the	 throat	 (“The	 pathogenesis	 of	Epstein-Barr	 virus	persistent	 infection.,”	 2013). Lytic	 replication	has	 been	 shown	 to	 be	associated	with	the	expression	of	most	virally	encoded	genes,	mediating	amplification	of	the	viral	genome,	synthesis	of	viral	structure	proteins,	 formation	of	the	viral	capsid	and	production	of	new	infectious	virions	which	can	be	spread	to	other	individuals	(“Epstein	Barr	 Virus	 Volume	 2,”	 2015b).	 Integral	 to	 lytic	 cycle	 induction	 are	 the	 virally	 encoded	transcription	factors	BZLF1	and	BRLF1,	which	are	sufficient	to	induce	lytic	replication	in	latently	 infected	cells	(“Lytic	cycle	switches	of	oncogenic	human	gammaherpesviruses.,”	2007).		
Latency	program	 Expressed	viral	genes	Latency	0	 None	Latency	I	 LMP-2A/EBNA-1	Latency	II	 EBNA-1,	LMP-1,	LMP-2A,	-2B	Latency	III	 EBNA-1,	-2,	-3,	-4,	-5,	-6,	LMP-1,	LMP-2A,	-2B,	EBERs	
Table	2.	EBV	latency	programs	(“Epstein-Barr	virus	oncogenesis	and	the	ubiquitin-proteasome	
system.,”	2004)	
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2.2	Immune	response	to	EBV		Disease	 progression	 of	 EBV	 has	 been	 hard	 to	 study,	 since	 early	 primary	 infection	 is	asymptomatic	 and	 therefore	difficult	 to	 detect.	 Accordingly,	much	of	 the	 knowledge	 on	the	 immunology	 of	 EBV	 was	 collected	 in	 IM	 patients	 after	 onset	 of	 symptoms.	 Only	recently	a	prospective	study	that	followed	college	students	to	monitor	the	immunological	changes	 before	 and	 during	 onset	 of	 IM	 provided	 some	 novel	 insights	 into	 the	 early	immune	response	to	primary	EBV	infection.	For	instance,	virus	was	not	detected	directly	after	transmission	in	the	oral	cavity	but	only	shortly	before	onset	of	symptoms	and	while	the	 number	 pDCs	was	 decreased	 during	 the	 incubation	 period,	 NK	 cells	 only	 came	 up	after	 disease	 onset	 (Dunmire	 et	 al.,	 2015).	 In	 addition,	 the	 lack	 of	 a	 murine-tropic	equivalent	of	EBV	meant	that	no	small	animal	model	was	available	to	study	the	virus	in	
vivo,	until	the	development	of	mice	reconstituted	with	a	human	immune	system	(see	next	chapter)	 (“Development	 of	 a	 human	 adaptive	 immune	 system	 in	 cord	 blood	 cell-transplanted	 mice.,”	 2004a).	 Accordingly,	 EBV	 was	 the	 first	 human	 pathogen	 to	 be	studied	 in	 this	 novel	 mouse	 model.	 Although	 many	 unresolved	 issues	 remain	 the	currently	defined	key	players	of	 the	 innate	and	adaptive	 immune	response	are	outlined	below. 	
2.2.1	Innate		The	first	responders	to	acute	EBV	infection	might	possibly	be	NK	cells,	which	undergo	a	significant	 expansion	 in	 peripheral	 blood	 (Balfour	 et	 al.,	 2013;	 Williams	 et	 al.,	 2005).	Humanized	 mice	 challenged	 with	 EBV	 increase	 an	 early	 subset	 of	 NK	 cells	 that	 is	predominantly	 KIR-negative	 and	 able	 to	 respond	 prior	 to	 CD8+	 T	 cells.	 Furthermore,	when	NK	 cells	were	 depleted	 in	mice,	 the	 lack	 of	 the	NK	 cell	 response	 led	 to	 elevated	CD8+	 T	 cell	 numbers	 and	 an	 exacerbated	 disease	 progression	 (Chijioke	 et	 al.,	 2013).	Interestingly,	a	similar	subset	of	NKG2A+KIR-	NK	cells	was	also	found	to	be	more	frequent	in	toddlers	and	young	children	compared	to	adolescents	or	adults	and	this	NK	cell	subset	could	efficiently	degranulate	and	proliferate	 in	response	to	 lytic	EBV-replicating	B	cells.	Thus,	 a	 decrease	 in	 the	 frequency	 and	 number	 of	 these	 early-differentiated	 NK	 cells	during	 the	 first	 decade	 of	 life	might	 probably	 causally	 be	 associated	 to	 the	 increase	 in	severity	of	 illness	and	 the	symptomatic	CD8+	T	cell	 lymphocytosis	 found	 in	adolescents	suffering	from	IM	(Azzi	et	al.,	2014).	In	addition,	CD56bright	NK	cells	secreting	IFN-γ	were	
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found	 to	prevent	B	 cell	 transformation	by	EBV	 in	vitro	 (Strowig	et	 al.,	 2008).	Together,	these	observations	show	that	NK	cells	are	vital	in	limiting	primary	lytic	EBV	infection.	Other	 responders	 of	 the	 innate	 immune	 system	 include	 the	 myeloid	compartment.	Using	their	TLRs,	monocytes	and	pDCs	are	able	to	sense	virions	and/or	un-methylated	EBV	genomes,	respectively	(“Epstein-Barr	virus	 induces	MCP-1	secretion	by	human	 monocytes	 via	 TLR2.,”	 2007;	 “Epstein-Barr	 virus	 promotes	 interferon-alpha	production	by	plasmacytoid	dendritic	cells.,”	2010;	“TLR9	contributes	to	the	recognition	of	 EBV	 by	 primary	 monocytes	 and	 plasmacytoid	 dendritic	 cells.,”	 2010).	 Furthermore,	conventional	DCs	are	able	to	detect	EBERs	released	from	latently	infected	cells	(“Epstein-Barr	 virus	 (EBV)-encoded	 small	 RNA	 is	 released	 from	 EBV-infected	 cells	 and	 activates	signaling	from	Toll-like	receptor	3.,”	2009).	Hence,	both	the	antiviral	type	I	IFNs	secreted	by	 pDCs	 as	 well	 as	 IL-12	 secreted	 by	 cDCs	 support	 and	 activate	 NK	 cells	 responses	(Strowig	et	al.,	2008).		
2.2.2	Adaptive		The	 adaptive	 immune	 response	 to	 EBV,	 particularly	 in	 IM,	 is	 characterized	 by	 a	 large	expansion	of	the	CD8+	T	cell	compartment,	with	up	to	50%	of	the	CD8+	T	cell	population	typically	responding	to	early	lytic	epitopes	(“CD8+	T	cell	responses	to	lytic	EBV	infection:	late	 antigen	 specificities	 as	 subdominant	 components	 of	 the	 total	 response.,”	 2013;	“Cellular	 responses	 to	 viral	 infection	 in	 humans:	 lessons	 from	 Epstein-Barr	 virus.,”	2007a).	 As	 lytic	 infection	 progresses,	 immune	 evasion	 proteins	 downregulate	 antigen	presentation	 on	 cells,	 thus	 reducing	 their	 availability	 to	 CD8+	 T	 cells	 (“Cooperation	between	 Epstein-Barr	 virus	 immune	 evasion	 proteins	 spreads	 protection	 from	CD8+	 T	cell	 recognition	across	all	 three	phases	of	 the	 lytic	 cycle.,”	2014;	 “Immune	responses	 to	Epstein-Barr	virus:	molecular	interactions	in	the	virus	evasion	of	CD8+	T	cell	immunity.,”	2010).	Responses	to	the	ensuing	latent	program	are	only	mounted	by	5%	of	CD8+	T	cells	and	mainly	 focused	 on	 the	 EBNA3	protein	 family	 that	 account	 for	 60%	of	 latent	 genes	(“Cellular	 responses	 to	 viral	 infection	 in	 humans:	 lessons	 from	 Epstein-Barr	 virus.,”	2007b;	 “Tonsillar	homing	of	Epstein-Barr	virus-specific	CD8+	T	cells	and	 the	virus-host	balance.,”	2005).	As	CD8	expansion	occurs	 simultaneously	with	onset	of	 symptoms,	 the	hypothesis	 that	 IM	 is	an	 immunopathologic	disease	 is	 further	 reinforced	 (Balfour	et	al.,	2013).	 Finally,	 as	 the	 viral	 loads	 drop,	 contraction	 of	 the	 peripheral	 CD8+	 T	 cell	
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compartment	back	to	steady	state	 levels	also	takes	place,	 indicating	a	resolution	of	EBV	infection	(Taylor	et	al.,	2015).	In	 contrast,	 CD4+	 T	 cell	 responses	 remain	 small	 and	 are	 mainly	 directed	 at	 the	latent	antigens	of	EBV	(Balfour	et	al.,	2013).	Especially	EBNA1-specific	CD4+	T	cells	can	be	found	at	high	frequencies	in	healthy	virus	carriers,	but	not	during	IM	(“Human	CD4(+)	T	 lymphocytes	 consistently	 respond	 to	 the	 latent	 Epstein-Barr	 virus	 nuclear	 antigen	EBNA1.,”	 2000).	 As	EBNA1	presentation	 relies	 on	 a	mechanism	 that	 first	 degrades	 and	processes	 the	 antigen,	 its	 accessibility	 to	 APCs	 is	 delayed.	 This	 could	 reflect	 the	postponed	 response	 of	 CD4+	 T	 cells	 and	 the	 ensuing	 antibody	 response	 (“Antibody	responses	 to	 Epstein-Barr	 virus-determined	 nuclear	 antigen	 (EBNA)-1	 and	 EBNA-2	 in	acute	 and	 chronic	 Epstein-Barr	 virus	 infection.,”	 1987a;	 “Nuclear	 location	 of	 an	endogenously	 expressed	 antigen,	 EBNA1,	 restricts	 access	 to	 macroautophagy	 and	 the	range	of	CD4	epitope	display.,”	2010).	B	cells,	which	albeit	being	the	primary	target,	are	still	able	to	secret	a	wide	range	of	 antibodies	 in	 response	 to	 lytic	 and	 latent	 cycle	antigens	 constitute	 the	 third	pillar	of	the	adaptive	response.	The	presence	of	IgM	and	rising	IgG	titers	toward	the	virus	capsid	antigen	complex	as	well	as	absence	of	EBNA1-specific	antibodies	are	used	as	serological	tools	 in	 the	 diagnosis	 of	 IM.	 (“Performance	 of	 the	 architect	 EBV	 antibody	 panel	 for	determination	 of	 Epstein-Barr	 virus	 infection	 stage	 in	 immunocompetent	 adolescents	and	young	adults	with	clinical	suspicion	of	 infectious	mononucleosis.,”	2014).	While	the	EBNA1	response	is	delayed	and	is	maintained	at	a	stable	level	only	after	3-6	months,	IgG	antibodies	 against	 EBNA2	 peak	 soon	 after	 disease	 onset	 before	 they	 start	 to	 decline	again.	 Healthy	 virus	 carriers	 eventually	 present	 a	 serological	 profile	 that	 includes	antibodies	 against	 the	 viral	 capsid	 and	 EBNA1	 (“Antibody	 responses	 to	 Epstein-Barr	virus-determined	 nuclear	 antigen	 (EBNA)-1	 and	 EBNA-2	 in	 acute	 and	 chronic	 Epstein-Barr	virus	infection.,”	1987b).		
PART	V	–	HUMANIZED	MICE		Humanized	mice	 (huMice)	 have	 become	 a	 highly	 valued	 tool	 to	 study	 processes	 of	 the	human	immune	system	that	can	otherwise	not	be	modeled	in	healthy	donors	or	patients.	To	 generate	 these	 models,	 mouse	 strains	 that	 lack	 mouse	 lymphocytes	 and	 whose	myeloid	 compartment	 tolerates	 human	 cells	 are	 currently	 used	 (Leung	 et	 al.,	 2013).	
Introduction	
	 	 	 	 47	
Preferentially,	 the	 non-obese	 diabetic	 (NOD)	 or	 the	 BALB/c	mouse	 strain	 with	 scid	 or	RAG	 mutations	 are	 used	 (Ishikawa	 et	 al.,	 2005)	 (“Human	 lymphoid	 and	 myeloid	 cell	development	 in	NOD/LtSz-scid	 IL2R	gamma	null	mice	engrafted	with	mobilized	human	hemopoietic	 stem	 cells.,”	 2005a;	 “Transgenic	 expression	 of	 human	 signal	 regulatory	protein	 alpha	 in	 Rag2-/-gamma(c)-/-	 mice	 improves	 engraftment	 of	 human	hematopoietic	cells	in	humanized	mice.,”	2011a).	The	scid	mutation	or	absence	of	one	of	the	recombination-activating	genes	(Rag-1	or	2)	prevent	somatic	rearrangement	of	the	B	and	 T	 cell	 receptors	 and	 thus	 impede	 development	 of	 these	 adaptive	 lymphocytes.	 In	addition,	deletion	of	the	common	gamma	chain	(γc)	blocks	signaling	of	IL-2,	-4,	-7,	-9,	-15,	and	 -21,	 which	 abolishes	 the	 development	 of	 innate	 lymphoid	 precursors	 (IL-7	dependent)	 and	 IL-15-dependent	 NK	 cell	 differentiation.	 The	 only	 remaining	 immune	compartment	 of	 mouse	 origin	 are	 murine	 myeloid	 cells,	 which	 can	 potentially	phagocytose	 engrafted	 human	 cells	 (“Functional	 CD47/signal	 regulatory	 protein	 alpha	(SIRP(alpha))	 interaction	 is	 required	 for	optimal	human	T-	and	natural	killer-	 (NK)	cell	homeostasis	 in	vivo.,”	2011;	 “Transgenic	expression	of	human	signal	regulatory	protein	alpha	 in	Rag2-/-gamma(c)-/-	mice	 improves	engraftment	of	human	hematopoietic	 cells	in	humanized	mice.,”	2011b).	The	most	 commonly	 used	 NOD-scid	 γc−/−	 (NSG)	 or	 BALB/c	 RAG2−/−	 γc−/−	 (BRG)	mouse	 backgrounds	 are	 then	 neonatally	 injected	 with	 CD34-positive	 hematopoietic	progenitor	 cells	 (HPCs)	 (Ishikawa	 et	 al.,	 2005).	 	 After	 three	 months,	 nearly	 60%	 of	huMouse	PBMCs	tend	to	be	of	human	origin	(Rämer	et	al.,	2011).	Of	the	total	human	cells	found	 in	 the	 periphery,	 B	 and	 T	 cells	make	 up	 the	 bulk	 at	 around	 45%	 each,	with	 the	majority	 of	 T	 cells	 being	 CD4+,	 NK	 cells	 contribute	 another	 5%	 and	 the	 rest	 of	 the	compartment	 are	monocytes	 (3%)	 and	 DCs	 (2%)	 (Rämer	 et	 al.,	 2011).	 Although	 these	mice	 engraft	 most	 human	 immune	 system	 compartments,	 they	 lack	 gut	 mucosa	reconstitution	 and	 germinal	 center	 development.	 	 The	 former	 can	 be	 resolved	 by	implanting	human	fetal	thymus	and	liver	organoid	under	the	kidney	capsule,	creating	the	so	 called	 bone	marrow−liver−thymus	 (BLT)	mice	 (“Cryptopatches	 are	 essential	 for	 the	development	of	human	GALT.,”	2013).	This	 for	 instance	 leads	to	T	cells	no	 longer	being	educated	 in	 the	 mouse	 thymus,	 but	 rather	 in	 the	 transplanted	 human	 organoid	 (“The	analysis	 of	 the	 functions	 of	 human	 B	 and	 T	 cells	 in	 humanized	 NOD/shi-scid/gammac(null)	 (NOG)	mice	 (hu-HSC	NOG	mice).,”	2009).	Taken	 together,	mice	such	as	 the	 NSG,	 BRG	 or	 BLT	mice	 are	 good	models	 of	 the	 human	 immune	 system	 and	 are	accordingly	used	to	investigate	human-tropic	viruses,	vaccines,	etc.		
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PART	VI	–	AIM	AND	OUTLINE		As	 outlined	 in	 the	 previous	 pages,	 NK	 cells	 are	 vital	 responders	 to	 a	 number	 of	pathologies.	 Therefore,	 understanding	 their	 biology	 in	 more	 detail	 could	 help	 develop	more	specific	 therapies,	which	might	 take	advantage	of	 their	natural	cytotoxicity.	Using	humanized	 mice	 as	 a	 model	 organism,	 the	 goal	 was	 to	 analyze	 late	 human	 NK	 cell	differentiation	 and	 repertoire	 development	 during	 steady	 state	 as	 well	 as	 under	inflammatory	 conditions.	 Furthermore,	 in	 depth	 study	 of	 NK	 cell	 education	 could	 help	decipher	which	of	the	models	currently	described	for	mouse	NK	cells	best	fits	the	actual	
in	vivo	process	for	human	NK	cells.	Moreover,	KIR	dependent	education	can	be	uniquely	studied	 in	 humanized	 mice,	 because	 this	 receptor	 family	 is	 not	 conserved	 in	 mice.	Additionally,	 performing	 these	phenotypic	 and	 functional	 studies	 of	NK	 cells	 in	 huNSG,	co-reconstituted	with	HLA-mismatched	donors,	allowed	us	to	observe	NK	cell	repertoire	development	and	responses	 in	conditions	 that	mimic	 those	of	hematopoietic	 transplant	patients.	 Apart	 from	 the	 study	 of	 NK	 cell	 development,	we	 also	wanted	 to	 explore	 the	involvement	 of	 accessory	 cells	 in	 shaping	NK	 cell	 responses.	 Therefore,	 in	 addition	we	investigated	 the	 cross-talk	 between	 pDCs	 and	NK	 cells	 to	 understand	 the	 formation	 of	this	unique	immunological	synapse	and	how	it	could	beneficially	be	targeted	to	improve	NK	cell	responses.		
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3.1	ABSTRACT		Natural	killer	 (NK)	 cells	 are	 innate	 lymphocytes	with	protective	 functions	against	 virus	infections	 and	 tumor	 formation.	 Human	 NK	 cells	 carry	 inhibitory	 killer	 cell	immunoglobulin-like	 receptors	 (KIRs),	 recognizing	 distinct	 human	 leukocyte	 antigens	(HLA).	 NK	 cells	 with	 KIRs	 for	 self-HLA	molecules	 acquire	 superior	 cytotoxicity	against	HLA-negative	 tumor	 cells	 during	 education	 for	 improved	missing-self	 recognition.	Here	we	 show	 that	 co-reconstitution	 of	 two	 KIR-ligand	mismatched	 human	 immune	 system	compartments	 in	 mice	 does	 not	 alter	 the	 frequency	 of	 KIR	 expressing	 NK	 cells,	 but	their	 education.	 NK	 cell	 education	 is	 diminished	 for	 KIRs,	 whose	 cognate	 HLA	molecules	are	 lacking	on	 leukocytes	 that	 reconstitute	 in	parallel	 in	 the	 same	mice.	This	change	 in	 NK	 cell	 education	 in	 mixed	 human	 donor	 reconstituted	 mice	 is	 functionally	relevant,	 because	 it	 improves	 NK	 cell	 mediated	 immune	 control	 of	 Epstein	 Barr	 virus	infection.	 Thus,	 leukocytes	 lacking	 cognate	 HLA	 ligands	 can	 disarm	 KIR-positive	 NK	cells	 for	 improved	immune	control	of	a	human	γ-herpesvirus.	
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3.2	INTRODUCTION		Natural	killer	(NK)	cells	are	the	prototypic	innate	lymphocytes	and	have	originally	been	identified	 by	 their	 ability	 to	 spontaneously	 kill	 transformed	 and	 infected	 cells	(Herberman	 et	 al.,	 1975a;	 Kiessling	 et	 al.,	 1975;	 Trinchieri	 and	 Santoli,	 1978).	 They	recognize	 their	 targets	 by	 balancing	 signals	 of	 activating	 and	 inhibitory	 receptors,	resulting	 in	 missing-self	 recognition	 upon	 loss	 of	 inhibitory	 ligands,	 mostly	 major	histocompatibility	 complex	 (MHC)	 class	 I	molecules,	 and	 altered-self	 recognition	 upon	gain	of	activating	ligands	on	the	surface	of	encountered	cells	(Long	et	al.,	2013;	Martinet	and	 Smyth,	 2015;	 Moretta	 et	 al.,	 2001).	 The	 ability	 of	 NK	 cells	 to	 detect	 too	 few	inhibitory	ligands	or	too	many	activating	ligands	in	reference	to	unaltered	host	tissue	is	thought	 to	 be	 acquired	 by	 NK	 cells	 in	 a	 continuous	 process	 called	 “education”	 or	“licensing”	via	the	interaction	of	inhibitory	NK	cell	receptors	and	MHC	class	I	molecules	(Elliott	and	Yokoyama,	2011;	Goodridge	et	al.,	2015;	Pradeu	et	al.,	2013).	Whether	NK	cell	 education	 is	mediated	 “in	 cis”	(on	 the	NK	 cell	 itself)	 or	 “in	 trans”	 (by	neighboring	cells)	 or	 both	 is	 still	 a	 matter	 of	 debate	 (Bessoles	 et	 al.,	 2013;	 Chalifour	 et	 al.,	 2009;	Ebihara	 et	 al.,	 2013;	 Joncker	 et	 al.,	 2010),	 however	 the	 hematopoietic	 compartment	seems	 to	 be	 sufficient	 in	 both	mouse	 and	 human	 for	NK	cell	education	(Ebihara	et	al.,	2013;	Haas	et	al.,	2011).	This	process	safeguards	NK	cell	cytotoxicity	by	either	“arming”	cells	 that	 express	 in	 parallel	 to	 activating	 NK	 cell	 receptors	 inhibitory	 receptors	 that	are	 sufficiently	engaged	by	unaltered	host	 cells,	 or	by	 “disarming”	 through	continuous	engagement	 of	 activating	 receptors	 without	 inhibitory	 signals	 (Tripathy	 et	 al.,	 2008;	Viant	 et	 al.,	 2014).	 While	 most	 activating	 NK	 cell	 receptors	 are	 nearly	 uniformly	expressed	 on	 all	 mature	 NK	 cells,	 inhibitory	 receptors	 are	 expressed	 on	 subsets,	whose	contribution	 to	 the	NK	cell	 repertoire	of	 an	 individual	 is	 guided	by	genetic	and	environmental	 factors,	 e.g.	 the	 genomic	 repertoire	 of	 killer	 immunoglobulin-like	receptors	 (KIRs)	and	 persistent	 cytomegalovirus	 (HCMV)	 infection	 in	 humans	 (Béziat	et	al.,	2013).	 This	 composition	 of	 the	NK	cell	repertoire	becomes	particularly	important	during	 primary	 infection	with	 pathogens,	 like	 herpesviruses,	 which	 clinically	 identify	individuals	 with	 primary	 immunodeficiencies	 that	 impair	 NK	 cell	 functions	 (Orange,	2013).	 One	 of	 these	 is	 the	 infection	 with	 the	 human	 oncogenic	 γ-herpesvirus	 Epstein	Barr	 virus	 (EBV).	 EBV	 persistently	 infects	 more	 than	 90%	 of	 the	 human	 adult	population	 (Taylor	 et	 al.,	 2015).	 While	 primary	 infection	 is	 usually	 asymptomatic	 in	children,	 adolescents	 more	 frequently	 suffer	 from	 infectious	 mononucleosis	 (IM)	during	 their	 first	 encounter	 with	 EBV	 (Balfour	 et	 al.,	 2013;	 Luzuriaga	 and	 Sullivan,	
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2010).	While	EBV	is	associated	with	B	cell	and	epithelial	malignancies	through	its	viral	oncogenes	 that	 are	 expressed	 during	 latent	 infection,	 lytic	 replication	 that	 produces	infectious	virions	seems	to	be	poorly	controlled	during	IM	and	causes	the	characteristic	immune	pathogenic	CD8+	T	cell	lymphocytosis	of	this	disease	(Cesarman,	2014).	NK	cells	were	reported	to	expand	during	IM	(Azzi	et	al.,	2014;	Balfour	et	al.,	2013;	Williams	et	al.,	2005)	and	seem	to	particularly	restrict	lytic	EBV	infection	that	is	deregulated	during	IM	(Azzi	 et	 al.,	 2014;	Chijioke	et	al.,	 2013).	 Interestingly	and	 in	 contrast	 to	 the	prototypic	terminally	 differentiated	 NK	 cell	 expanding	 pathogen	 HCMV,	 EBV	 seems	 to	 drive	proliferation	 of	 early	 differentiated	 non-KIR	 educated	 NK	 cells	 (Azzi	 et	 al.,	 2014;	Dunmire	 et	 al.,	 2015).	 These	 NK	 cells	 have	 been	 reported	 to	 recognize	 lytically	 EBV	replicating	B	cells	via	recognition	by	the	activating	NK	cell	receptors	NKG2D	and	DNAM-1	 (Pappworth	et	al.,	2007),	 and	 the	respective	 ligands	 for	 these	 receptors	 seem	 to	 be	up-regulated	 during	 transition	 from	 latent	 to	 lytic	 EBV	 infection	 (Azzi	 et	 al.,	 2014;	Pappworth	et	al.,	2007).	Loss	of	NK	cells	 leads	 to	elevated	viral	 loads	of	wild-type,	but	not	lytic	replication	incompetent	EBV	in	vivo	(Chijioke	et	al.,	2013).	This	in	turn	causes	hallmarks	of	IM,	including	enhanced	CD8+	T	cell	expansion	as	well	as	lymphadenopathy,	and	 in	 addition	 weight	 loss	 and	 EBV	 associated	 tumorigenesis	 in	 EBV	 infected	experimental	 animals	 (Chijioke	 et	 al.,	 2013).	 Moreover,	 the	 protective	 early	differentiated	 NK	 cell	 subset	 decreases	 in	 frequency	 within	 the	 NK	 cell	 repertoire	 of	humans	during	the	first	decade	of	life	(Azzi	et	al.,	2014),	and	therefore	could	explain	the	increased	 susceptibility	 to	 IM	 in	 adolescents.	 Thus,	 EBV	 infection	 seems	 to	 be	sensitive	 to	 the	 balance	 between	 non-KIR	 educated	 NK	 cells,	 who	 are	 either	 KIR	negative	or	whose	KIRs	have	not	encountered	cognate	MHC	class	 I	molecules,	and	KIR	educated	NK	cells.	In	 our	 study	 we	 have	 investigated	 NK	 cell	 repertoire	 generation,	 NK	 cell	education	 and	 its	 influence	 on	 the	 control	 of	 EBV	 infection	 in	mice	with	 reconstituted	human	 immune	 system	 components	 (huNSG	 mice).	 For	 this	 purpose	 we	 have	 either	reconstituted	 human	 NK	 cell	 compartments	 from	 hematopoietic	 progenitor	 cells	 that	homozygously	 carry	 MHC	 class	 I	 molecules	 for	 distinct	 KIRs	 individually	 or	 in	 mixed	chimeras.	We	found	that	the	distribution	of	KIRs	on	the	reconstituted	human	NK	cells	is	donor	 autonomous	 and	 independent	 of	 environmental	 MHC	 class	 I	 molecules,	 while	education,	mediated	by	the	hematopoietic	compartment	in	this	setting,	is	compromised	as	soon	as	a	subset	of	 immune	cells	does	not	carry	the	 cognate	MHC	class	 I	molecules.	Thus,	 the	 abrogation	 of	 the	 educational	 process	 seems	 to	 be	 dependent	 on	 trans-interactions	 with	 co-reconstituting	 hematopoietic	 cells.	 This	 results	 in	 higher	
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frequencies	 of	 non-educated	 NK	 cells	 in	 the	 mixed	 reconstitutions	 and	 an	 improved	immune	 control	 of	 EBV	 infection.	 Therefore,	 our	 findings	 are	 most	 consistent	 with	 a	disarming	model	of	KIR	mediated	education,	resulting	 in	NK	cell	compartments,	which	due	to	the	inflammatory	environment	of	EBV	infection,	nevertheless,	efficiently	control	this	human	tumor	virus.	
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3.3	RESULTS		
3.3.1	A	novel	in	vivo	model	with	parallel	reconstitution	of	two	donors’	
immune	compartments	in	NSG	mice		Double-unit	umbilical	cord	blood	transplantation	is	successfully	being	used	to	improve	engraftment	and	to	decrease	mortality	in	patients	(Barker	et	al.,	2005;	Scaradavou	et	al.,	2013).	During	the	engraftment	process,	mostly	one	donor	prevails	which	leads	to	single	unit	 engraftment	 (Gutman	 et	 al.,	 2010;	 Hashem	 and	 Lazarus,	 2015).	 Human	 NK	 cell	education	 however	 has	 been	 shown	 to	 be	 driven	 by	 the	 hematopoietic	 compartment	(Haas	 et	 al.,	 2011).	 Therefore,	 little	 data	 is	 available	 on	 how	 the	 absence	 of	 cognate	human	MHC	class	 I	molecules,	namely	cognate	human	 leukocyte	antigen	 (HLA)	class	 I,	on	hematopoietic	cells	influences	the	education	and	KIR	repertoire	of	human	NK	cells	in	trans.	 In	 order	 to	 study	 the	 effect	 of	 cognate	 versus	 non-cognate	 HLA	 on	 NK	 cell	development,	 we	 reconstituted	 NOD-scid	 γc-/-	 (NSG)	 mice	 with	 HLA	 typed	 human	hematopoietic	 progenitor	 cells	 (HPC)	 isolated	 from	 fetal	 livers	 (huNSG	mice).	 Human	fetal	 liver	 (HFL)	 donors	 were	 chosen	 to	 be	 homozygous	 for	 the	 HLA-C	 and	 -B	allotypes	 (HLA-C1,	 -C2	 and	 -Bw4),	 which	 are	 recognized	 by	 KIR2DL	 and	 KIR3DL	molecules,	 respectively.	 Furthermore,	 donors	 were	 disparate	 for	 HLA-A2	 expression,	which	 allowed	 us	 to	 track	 the	 progeny	 of	 specific	 donors	 in	 mixed	 reconstitution	experiments	 (Figure	 1A).	 Three	 types	 of	 experimental	 mouse	 groups	 were	reconstituted	 in	 this	 study.	 Two	 single	 reconstituted	 groups	 homozygous	 for	 either	HLA-C1	 (recognized	 by	 KIR2DL2/3)	 or	 -C2	 (recognized	 by	 KIR2DL1)	 and	 HLA-Bw4	(recognized	by	KIR3DL1)	were	set	up	in	parallel	to	a	third	group	that	was	 reconstituted	with	 a	mix	 from	 both	 donors.	Reconstitution	 of	 human	CD45+	leukocytes	 in	general	as	well	 as	 frequencies	 of	 reconstituted	 T	 cells,	 B	 cells	 and	 NK	 cells	 were	 comparable	 to	previous	 data	 generated	 in	 our	 lab	 (Figure	 1B)	 (Strowig	et	 al.,	 2010;	2009).	 Notably,	mixed	 reconstituted	 huNSG	mice	 developed	 cells	 from	both	 donors	 side-by-side	 in	 all	the	 reconstituted	 human	 immune	 system	 compartments	 (Figure	 1C).	 Thus	 we	established	 a	 model	 to	 study	 the	 influence	 of	 cognate	 HLA	 presence	 or	 absence	 in	trans	on	NK	cell	education	and	KIR	repertoire	development.		 	
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Figure	1.	Mixed	 reconstitution	 of	 human	 immune	 system	 compartments	 from	 HLA	mis-matched	
hematopoietic	progenitor	cells	in	NSG	mice.	
(A)	 Representative	 experimental	 overview.	 Three	 types	 of	 experimental	 groups,	 two	 reconstituted	homozygously	for	HLA-C	and	-B	allotype	(HLA-C1,	-C2	and	-Bw4)	while	disparate	for	HLA-A2	and	the	third	with	 a	 mix	 of	 both,	 were	 used.	 (B)	 Reconstitution	 of	 human	 immune	 cell	 compartments	 in	 the	 three	experimental	 groups	 as	 percentage	 of	 human	 CD45+	lymphocytes.	 (C)	Ratio	of	HLA-C1	donor	vs.	HLA-C2	donor	 frequencies	 as	 distinguished	 by	 HLA-A2	 expression	 in	 immune	 cell	 compartments	 of	 mixed	reconstituted	huNSG	mice.	Data	are	pooled	data	from	at	least	four	independent	experiments.	n=34-49,	bar	represents	mean	in	the	respective	graphs.			 	
huCD45+ T cells B cells NK cells
0
5
10
10
40
70
100 C1
C1/C2
C2
Fr
eq
ue
nc
y 
in
 %
of lymphocytes of huCD45+ of huCD45+ of huCD45+
B
huCD45+ T cells B cells NK cells
0.0
0.2
0.4
0.6
0.8
1.0
C1
C2
ra
tio
 C
1:
C
2
C
NK	cell	repertoire	and	education	
	58	
3.3.2	Development	of	the	KIR	repertoire	on	NK	cells	is	not	influenced	by	the	
HLA	haplotype	in	trans		Next	 we	 analyzed	 the	 KIR	 repertoire	 of	 NK	 cells	 in	 liver	 and	 spleen	 of	 reconstituted	huNSG	mice	 and	 compared	 it	 to	 the	KIR	 repertoire	 as	 present	 in	 the	 fetal	 liver	 of	 the	original	 donor	 (Figure	 2,	 Figure	 S1	 for	 gating,	 Figure	 S2	 and	 data	 not	 shown).	 In	order	 to	 detect	 differences	 in	 mixed	 reconstituted	 huNSG	 mice,	 NK	 cells	 from	 these	mice	 were	 separately	 evaluated	 as	 per	 donor	 origin.	 The	 overall	 diversity	 of	 the	 KIR	repertoire	 was	 comparable	 among	 all	 groups	 as	 well	 as	 to	 the	 donor	 HFLs	 and	 no	preferential	expansion	of	KIR	subsets	could	be	seen	(Figure	2).	When	relating	 the	 KIR	frequencies	 of	 reconstituted	 mice	 to	 their	 specific	 HFL	 donors,	 a	 correlation	could	be	detected	 between	 the	 two	 (Figure	 S2).	 Namely,	 HFL	 donors	 with	 for	 example	 high	frequencies	of	KIR2DL1,	KIR2DL2/3	or	KIR3DL1	single	positive	NK	 cells	 reconstituted	the	 respective	 NK	 cell	 subsets	 also	 at	 higher	 frequencies.	 Importantly,	 in	 mixed	reconstituted	 huNSG	 mice,	 the	 presence	 of	 non-cognate	 HLA	 in	 trans	 did	 not	significantly	 change	 the	 KIR	 repertoire	 (Figures	 2B	 and	 2C)	 and	 no	 differences	 were	detectable	 when	 comparing	 specific	 KIR	 frequencies	 to	 those	 of	 single	 reconstituted	mice	 (Figure	 S2).	 In	 spleen,	 a	 similar	 KIR	 repertoire	 composition	 as	 in	 the	 liver	 was	observed,	 but	 could	 not	 be	 compared	 with	 the	 splenic	 NK	 cell	 repertoire	 of	 the	 HFL	donors	 (data	 not	 shown).	 Hence	 it	 seems	 that	 the	 absence	 of	 cognate	 HLA	 on	 co-reconstituting	 hematopoietic	 cells	 does	 not	 influence	 the	 development	 of	 the	 KIR	repertoire	in	the	steady	state.		 	
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Figure	2.	HLA	haplotype	in	trans	does	not	influence	KIR	repertoire	in	steady	state	
HuNSG	mice	were	single	 reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	 (HLA-C1,	 -C2	and	-Bw4)	or	reconstituted	with	two	donors	disparate	for	allotype	and	HLA-A2	expression	 (mix).	Grey	pie	charts	depict	 the	 frequencies	of	KIR+	and	KIR-	NK	cells	and	colored	pie	charts	represent	the	indicated	KIR+	NK	cell	subsets.	(A	 to	F)	Representation	of	KIR	expressing	NK	cell	 subsets	as	percentages	of	 total	KIR+	 NK	cells	 in	 liver	of	huNSG	mice	(A	to	D)	or	human	fetal	liver	(HFL)	donors	(E	and	F).	KIR	subsets	of	liver	NK	cells	from	huNSG	mice	 reconstituted	with	 single	 donors	 homozygous	 for	HLA-C1	 (A)	 or	 -C2	 (D).	 (B	 and	 C)	 KIR	 subsets	 of	liver	NK	cells	 from	mixed	 donor	 reconstituted	huNSG	mice,	with	NK	cells	derived	from	HLA-C1	donor	(B)	and	-C2	donor	(C).	(E	and	F)	KIR	subsets	of	HFL	NK	cells	from	HLA-C1	(E)	or	-C2	HFLs	(F).	n=3.	Data	 in	(A)	to	(D)	are	pooled	data	from	at	 least	 three	independent	experiments.	n	=11-14	mice	per	group.		 	
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3.3.3	EBV	infection	does	not	force	skewing	of	the	KIR	repertoire	on	NK	cells	in	
huNSG	mice	
	Previous	work	has	established	profound	effects	of	human	CMV	infection	on	the	NK	cell	KIR	 repertoire	 and	 expansion	 of	 KIR	 educated	 NKG2C+	 NK	 cells	 (Béziat	 et	 al.,	 2013;	Gumá	et	 al.,	 2004).	 In	 an	 effort	 to	 examine	 if	 the	 KIR	 repertoire	 could	 be	 skewed	 by	another	 herpesvirus,	 huNSG	 mice	 were	 infected	 with	 Epstein	 Barr	 virus	 (EBV)	 and	monitored	 for	 5	 weeks.	 At	 endpoint,	 livers	 and	 spleens	 of	 infected	 animals	 were	analyzed	 for	 KIR	 expression	 in	 NK	 cells	 (Figure	 3,	 Figure	 S3).	 EBV	 infection	 did	 not	lead	 to	 obvious	 changes	 in	 the	 KIR+	 NK	 cell	 subset	 composition	 in	 single	 and	 mixed	reconstituted	 huNSG	 mice	 (Figures	 3A-B	 and	 Figures	 3C-D).	 Furthermore,	 when	comparing	frequencies	of	NK	cells	single	positive	for	KIR2DL1,	KIR2DL2/3	or	KIR3DL1	in	EBV	 infected	animals	 to	 controls,	 no	 differences	 could	 be	 detected	 (Figures	 3E-P).	Stable	 KIR	 repertoires	were	also	observed	in	livers	of	EBV	infected	huNSG	mice	(Figure	S3).	 It	 therefore	 appears	 that	 EBV	 infection	 is	 not	 able	 to	 induce	 skewing	 of	 the	 KIR	repertoire	in	huNSG	mice.	
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Figure	3.	Infection	with	EBV	does	not	lead	to	skewing	of	KIR	repertoire	
HuNSG	mice	were	single	 reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	 (HLA-C1,	 -C2	and	-Bw4)	or	reconstituted	with	two	donors	disparate	for	allotype	and	HLA-A2	expression	 (mix).	Grey	pie	charts	depict	 the	frequencies	of	KIR+	 and	KIR-	 NK	cells	and	colored	pie	charts	represent	the	indicated	KIR+	NK	cell	subsets.	(A	to	D)	Subsets	of	KIR-expressing	NK	cells	as	percentages	of	total	KIR+	NK	cells	in	spleen	of	EBV	infected	huNSG	mice.	(E	to	P)	Frequency	of	single	KIR+	NK	cells	in	spleens	of	huNSG	mice	at	endpoint.	Comparison	of	PBS	 controls	 to	 EBV	 infected	 animals	 for	 frequency	 of	 KIR2DL1+,	 KIR2DL2/3+	 or	 KIR3DL1+	 NK	 cells	 in	homozygous	reconstituted	mice	with	HLA-C1	donor	 (E	 to	G),	mixed	reconstituted	mice	with	cells	derived	from	HLA-C1	donor	(H	to	J)	or	-C2	donor	(K	to	M)	and	homozygous	reconstituted	mice	with	HLA-C2	donor	(M	to	P).	Data	are	pooled	data	from	at	least	three	independent	experiments.	n=8-15	mice	per	group,	bar	represents	mean,	unpaired	t	test,	n.s.,	not	significant.	
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3.3.4	Absence	of	cognate	HLA	abrogates	NK	cell	education	in	huNSG	mice	
	Whether	 human	NK	 cells	 in	mouse	models	 reconstituted	with	 human	 immune	 system	components	are	educated	has	not	been	addressed	so	far.	To	quantify	education	in	huNSG	mice,	 we	 assessed	 degranulation	 of	 single	 KIR+	NK	 cells	 towards	 a	 prototypic	 NK	 cell	target,	 the	 MHC-class	 I	 negative	 erythroleukemic	 K562	 cells,	 in	 the	 context	 of	 the	educating	HLA	ligands.	The	presence	of	solely	the	educating,	cognate	HLA	as	in	the	case	of	 single	 reconstituted	huNSG	mice	 resulted	 in	education	of	KIR2DL1,	KIR2DL2/3	and	KIR3DL1	positive	NK	cells	in	HLA-C2,	-	C1	and	-Bw4	reconstituted	animals	respectively	(Figures	4A-C),	with	functional	differences	similar	to	the	differences	between	educated	and	 non-educated	 NK	 cells	 from	 healthy	 volunteers	 (Charoudeh	 et	 al.,	 2012;	 2006).	Furthermore,	 acute	 infection	 with	 EBV	 did	 not	 influence	 this	 process.	 In	 contrast	however,	 the	 additional	 presence	 of	 non-cognate	HLA	 in	 trans	 in	mixed	 reconstituted	huNSG	 mice	 prevented	 NK	 cells	 from	 being	 educated	 (Figures	 4A-C).	 Interestingly,	education	 was	 lost	 regardless	 of	 the	 donor	 ratio	 in	 mixed	 reconstituted	 animals	 and	even	observed	when	the	cognate	HLA	negative	leukocyte	reconstitution	only	amounted	to	5%	of	 the	total	human	 immune	components	(Figure	S4).	This	argues	against	a	dose	effect	of	cognate	HLA	and	 for	 the	disarming	model	 in	KIR	mediated	NK	cell	education.	When	 looking	 at	 education	 in	 the	 context	 of	 NKG2A	 and	 its	 ubiquitously	 present	educating	 HLA-E	 ligand,	 both	 mixed	 and	 single	 reconstituted	 huNSG	 mice	 displayed	equal	education,	consistent	with	invariant	HLA-E	expression	by	all	HFL	donors	(Figure	4D).	Therefore,	education	of	human	NK	cells	takes	place	in	huNSG	mice,	independently	of	EBV	 infection,	 is	mediated	by	 the	hematopoietic	 compartment	 and	 is	 reliant	on	 the	presence	of	cognate	HLA	on	all	hematopoietic	cells.	Furthermore,	the	abrogation	of	NK	cell	education	in	mixed	reconstituted	animals	is	dependent	on	trans-	interactions.	
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Figure	4.	Loss	of	NK	cell	education	in	the	presence	of	non-cognate	MHC	class	I	in	mixed	reconstituted	
huNSG	mice.	
HuNSG	mice	were	single	 reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	 (HLA-C1,	 -C2	and	-Bw4)	or	reconstituted	with	two	donors	disparate	for	allotype	and	HLA-A2	expression	(mix).	(A	to	C)	Degranulation	of	single	KIR-positive	NK	cells	after	incubation	of	K562	cells	with	splenocytes	from	huNSG	 mice	 reconstituted	 with	 (A)	 homozygous	 HLA-C2	 or	 mixed	 (n=12-18	 mice	 per	 group),	 (B)	homozygous	HLA-C1	 or	mixed	 (n=11-14	mice	 per	 group)	 or	 (C)	 homozygous	HLA-Bw4	 or	mixed	 donors	(n=15-20	mice	per	 group),	 infected	 (red	 lines)	 or	not	 (black	 lines)	with	EBV	 for	 five	weeks.	According	 to	single	reconstituted	allotypes,	eduKIR	denotes	educated	NK	cells	and	non-eduKIR	denotes	non-educated	NK	cells	 gated	 on	 cells	 derived	 from	 donors	 used	 for	 single	 reconstitution	 in	 both	 single	 and	 mixed	reconstituted	huNSG	mice,	respectively.	(D)	Degranulation	of	KIR-	NKG2A-	 (non-edu)	and	KIR-	NKG2A+	 (edu)	NK	cells	after	incubation	of	K562	cells	with	splenocytes	from	single	or	double	(mix)	reconstituted	huNSG	mice	(n=7-10	per	group),	gated	on	cells	derived	from	donors	used	for	single	reconstitution.	Data	in	(A)	to	(C)	are	pooled	data	from	at	least	three	independent	experiments;	data	in	(D)	are	compound	data	from	two	independent	experiments.	Data	were	analyzed	by	multiple	t	 tests.	n.s.,	not	significant,	**p	<	0.01,	***p	<	0.001.		
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3.3.5	Non-educated	NK	cells	still	display	inhibition	in	response	to	cognate	HLA			In	 addition	 to	 analyzing	 education	 of	 human	 NK	 cells	 in	 huNSG	 mice,	 we	 also	studied	 the	 inherent	 inhibitory	potential	of	 specific	KIR	receptors.	To	do	so,	we	 tested	degranulation	 towards	 K562	 cells	 stably	 expressing	 individual	 HLA-C1,	 -C2	 or	 -Bw4	molecules.	 Both	 educated	 and	non-educated	NK	cells	that	carry	a	single	KIR	specific	to	the	transfected	HLA	on	the	target	cell	showed	reduced	levels	of	degranulation	compared	to	 unaltered	 or	 non-cognate	 HLA	 transfected	 K562	 cells	 (Figure	 5;	 data	 not	 shown).	Thus,	 despite	 the	 loss	 of	 education	 in	 NK	 cells	 from	mixed	 reconstituted	mice,	 non-educated	 single	 KIR+	 NK	 cells	 still	 dampened	 their	 response	 and	 exhibited	 self-inhibition,	as	previously	 observed	for	NK	cells	of	healthy	volunteers	(Yu	et	al.,	2007).	In	addition	 to	 a	 reduced	 education,	 the	 inhibition	 of	 NK	 cell	 reactivity	 by	 KIR-ligand	expressing	targets	likely	contributes	to	NK	cell	tolerance	in	mixed	chimeras.	 	
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Figure	 5.	 Inhibition	 by	 cognate	 MHC	 class	 I	 ligands	 is	 maintained	 in	 non-educated	 NK	cells.	
HuNSG	mice	were	single	 reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	 (HLA-C1,	 -C2	and	 -Bw4)	 or	 reconstituted	 with	 two	 donors	 disparate	 for	 allotype	 and	 HLA-A2	 expression	 (mix)	 and	incubated	with	MHC	class	I	negative	target	cells	(K562)	or	K562	transfectants	expressing	HLA-C1,	-C2	or	-Bw4	MHC	 class	 I	 ligands.	 According	 to	 single	 reconstituted	 allotypes,	 eduKIR	 denotes	 educated	 NK	 cell	subset	 gated	 on	 cells	 derived	 from	 donor	 used	 for	 single	 reconstitution	 in	 both	 single	 and	 mixed	reconstituted	huNSG	mice.	(A	 to	 C)	 Degranulation	 of	 single	 KIR2DL1+	 NK	 cells	 after	 incubation	 of	 K562	 or	 K562-C2	 cells	 with	splenocytes	 from	 huNSG	 mice	 reconstituted	 with	 HLA-C2	 homozygous	 or	 mixed	 donors	 (A)	 and	 paired	analysis	for	incubation	with	K562	cells	(B)	or	K562-C2	transfectants	(C).	(D	 to	 F)	 Degranulation	 of	 single	 KIR2DL2/3+	 NK	 cells	 after	 incubation	 of	 K562	 or	 K562-C1	 cells	 with	splenocytes	 from	 huNSG	 mice	 reconstituted	 with	 HLA-C1	 homozygous	 or	 mixed	 donors	 (D)	 and	 paired	analysis	for	incubation	with	K562	cells	(E)	or	K562-C1	transfectants	(F).	(G	 to	 I)	 Degranulation	 of	 single	 KIR3DL1+	 NK	 cells	 after	 incubation	 of	 K562	 or	 K562-Bw4	 cells	 with	splenocytes	 from	 huNSG	mice	 reconstituted	with	 HLA-Bw4	 homozygous	 or	mixed	 donors	(G)	and	paired	analysis	for	incubation	with	K562	cells	(H)	or	K562-Bw4	transfectants	(I).	Data	are	pooled	data	from	at	least	two	independent	experiments	and	were	analyzed	by	multiple	t	tests.	Bar	represents	mean	on	relevant	graphs.	n=7-14	mice	per	group,	n.s.,	not	significant,	*p	<0.05,	**p	<	0.01,	***p	<	0.001.	
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3.3.6	Mixed	reconstituted	huNSG	mice	display	superior	immune	control	
towards	EBV			In	 order	 to	 assess	 the	 functional	 consequence	 of	 reduced	 NK	 cell	 education,	 we	evaluated	 immune	 control	 of	 EBV	 infection.	 It	 had	 been	 previously	 shown	 that	 non-educated	 NK	 cells	 are	 mainly	 responsible	 for	 the	 innate	 immune	 response	 to	 mouse	cytomegalovirus	 (MCMV)	 infection	 (Orr	 et	 al.,	 2010).	 Therefore,	 we	 investigated	 if	 an	increased	abundance	of	non-educated	NK	cells	would	 improve	 immune	control	of	EBV	infection.	 To	 follow	disease	 progression	 of	 EBV	 infected	 huNSG	mice,	 viral	 loads	were	assessed	on	a	weekly	basis	 in	blood	and	in	spleen	at	 the	experimental	endpoints.	Viral	titers	 were	 significantly	 reduced	 in	 both	 blood	 and	 spleen	 of	 mixed	 reconstituted	animals	at	the	endpoints	of	the	experiments,	when	compared	to	EBV	infection	of	single	donor	reconstituted	animals	(Figures	6A-D).	Furthermore,	we	also	observed	a	reduced	CD8+	T	cell	expansion	 in	response	 to	EBV	 infection	 in	mixed	reconstituted	huNSG	mice	(Figure	 6E),	 which	 indicates	 a	 lower	 viral	 burden	 and	 antigen	 amount.	 However,	 the	decreased	 conversion	 to	 CD8+	T	 cells	 in	 mixed	 reconstituted	 animals	 did	 not	 result	in	 an	 altered	 CD8+	T	 cell	 composition	(Figures	 S5A-H),	 nor	were	 there	 differences	 in	the	CD8+	T	cell	effector	memory	response	of	the	various	groups	(Figure	S5I).	Thus,	side-by-side	reconstitution	of	huNSG	mice	with	two	donors,	which	leads	to	less	educated	NK	cells,	allows	for	improved	immune	control	against	EBV	infection.		
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Figure	6.	Improved	EBV	specific	immune	control	in	mixed	reconstituted	huNSG	mice	
Viral	loads	of	huNSG	mice	were	read	out	over	time	in	blood	and	at	endpoint	in	spleen.	Homozygous	single	reconstituted	huNSG	(single)	were	compared	to	mixed	reconstituted	animals	(mix).	(A	 and	 B)	 Viral	 loads	 in	 blood	 at	 weekly	 time	 points	 (A)	 and	 in	 spleen	 (B)	 of	 single	 vs.	 mixed	reconstituted	 huNSG	 mice	 for	 a	 representative	 experiment	 (n=3-9	 mice	 per	 group,	 A,	 mean	 ±	 SEM,	ANOVA	with	Bonferroni	correction).	(C	and	D)	Fold	difference	in	viral	load	for	blood	(C)	and	spleen	(D)	at	endpoint	normalized	to	mean	of	mixed	reconstituted	group.	(E)	CD8+	 to	CD4+	T	cell	ratio	in	blood	at	endpoint	in	single	vs.	mixed	reconstituted	huNSG	mice.	Data	 in	 (C)	 to	 (E)	 are	 pooled	 data	 from	 at	 least	 three	 independent	 experiments.	 n=15-40,	 bar	 represents	mean,	Mann-Whitney	or	unpaired	t	test	where	appropriate,	*p	<	0.05.		
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3.3.7	NK	cells	mediate	improved	immune	control	of	EBV	infection	in	mixed	
reconstituted	mice			To	elucidate	a	possible	role	of	NK	cells	in	the	improved	immune	control	of	EBV,	huNSG	mice	were	depleted	of	NK	cells	prior	to	infection	with	EBV.	Interestingly,	depletion	of	NK	cells	 leveled	 the	 differences	 previously	 observed	 in	 viral	 loads	 between	 mixed	reconstituted	and	single	reconstituted	huNSG	mice	(Figure	7A).	Moreover,	viral	titers	in	both	 blood	 and	 spleen	 of	 mixed	 reconstituted	 animals	 depleted	 of	 NK	 cells	 were	significantly	 higher	 compared	 to	 viral	 loads	 in	 mixed	 reconstituted	 animals	 without	depletion	 of	 NK	 cells	 (Figures	 7B	 and	 7C).	 Additionally,	 the	 loss	 of	 NK	 cell	 mediated	protection	correlated	with	an	elevated	CD8+	T	cell	expansion	in	NK	cell-depleted	mixed	reconstituted	 huNSG	 mice	 (Figure	 7D).	 Finally,	 in	 order	 to	 investigate	 NK	 cell	memory	 formation	 upon	 EBV	 infection,	 we	 assessed	 surface	 markers	 that	 had	 been	implicated	 in	 NK	 cell	 memory	 formation	 during	 viral	 infections	 (Lee	 et	 al.,	 2015;	Schlums	et	al.,	2015).	Phenotypically,	however,	we	could	not	detect	differences	between	single	 and	 mixed	 reconstituted	 huNSG	 mice	 in	 educated	 or	 non-educated	 NK	 cells,	exemplified	by	the	expression	of	CD2,	as	a	possible	marker	of	memory	NK	cells	 (Figure	S6).	 These	 data	 indicate	 that	 non-educated	 NK	 cells	 might	 play	 a	 key	 role	 in	 the	improved	control	of	EBV	infection	in	mixed	reconstituted	huNSG	mice,	but	do	not	form	a	phenotypically	identifiable	memory	NK	cell	compartment.		 	
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Figure	7.	NK	cells	mediate	protection	in	mixed	reconstituted	huNSG	mice	
Viral	loads	of	huNSG	mice	were	read	out	over	time	in	blood	and	at	endpoint	in	spleen.	Homozygous	single	reconstituted	huNSG	were	 compared	 to	mixed	 reconstituted	 animals	 and	non-NK	 cell-depleted	 (nondepl)	were	compared	to	NK	cell-depleted	(depl)	mixed	reconstituted	huNSG	mice.	(A)	Representative	experiment	for	viral	 loads	in	blood	at	weekly	time	points	of	NK	cell-depleted	single	vs.	NK	cell-depleted	mixed	reconstituted	huNSG	mice	(n=3-8	mice	per	group).	(B)	Viral	loads	in	blood	over	time	of	non-depleted	(nondepl)	vs.	NK	cell-depleted	(depl)	mixed	reconstituted	huNSG	mice.	(C)	 Viral	 loads	 in	 spleen	 at	 endpoint	 of	 non-depleted	 (nondepl)	 vs.	 NK	 cell-depleted	 (depl)	 mixed	reconstituted	huNSG	mice.	(D)	 CD8+	 to	 CD4+	 T	 cell	 ratio	 in	 blood	 at	 endpoint	 of	 non-depleted	 (nondepl)	 vs.	 NK	 cell-depleted	 (depl)	mixed	huNSG	mice.	Data	in	(B)	to	(D)	are	pooled	data	from	at	least	two	independent	experiments.	n=8-15	mice	per	group,	mean	±	SEM	or	bar	represents	mean.	Data	were	analyzed	by	ANOVA	with	Bonferroni	correction,	Mann-Whitney	or	 unpaired	 t	 test	where	 appropriate,	 n.s.,	 not	 significant,	 *p	 <	 0.05,	***p	<	0.001.	
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3.4	DISCUSSION		Using	 mixed	 hematopoietic	 progenitor	 cell	 reconstitution	 in	 NSG	 mice,	 we	 were	 able	to	 assess	 the	 influence	 of	 cognate	HLA	 absence	 in	 trans	 on	KIR	 repertoire	 generation	and	NK	cell	 education	 in	 the	 reconstituting	 human	 immune	 system.	We	observed	 that	similar	repertoires	of	KIR	positive	NK	cells	reconstituted	in	single	donor	and	mixed	KIR-ligand	mismatched	donor	reconstituted	NSG	mice	as	well	as	in	the	fetal	liver	of	the	HPC	donors	used	 for	huNSG	generation.	 In	 contrast,	 KIR	 mediated	 NK	 cell	 education	 was	compromised	 if	 even	 a	 small	 subset	 of	 leukocytes	 that	 lacked	 the	 respective	 KIR-ligand	 reconstituted	 in	 the	 same	 NSG	 mouse	 in	 parallel.	 This	 indicates	 that	 KIR	mediated	 education	 seems	 to	 be	 even	 more	 sensitive	 than	 Ly49	mediated	 education,	with	disarming	taking	place	at	a	KIR-ligand	negative	frequency	below	10%	compared	to	20%	for	the	required	Ly49	ligand	negative	frequency	in	the	murine	system	(Johansson	and	Höglund,	 2004;	 Johansson	 et	 al.,	 1997).	 Therefore,	 our	 findings	 suggest	 that	 such	small	 KIR-ligand	 negative	 leukocyte	 populations	 are	 able	 to	 disarm	 NK	 cells	 for	decreased	missing-self	 recognition.	 However,	 our	data	suggest	that	the	availability	of	a	low	affinity	binding	ligand,	as	is	the	case	for	the	KIR2DL2/3-ligand	HLA-C2	(Pende	et	al.,	2009),	 can	be	sufficient	 to	prevent	disarming	of	NK	cells	 in	 trans	 (Figures	 4B,	 5D	 and	E).	 Hence	 the	 mechanism	 of	 disarming	 and	 which	 leukocyte	 populations	 are	 mainly	involved	 require	 further	 investigations.	 Nevertheless,	 disarming,	 while	 disabling	 HLA	negative	 tumor	 cell	 recognition,	 improves	 NK	 cell	 mediated	 immune	 control	 of	herpesvirus	 infections,	 as	 previously	 shown	 for	 the	 γ-herpesvirus	 MCMV	 (Orr	 et	 al.,	2010)	and	shown	here	for	the	γ-herpesvirus	EBV	(Figures	6	and	7).		This	 study	 addresses	 for	 the	 first	 time	 KIR	 mediated	 NK	 cell	 education	 by	cognate	and	non-	cognate	HLA	molecules	on	neighboring	leukocytes,	because	this	family	of	 inhibitory	 NK	 cell	 receptors	 is	 absent	 in	 mice	 (Long	 et	 al.,	 2013)	 and	 during	transplantation	 with	 double	 cord	 blood	 units	 usually	 one	 donor	 eliminates	 the	 other	due	to	alloreactive	responses	by	co-transferred	T	cells	(Gutman	et	al.,	2010).	Therefore,	KIR	 mediated	 NK	 cell	 education	 cannot	 be	 studied	 in	 these	 settings.	 Nevertheless,	understanding	 KIR	 mediated	 NK	 cell	 education	 is	 of	 clinical	 importance,	 because	 it	has	 been	shown	that	haploidentical	hematopoietic	cell	transplantation,	harnessing	KIR-HLA	 mismatch	 recognition,	 provides	 therapeutic	 benefits	 in	 adult	 acute	 myeloid	leukemia	(AML)	and	pediatric	acute	lymphoblastic	leukemia	(ALL)	patients	(Locatelli	et	al.,	 2015;	 Ruggeri	 et	 al.,	 2002;	 Velardi	 et	 al.,	 2012)	 (46).	 It	 is	 thought	 that	 NK	 cells	reconstituting	 from	 the	 KIR-ligand	mismatched	 graft	mediate	 a	 graft-versus-leukemia	
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(GvL)	 effect	 via	 missing-self	 recognition	 of	 the	 leukemic	 blasts.	 Indeed,	 it	 has	 been	observed	that	the	reconstituting	NK	cells	mediate	allorecognition	against	the	recipient’s	leukemic	blasts	to	a	similar	extent	as	the	donor’s	mature	NK	cells,	and	that	the	degree	of	donor	allorecognition	of	recipient	cells	 is	 the	best	predictor	 for	clinical	 efficacy	(Pende	et	al.,	2009;	Pietra	et	al.,	2015).	 These	 findings	 suggest	 that	 the	 donor’s	reconstituting	human	 immune	 system	 components	 are	 sufficient	 to	 educate	 NK	 cells	 for	 KIR-	 ligand	mismatched	 leukemia	 recognition,	 that	 the	 allogeneic	 residual	 leukemia	 blasts	 of	 the	recipient	are	not	able	to	sufficiently	disarm	the	reconstituting	NK	cells	and	that	also	the	recipient’s	 somatic	 cells	 are	 not	 able	 to	 sufficiently	 induce	 tolerance	 in	 the	reconstituting	 donor	 NK	 cells.	 However,	 our	 data	 suggest	 that	 this	 effect	 cannot	 be	further	 potentiated	 by	 combining	 donors	 with	 high	 anti-leukemic	 NK	 cell	 reactivity,	because	 their	 reconstituting	 leukocytes	 might	 disarm	 each	 other	 and	 result	 in	diminished	 GvL	 reactivity,	 as	 observed	 in	 our	 study	 in	 the	 recognition	 of	 the	 human	erythroleukemia	cell	line	K562.		In	 contrast	 to	 possibly	 diminished	 GvL	 activity	 in	 mixed	 reconstitutions,	 the	resulting	mixed	NK	cell	compartments	might	be	superior	 in	preventing	EBV	associated	lymphomas	 during	 transplantation.	 Indeed,	 most	 post-transplant	 lymphoproliferative	diseases	(PTLDs)	are	EBV	positive	(Cesarman,	2014)	and	plasma	EBV	DNA	copy	number	seems	to	be	a	reliable	indicator	of	PTLD	occurrence	and	treatment	response	(Ruf	et	al.,	2012;	Tsai	et	al.,	2008).	This	might	 in	part	reflect	uncontrolled	 lytic	EBV	replication	 in	transplant	 patients	 prior	 to	 PTLD,	 infecting	 and	 transforming	 reconstituting	 B	 cells	 to	result	 in	 poly-	 or	 oligoclonal	 lymphoproliferations.	 This	 lytic	 replication	 is	 indeed	susceptible	 to	 NK	 cell	mediated	 immune	 control	 and	 non-KIR	 educated	NK	 cells	 have	been	shown	to	preferentially	 target	 lytically	 EBV	 replicating	 B	 cells	 (Azzi	et	al.,	2014;	Chijioke	 et	 al.,	 2013).	 Furthermore,	 in	 the	 presence	 of	 side-by-side	 KIR-ligand	mismatched	donor	reconstitution,	mismatched	EBV-transformed	B	cells	might	 be	 more	susceptible	 to	 NK	 cell	 lysis,	 while	 the	 response	 to	 their	 matched	 counterpart	would	still	 be	 dampened	 by	KIR	 inhibition	 (Yu	 et	 al.,	 2007).	 Therefore,	mixed	 hematopoietic	progenitor	cell	reconstitutions	could	be	beneficial	for	controlling	herpesvirus	infections,	resulting	 in	mixed,	 less	 educated	 NK	 cell	 compartments	 that	 more	 efficiently	 control	EBV	 infection,	 as	 shown	 in	 this	 study,	 and	 possibly	 also	 cytomegalovirus	 infection	 in	humans.		Our	 study,	 therefore,	 contributes	 to	 an	 increasing	 body	 of	 literature	 that	suggests	 that	 hematopoietic	 cell	 transplantation	 should	 be	 tailored	 to	 address	
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different	 therapeutic	 needs	 of	 patients.	 Completely	 HLA	 matched	 transplantation	reduces	 the	 risk	 for	 graft-versus-host	 disease,	 but	 haploidentical	 HLA	 mismatched	transplantation	 of	 T	 cell	 depleted	 grafts	 mediates	 a	 potent	 GvL	 effect	 by	 NK	 cell	alloreactivity.	In	addition,	mixed	transplantation	of	T	cell	depleted	grafts	might	alter	NK	cell	education	for	more	efficient	herpesvirus	specific	immune	control.	In	support	of	this	notion,	 our	 data	 suggest	 that	 even	 minor	 leukocyte	 populations	 lacking	 cognate	 HLA	molecules	 for	 KIRs	 might	 reduce	 education	 of	 the	 respective	 KIR	 carrying	 NK	 cell	populations	for	improved	EBV	specific	immune	control.	
	 	
NK	cell	repertoire	and	education	
	 73	
3.5	METHODS	
	
Mice	NOD/LtSz-scid	 IL2Rγnull	(NOD-scid	 γc−/−	 or	NSG)	mice	were	 obtained	 from	 the	 Jackson	Laboratory	 and	 bred	 and	 maintained	 at	 the	 Institute	 of	 Experimental	 Immunology,	University	 of	 Zürich,	 Switzerland,	 under	 specific	 pathogen-free	 conditions.	 Newborn	NSG	mice	 (1	 to	5	days	old)	were	irradiated	with	1	Gy	using	a	Cs	or	X-ray	source.	Five	to	six	 hours	 after	 irradiation,	 mice	 were	 injected	 intrahepatically	 with	 1–2	 ×	 105	CD34+	human	 hematopoietic	 progenitor	 cells	 (HPCs)	 derived	 from	 human	 fetal	 liver	 tissue	obtained	 from	Advanced	 Bioscience	 Resources.	Injected	HPCs	were	either	from	a	single	donor	or	a	mix	of	 two	donors	at	a	1:1	 ratio,	 amounting	 to	 the	 same	 total	 cell	number.	Preparation	of	human	fetal	 liver	tissue	and	isolation	of	human	CD34+	cells	was	done	as	described	previously	 (Strowig	et	al.,	2009;	2010;	White	et	al.,	2012).	Reconstitution	of	human	 immune	 system	 components	 in	 mice	 (huNSG)	 was	 analyzed	 10–12	 weeks	after	 engraftment	 and	 again	 just	before	 the	 start	 of	 the	 experiments.	Mice	with	more	than	 40%	 reconstitution	 of	 huCD45+	 human	 immune	 system	 components	 in	 the	lymphocytes	of	peripheral	blood	were	used	in	the	described	experiments	(average	70%	huCD45+	 cells	 of	 peripheral	 blood	 lymphocytes,	 25%	 CD3+	 T	 cells	 of	 human	lymphocytes,	 60%	 CD19+	 B	 cells	 of	 human	 lymphocytes,	 5%	 NK	 cells	 of	 human	lymphocytes,	 80%	 CD4+,	 and	 20%	 CD8+	T	 cells	 of	 human	 T	 cells),	 were	 sex	matched,	and	were	 12–18	weeks	 old	 at	 the	 start	 of	 the	 experiments.	 All	 animal	 protocols	were	approved	by	the	cantonal	veterinary	office	of	the	canton	of	Zürich,	Switzerland	(protocol	nos.	148/2011	and	209/2014).	All	studies	involving	human	samples	were	reviewed	and	approved	by	 the	 cantonal	 ethical	 committee	of	 Zürich,	 Switzerland	 (protocol	no.	KEK-StV-Nr.19/08).		
HLA	typing	To	 perform	HLA	 genomic	 typing,	 DNA	was	 extracted	 using	 the	Qiagen	GmbH	 reagent,	according	to	manufacturer’s	 instruction.	HLA	alleles	were	 identified	by	PCR–Sequence-	Specific	 Oligonucleotide	 Reverse	 assay	 using	 commercial	 HLA	 Kits	 (Fujirebio	 Italia	s.r.l.).	Data	analysis	was	performed	using	the	LIPA	Interpretation	Software	(Fujirebio).		
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Virus	Infection	and	NK	Cell	Depletion	GFP-Epstein-Barr	 virus	 (EBV)	B95-8	wild-type	was	produced	 in	 293	 cells.	 Titration	 of	viral	 concentrates	 was	 done	 on	 Raji	 cells	 in	 serial	 dilutions	 and	 calculated	 as	 Raji-infecting	units	(RIU)	using	flow	cytometric	analysis	of	GFP-positive	Raji	cells	2	days	after	infection	of	cells.	HuNSG	mice	were	infected	via	intraperitoneal	injection	of	1	×	105	RIUs	and	 followed	 for	 5	 weeks.	 Depletion	 of	 NK	 cells	 in	 huNSG	 mice	 was	 done	 via	intraperitoneal	 injection	 of	 purified	 anti-NKp46	 antibody	 (clone	 BAB281)	 in	 PBS	 on	three	consecutive	days	(total	of	300	μg	per	mouse).	On	the	following	day,	animals	were	infected	by	inoculation	via	intraperitoneal	injection	of	1	×	105	RIU	EBV.		
Flow	Cytometry	All	 fluorescently	 labeled	 antibodies	 were	 purchased	 from	 BD	 Biosciences,	Beckman&Coulter,	 BioLegend,	 Invitrogen	 and	 R&D	 Systems	 (Table	 S1).	 Spleens	 were	mechanically	 disrupted	 and	 filtered	 through	 a	 70	 μm	 cell	 strainer	 before	 separation	of	 mononuclear	 cells	 on	 Ficoll-Paque	gradients.	 Livers	 were	 first	 digested	 in	 a	 buffer	containing	 DNase	 and	 CollagenaseD	 (Roche).	 After	 being	 mechanically	 disrupted,	mononuclear	 cells	 were	 separated	 using	 a	 Percoll	 gradient.	 Lysis	 of	 erythrocytes	 in	whole	blood	was	done	with	NH4Cl.	For	 intracellular	staining,	 the	Cytofix/Cytoperm	Kit	from	BD	Biosciences	was	used.	Cell	suspensions	were	stained	with	antibodies	for	30	min	on	 ice,	 washed,	 and	 analyzed	 on	 FACSCanto	 or	 LSR	 Fortessa	 cytometers	 (BD	Biosciences).	Analysis	of	flow	cytometric	data	was	performed	with	FlowJo	(Tree	Star).		
K562	cells	and	their	HLA	class	I	transfection	K562	 cells	 were	 maintained	 in	 RPMI	 1640	medium	 (GIBCO	 BRL)	 supplemented	 with	gentamicin	 (20μg/ml)	 and	10%	FCS	 (GIBCO	BRL).	 Cell	 cultures	were	 kept	 in	 a	water-saturated	atmosphere	with	 5%	 CO2	at	 37°C.	 For	 the	 generation	 of	 HLA-Bw4,	 HLA-C1	or	 HLA-C2-expressing	 K562	cells,	K562	cells	were	transfected	with	HLA-B*51:01,	HLA-C*03:03	 or	 HLA-C*05:02	 cDNA,	 respectively,	 inserted	 into	 the	 expression	 vector	pcDNA3.1	(Invitrogen,	Groningen,	Netherlands).	Briefly,	K562	 cells	were	 transfected	by	electroporation	 with	 plasmid	 DNA	 (10μg/1x106	 cells)	 in	 OPTIMEM1	 with	 Glutamax	(GIBCO	 BRL).	 Electroporation	 conditions	 were	 250V,	 300μF	 using	 the	 Gene	 Pulser	 ®	II	 (BioRad).	 Transfected	 cells	 were	 selected	 by	 the	 addition	 of	 G418	 (1	mg/ml)	 to	the	 culture	 medium	 and	 subsequently	 cloned	 by	 single	 cell	 sorting	 of	 HLA-positive	cells	using	flow	cytometry.	
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Degranulation	Assay	For	the	degranulation	assay,	splenic	cell	suspensions	and	non-transfected	K562	or	HLA-	transfected	 K562	 cells	 were	 cocultured	 at	 a	 ratio	 of	 10:1	 for	 5	 h	 with	 addition	 of	monensin	after	1	h,	and	NK	cells	were	then	analyzed	for	expression	of	the	degranulation	marker	CD107a.	Single	KIR-positive	NK	cells	were	not	pre-gated	on	NKG2A.		
Quantification	of	EBV	load	by	real-time	PCR	Total	 DNA	 from	 the	 whole	 blood	 was	 extracted	 using	 NucliSENS	 EasyMAG	 system	(bioMérieux)	 according	 to	 manufacturer's	 instructions.	 Splenic	 tissue	 was	 processed	using	 using	 QIAamp	 DNA	 tissue	 Kit	 (QIAGEN)	 using	 the	 manufacturer's	 protocol.	Quantitative	 analysis	 of	 EBV	 DNA	 was	 performed	 by	 TaqMan	 (Applied	 Biosystems)	real-time	 PCR	 technique	 as	 described	 (51)	 with	 modified	 primers	 for	 the	 BamH1	W	fragment	 (5′-CTTCTCAGTCCAGCGCGTTT-3′	 and	 5′-	 CAGTGGTCCCCCTCCCTAGA-3′)	 and	a	fluorogenic	probe	(5′-(FAM)-	CGTAAGCCAGACAGCAGCCAATTGTCAG-(TAMRA)-3′).	All	PCRs	 were	 run	 on	 an	 ABI	 Prism	 7700	 Sequence	 Detector	 (Applied	 Biosystems)	 and	samples	were	analyzed	 in	duplicates.	No	EBV	DNA	was	detected	 in	the	blood	of	mock-infected	animals	for	the	duration	of	the	experiment.	Mice	were	considered	uninfected	if	EBV	DNA	was	not	detected	in	the	blood	and	spleen	during	the	experiment.		
Statistics	All	data	were	analyzed	with	an	unpaired	two-tailed	Student’s	t	test,	Mann-Whitney	t	test	or	 ANOVA	 with	 Bonferoni	 correction	 as	 stated.	 A	 p	 value	 of	 <	 0.05	 was	 considered	statistically	significant.	Statistical	analysis	and	generation	of	graphs	was	performed	with	Prism	software	(GraphPad).		 	
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3.8	SUPPLEMENTAL	FIGURES		
		
Figure	S1,	related	to	Figure	2.	Gating	strategy	of	KIR	subsets.	
Spleen	and	livers	of	huNSG	were	processed	and	stained	with	fluorescent	markers	for	flow	cytometry.	Cells	were	 pre-gated	 on	 lymphocytes	 and	 singlets	 before	 discriminating	 for	 the	 huCD45+	population.	 HuCD45+	lymphocytes	 were	 gated	 on	 Lin-,	 L/D-	 vs.	 NKp46.	 NKp46+	 cells	 were	 further	 characterized	 by	 CD16	 to	arrive	at	the	NK	cell	population.	NK	cells	were	assessed	according	to	HLA-A2	for	their	donor	origin	and	then	gated	 on	KIR	 expression.	 To	 arrive	 at	 single	 positive	 KIR	 populations,	 double	 negative	 quadrants	 were	gated	 on	 the	 third	 parameter	 as	shown	 in	a	representative	plot.	Gatings	 for	KIR	subsets	were	replicated	in	all	the	necessary	combinations.		
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Figure	S2,	related	to	Figure	2.	KIR	frequencies	at	steady	state	represent	original	donor	values	and	do	
not	change	in	presence	of	non-cognate	HLA	in	trans	
HuNSG	mice	were	single	reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	 (HLA-C1,	 -C2	and	-Bw4)	or	reconstituted	with	two	donors	disparate	for	allotype	and	HLA-A2	expression	(mix).	(A	 to	 L)	Mean	 percentage	 per	 experiment	 of	 single	 KIR+	 liver	 NK	 cells	 as	 derived	 from	 total	 NK	 cells	 of	huNSG	mice.	(A	to	D)	KIR2DL1+	NK	cells	of	HLA-C1	single	reconstituted	huNSG	mice	as	compared	to	HLA-C1	donor	HFL	NK	cells	 (A)	or	HLA-C1	donor	derived	cells	 from	mixed	reconstituted	huNSG	mice	 (B)	and	conversely	 for	HLA-C2	 single	 reconstituted	 huNSG	mice	 to	 HLA-C2	 donor	 HFL	 (C)	 or	 HLA-C2	 donor	 derived	 cells	 from	mixed	reconstituted	huNSG	mice	(D).	(E	 to	H)	KIR2DL2/3+	NK	cells	 of	HLA-C1	 single	 reconstituted	huNSG	mice	 as	 compared	 to	HLA-C1	donor	HFL	NK	cells	(E)	or	HLA-C1	donor	derived	cells	 from	mixed	reconstituted	huNSG	mice	(F)	and	conversely	for	HLA-C2	single	reconstituted	huNSG	mice	to	HLA-C2	donor	HFL	(G)	or	HLA-C2	donor	derived	cells	from	mixed	reconstituted	huNSG	mice	(H).	(I	to	L)	KIR3DL1+	NK	cells	of	HLA-C1	single	reconstituted	huNSG	mice	as	compared	to	HLA-C1	donor	HFL	NK	 cells	 (I)	 or	 HLA-C1	 donor	 derived	 cells	 from	mixed	 reconstituted	 huNSG	mice	 (J)	 and	 conversely	 for	HLA-C2	 single	 reconstituted	 huNSG	mice	 to	 HLA-C2	 donor	 HFL	 (K)	 or	 HLA-C2	 donor	 derived	 cells	 from	mixed	reconstituted	huNSG	mice	(L).Data	in	are	pooled	data	from	at	least	three	independent	experiments.	Dots	represent	mean	of	population	in	separate	experiments,	paired	t	test,	n.s.,	not	significant.	
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Figure	S3,	related	to	Figure	3.	Infection	with	EBV	does	not	lead	to	skewing	of	KIR	repertoire	
HuNSG	mice	were	single	reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	 (HLA-C1,	 -C2	and	-Bw4)	or	reconstituted	with	two	donors	disparate	for	allotype	and	HLA-A2	expression	(mix).	Grey	pie	charts	depict	the	ratio	of	KIR+	to	KIR-	NK	cells	and	colored	pie	charts	represent	the	indicated	KIR+	NK	cell	subsets.	(A	 to	D)	 Subsets	of	KIR	expressing	NK	cells	 as	percentages	of	 total	KIR+	NK	cells	 in	 liver	of	EBV	 infected	huNSG	mice.	(E	to	P)	Frequency	of	single	KIR+	NK	cells	in	liver	of	huNSG	at	endpoint.	Comparison	of	PBS	controls	to	EBV	infected	 animals	 for	 frequency	 of	 KIR2DL1+,	 KIR2DL2/3+	 or	 KIR3DL1+	 NK	 cells	 in	 homozygously	reconstituted	huNSG	mice	with	HLA-C1	donor	(E	 to	G),	mixed	donor	reconstituted	huNSG	mice	with	cells	derived	from	HLA-C1	donor	(H	to	J)	or	HLA-C2	donor	(K	to	M)	and	homozygously	reconstituted	huNSG	mice	with	HLA-C2	donor	(M	to	P).	Data	are	pooled	data	from	at	least	three	independent	experiments.	n=8-15	mice	per	group,	bar	represents	mean	in	relevant	graphs,	unpaired	t	test,	n.s.,	not	significant.	
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Figure	S4,	related	to	Figure	4.	No	titrating	effect	of	non-cognate	MHC	class	I	on	human	NK	cell	
education.	
HuNSG	mice	were	single	reconstituted	with	donors	homozygous	for	HLA-C	and	-B	allotypes	(HLA-C1	or	C2)	or	 reconstituted	 with	 both	 the	 same	 HLA-C1	 and	 -C2	 donor	 disparate	 for	 HLA-A2.	 Representative	experiment	with	unequal	reconstitution	in	mixed	huNSG	mice.	(A)	Representative	dot	plot	 showing	overall	 human	 leukocyte	 reconstitution	derived	 from	HLA-C1	donor	(HLA-A2	negative)	and	HLA-C2	donor	(HLA-A2	positive)	in	mixed	donor	reconstituted	huNSG	mice	(mix).	(B	and	C)	Degranulation	of	single	KIR-positive	NK	cells	after	incubation	of	K562	cells	with	splenocytes	from	huNSG	mice	 reconstituted	with	HLA-C1	 homozygous	 and/or	HLA-C2	 homozygous	 donors	 from	 the	 same	experiment	as	shown	in	(A).	Single	KIR-positive	NK	cells	were	gated	in	both	single	and	mixed	reconstituted	huNSG	mice	on	cells	derived	from	(B)	HLA-C2	donor	(A2	positive)	or	from	(C)	HLA-C1	donor	(A2	negative).	Data	were	analyzed	by	paired	t	tests.	n.s.,	not	significant.		 	
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Figure	S5,	related	to	Figure	6.	No	change	in	T	cell	response	of	different	
reconstitutions	
HuNSG	mice	were	 single	 reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	(HLA-C1,	 -C2	and	 -Bw4)	or	reconstituted	with	 two	donors	disparate	for	allotype	and	HLA-A2	expression	(mix).	(A	 to	 I)	 Frequencies	 of	 T	 cell	 subsets	 in	 spleens	 of	 huNSG	 mice	 at	experimental	endpoints.	(A	to	D)	CD8+	T	cell	subsets	in	PBS	control	huNSG	mice	single	reconstituted	with	 homozygous	 HLA-C1	 donor	 (A),	 HLA-C2	 donor	 (D)	 or	 mixed	 donor	reconstituted	huNSG	mice	with	T	cells	derived	 from	HLA-C1	donor	(B)	and	derived	from	HLA-C2	donor	(C).	(E	to	H)	CD8+	T	cell	subsets	in	EBV	infected	huNSG	mice	single	reconstituted	with	 homozygous	 HLA-C1	 donor	 (E),	 HLA-C2	 donor	 (H)	 or	 mixed	 donor	reconstituted	huNSG	mice	with	T	cells	derived	 from	HLA-C1	donor	 (F)	and	derived	from	HLA-C2	donor	(G).	(I)	 Comparison	 of	 frequencies	 of	 effector	 memory	 CD8+	 T	 cells	 in	 EBV	infected	 single	 and	 mixed	 reconstituted	 huNSG	 mice	 at	 experimental	endpoints	in	spleen.	Data	are	pooled	data	from	at	least	two	independent	experiments.	n=5-8	mice	per	group,	mean	±	SEM,	unpaired	t	test,	n.s.,	not	significant.		 	
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Figure	S6,	related	to	Figure	7.	No	increase	in	CD2+	NK	cells	in	mixed	donor	reconstituted	huNSG	mice	
HuNSG	mice	were	single	reconstituted	with	donors	homozygous	 for	HLA-C	and	 -B	allotypes	 (HLA-C1,	 -C2	and	-Bw4)	or	reconstituted	with	two	donors	disparate	for	allotype	and	HLA-A2	expression	(mix).	According	to	single	reconstituted	allotypes,	eduKIR	denotes	educated	NK	cell	subset	gated	on	cells	derived	from	donor	used	for	single	reconstitution	in	both	single	and	mixed	reconstituted	huNSG	mice,	respectively.	(A	to	C)	Percentage	of	CD2+	cells	in	educated	(edu)	compared	to	non-educated	(nonedu)	NK	cells	in	liver	of	huNSG	mice	(A)	educated	on	HLA-C2	(KIR2DL1),	HLA-C1	(KIR2DL2/3)	(B)	and	HLA-Bw4	(KIR3DL1)	(C).	Data	 are	 pooled	 data	 from	 at	 least	 two	 independent	 experiments.	 n=5-10	mice	 per	 group,	mean	 ±	 SEM,	ANOVA	with	Bonferroni	correction	and	unpaired	t	test,	n.s.,	not	significant,	*p	<	0.05.			 		 	
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3.9	SUPPLEMENTAL	EXPERIMENTAL	PROCEDURES	
Table	S1.	Overview	of	fluorescently	labeled	antibodies	
	
	
Molecule	 Clone	 Fluorophore	 Company	
CD107a	 H4A3	 FITC	 BD	Biosciences	
NKp46	 9E2	 APC	 BD	Biosciences	
KIR2DL1/S1	 EB6B	 PE	Cy7	 Beckman&Coulter	
KIR2DL2/L3	 GL183	 PE	Cy5.5	 Beckman&Coulter	
NKG2A	 Z199	 PE	 Beckman&Coulter	
CD14	 M5E2	 BV510	 BioLegend	
CD16	 3G8	 APC	Cy7	 BioLegend	
CD19	 HIB19	 BV510	 BioLegend	
CD2	 RPA-2.10	 FITC	 BioLegend	
CD3	 OKT3	 BV510	 BioLegend	
CD3	 OKT3	 BV785	 BioLegend	
CD4	 RPA-T4	 BV510	 BioLegend	
CD4	 RPA-T4	 APC	Cy7	 BioLegend	
CD45	 HI30	 BV605	 BioLegend	
CD45RA	 HI100	 BV510	 BioLegend	
CD57	 HCD57	 Pacific	Blue	 BioLegend	
CD8	 SK1	 PerCP	 BioLegend	
HLA-A2	 BB7.2	 Pacific	Blue	 BioLegend	
HLA-A2	 BB7.2	 FITC	 BioLegend	
HLA-A2	 BB7.2	 PE	 BioLegend	
HLA-DR	 L243	 PE	Cy7	 BioLegend	
KIR2DL1/S1	 HP-MA4	 FITC	 BioLegend	
KIR2DL2/L3	 DX27	 PE	 BioLegend	
KIR3DL1	 DX9	 Alexa	Fluor	700	 BioLegend	
CD19	 SJ25-C1	 PE	Texas	Red	 invitrogen	
CCR7	 150503	 PE	 R&D	Systems	
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4.1	ABSTRACT	
	Resting	 natural	 killer	 (NK)	 cells	 require	 activation	 by	 dendritic	 cells	 (DCs)	 to	 achieve	their	full	protective	functions	during	viral	infections.	While	the	interaction	of	human	NK	cells	with	conventional	DCs	has	been	investigated	in	great	detail,	the	stimulation	of	NK	cells	 by	 plasmacytoid	 DCs	 (pDCs)	 has	 been	 less	 explored.	 Here,	 we	 report	 that	 pDCs	form	 immunological	 synapses	with	 NK	 cells.	 These	 are	 enriched	 in	 NK	 cell	 derived	 f-actin	and	type	I	interferon	(IFN)	receptors.	Furthermore,	NK	cells	are	activated	through	this	 interaction	with	IFN	receptor	signaling	via	STAT1	phosphorylation	at	the	synapse.	However,	 despite	 the	 immunological	 synapse	 between	 pDCs	 and	 NK	 cells	 displaying	hallmarks	of	an	activating	NK	cell	synapse,	pDCs	are	not	killed	in	this	interaction.	Thus,	the	 two	 innate	 leucocyte	 populations,	 pDCs	 and	 NK	 cells	 might	 sustain	 anti-viral	functions	by	their	interaction	early	during	infections.	 	
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4.2	INTRODUCTION		Natural	 killer	 (NK)	 cells	 have	 been	 originally	 recognized	 for	 their	 cytotoxic	 function	against	transformed	and	infected	cells	(Herberman	et	al.,	1975a;	Kiessling	et	al.,	1975).	Different	developmental	stages	of	 this	 innate	 lymphocyte	 lineage	can	be	 found	outside	the	 bone	 marrow	 and	 these	 seem	 to	 fulfill	 specific	 functions	 in	 their	 respective	anatomical	 locations	 in	 humans	 (Ferlazzo	 and	 Münz,	 2004).	 CD56brightCD16-	NK	 cells	constitute	 the	 main	 NK	 cell	 subpopulation	 in	 human	 secondary	 lymphoid	 tissues	(Fehniger	 et	 al.,	 2003;	 Ferlazzo	 et	 al.,	 2004b).	 They	 produce	 mainly	 cytokines	 after	cytokine	stimulation	at	these	sites	and	seem	to	polarize	as	well	as	mature	dendritic	cells	(DCs)	 to	 facilitate	 the	priming	of	Th1	responses	 (Morandi	et	al.,	2006;	Moretta,	2002).	These	 CD56bright	 NK	 cells	 can	 be	matured	 into	 CD56dimCD16+	 NK	 cells	 (Ferlazzo	 et	 al.,	2004b;	Huntington	et	al.,	2009;	Romagnani	et	al.,	2007),	which	predominate	in	the	blood	and	respond	 to	 infected	or	 transformed	 target	 cell	 recognition	by	cytokine	production	and	cytotoxicity	(De	Maria	et	al.,	2011;	Vivier	et	al.,	2011).	Upon	further	differentiation	they	 acquire	 more	 and	 more	 killer	 immunoglobulin-like	 receptor	 (KIR)	 expression	(Björkström	et	 al.,	 2010).	 Thus	human	NK	 cells	 home	 to	different	 tissues	during	 their	differentiation	and	fulfill	different	functions	at	these	sites.		 Preferentially	 in	 secondary	 lymphoid	 tissues,	NK	 cells	 can	 be	 activated	by	dendritic	cells	(DCs)	in	order	to	fulfill	a	barrier	function	against	invading	pathogens	at	these	sites	and	to	polarize	T	cell	responses	(Ferlazzo	et	al.,	2004a;	Lucas	et	al.,	2007;	Strowig	et	al.,	2008).	In	this	 interaction	different	DC-derived	cytokines	mediate	the	NK	cell	 activation.	 While	 IL-12	 stimulates	 cytokine	 production,	 IL-15	 promotes	 NK	 cell	survival	 and	 proliferation,	 while	 type	 I	 interferons	 (IFN-α/β)	 enhance	 NK	 cell	cytotoxicity	(Brilot	et	al.,	2007;	Ferlazzo	et	al.,	2004a;	Gerosa	et	al.,	2005;	Strowig	et	al.,	2008).	In	humans,	this	type	I	IFN	can	come	from	plasmacytoid	DCs	(pDCs),	in	particular	after	 their	 stimulation	 with	 single-stranded	 RNA	 (toll-like	 receptor	 7	 [TLR7]	recognition)	 or	 with	 unmethylated	 DNA	 (TLR9	 recognition)	 (Gilliet	 et	 al.,	 2008;	Meixlsperger	 et	 al.,	 2013).	 Thus,	 cytokines	 play	 a	 prominent	 role	 in	 the	 cross-talk	between	NK	cells	and	DCs,	particularly	type	I	IFN	in	the	interaction	with	pDCs.		 NK	cells	mediate	 their	 cellular	 interactions	via	 immunological	 synapses	(IS)	 (Orange,	 2008).	 The	 phenotypic	 characteristics	 of	 these	 synapses	 determine	 the	outcome	 of	 the	 interaction.	 Activating	 IS,	 which	 lead	 to	 the	 killing	 of	 the	 conjugated	target	cells,	are	characterized	by	actin	polymerization	at	the	IS	side	of	the	conjugated	NK	
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cell,	 polarization	 of	 the	 microtubule	 organizing	 center	 (MTOC)	 of	 the	 NK	 cell	 to	 the	interface	and	directed	 secretion	of	 cytotoxic	granules	and	 IFN-γ	 into	 the	 synaptic	 cleft	(Brown	 et	 al.,	 2012).	 In	 contrast,	 when	 inhibitory	 interactions	 dominate	 the	 synapse	between	 NK	 cells	 and	 target	 cells,	 the	 IS	 disassembles	 faster,	 and	 shows	 none	 of	 the	above	mentioned	polarization	events.	Therefore,	NK	cells	 stabilize	 activating	 synapses	with	transformed	and	infected	cells	by	cytoskeletal	remodeling	to	deliver	directed	lethal	blows	to	these	targets.			 In	 contrast	 to	 these	 classical	 categories	of	NK	cell	 synapses	we	present	here	the	characterization	of	the	immunological	synapse	between	plasmacytoid	DCs	and	NK	cells.	Although	NK	cells	polymerize	actin	at	the	interface	with	pDCs,	polarize	the	type	I	IFN	receptor	to	the	resulting	IS	and	get	activated	through	this	interaction,	pDCs	are	not	killed	in	the	process.	
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4.3	RESULTS	
4.3.1	Human	NK	cells	and	pDCs	form	immunological	synapses	with	
polarization	of	actin	and	the	type	I	IFN	receptor	in	NK	cells	
	It	has	been	previously	shown	that	conventional	DCs	can	form	regulatory	immunological	synapses	with	autologous	NK	cells	and	that	this	leads	to	the	efficient	activation	of	these	innate	 lymphocytes	 (Barreira	 da	 Silva	 et	 al.,	 2011;	 Brilot	 et	 al.,	 2007).	 Furthermore,	plasmacytoid	DCs	as	main	type	I	IFN	producers	are	known	to	be	potent	activators	of	NK	cell	 cytotoxicity	 (Gerosa	 et	 al.,	 2005;	 Trinchieri,	 1989;	 Trinchieri	 and	 Santoli,	 1978).	Therefore,	we	investigated	whether	pDCs	were	also	capable	of	 forming	conjugates	and	structured	immunological	synapses	with	NK	cells.	To	study	this,	we	stimulated	purified	human	 pDCs	 with	 the	 toll-like	 receptor	 9	 (TLR9)	 agonist	 CpG	 and	 cultured	 them	 or	unstimulated	 control	 cells	 with	 resting	 autologous	 NK	 cells	 for	 20	 min.	 We	 then	analyzed	 the	 formation	 of	 immunological	 synapses	 by	 immunofluorescence	 (Fig.	 1A).	Both	CpG-stimulated	and	unstimulated	pDCs	were	able	to	form	conjugates	with	NK	cells.	However,	only	CpG-stimulated	pDCs	were	able	to	induce	a	significant	polymerization	of	filamentous	 actin	 (f-actin)	 as	 well	 as	 of	 the	 NK	 cell	 specific	 marker	 NKp46	 at	 the	synapse.	In	contrast	the	type	I	IFN	receptor	subset	IFN-α/βR2	was	significantly	enriched	at	the	synapses	of	both	unstimulated	and	CpG-stimulated	pDCs	with	NK	cells	(Fig.	1B).	However,	 IFN-α/βR2	 was	 more	 significantly	 enriched	 at	 immunological	 synapses	 of	CpG-stimulated	pDCs	with	NK	cells.	To	determine	which	interaction	partner	contributed	the	accumulation	of	 f-actin	and	IFN-α/βR2	at	the	cellular	 interface,	staining	for	NKp46	was	overlayed	with	stainings	for	the	molecules	in	question.	In	both	cases,	colocalization	of	fluorescence	intensity	was	on	the	NK	cell	derived	side	of	the	immunological	synapse	(Fig.	 1C).	 Analysis	 of	 the	 peripheral	 and	 central	 supramolecular	 activation	 clusters	(pSMAC,	cSMAC)	showed	accumulation	of	f-actin	in	a	ring-like	structure	along	the	plane	of	interaction	between	NK	cells	and	pDCs	with	the	IFN-α/βR2	interspersed	between	the	f-actin	 (Fig.	 1E).	 Although	 the	 immunological	 synapse	 between	 pDCs	 and	 NK	 cells	showed	with	 NK	 cell	 derived	 f-actin	 polarization	 the	 hallmarks	 of	 a	 cytotoxic	 NK	 cell	synapse,	 we	 did	 not	 observe	 polarization	 of	 cytotoxic	 granules	 to	 the	 interface.	 For	example,	immunofluorescence	staining	for	perforin	showed	random	distribution	of	this	cytolytic	 protein	within	 the	 conjugated	NK	 cells	 (Figure	 1D).	 These	 observations	 pose	the	question	which	 function	 the	observed	synapse	between	pDCs	and	NK	cells	has.	To	that	end	we	investigated	downstream	signaling	through	the	IFN-α/βR	receptor,	which	relies	 on	 the	 JAK-STAT	 pathway	 (Platanias,	 2005).	 Conjugates	 were	 stained	 for	
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phosphorylation	 of	 tyrosine	 701	 on	 the	 STAT1	 protein	 (Fig.	 2A).	 Quantification	 of	phosphorylated	STAT1	demonstrated	that	 it	accumulated	to	a	greater	extent	 in	NK	cells	at	synapses	of	unstimulated	pDCs	(Fig.	2B,C),	 indicating	a	possible	function	of	the	synapse,	 to	concentrate	and	direct	 type	 I	 IFN	signaling	 towards	NK	cells	 in	 the	absence	of	strong	IFN-α	secretion.	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.	The	formation	of	an	activating	synapse	between	stimulated	pDCs	and	resting	NK	cells	leads	
to	the	accumulation	of	f-actin	and	IFN-α /βR2	at	the	synapse.		
(A)	pDCs	with	or	without	CpG	stimulation	overnight	were	 incubated	with	 resting	NK	cells	 for	20min	and	fixed.	F-actin	was	stained	with	bodipy	conjugated	phallacidin	(green),	nuclear	DNA	was	stained	with	DAPI	(blue),	 anti-IFN-α/βR2	 (red)	 and	 anti-NKp46	 (grey)	 antibodies	 were	 used	 for	 surface	 markers.	 (B)	 The	fluorescence	 intensity	 of	 the	 opposite	 sides	 in	 both	 cells	 was	 summed	 up	 and	 plotted	 against	 the	fluorescence	 intensity	at	 the	synapse	 to	plot	 the	accumulation	of	 f-actin	and	 IFN-α/βR2	and	NKp46	at	 the	synapse.	(C)	The	fluorescence	intensity	was	plotted	along	a	trajectory	through	both	cells	with	the	synapse	indicated	by	boxes.	(D)	Synapses	were	analyzed	through	their	volume	and	the	z-plane	was	reconstructed	to	visualize	the	pSMAC	and	cSMAC.		(E)	pDCs	with	or	without	CpG	stimulation	overnight	were	incubated	with	resting	 NK	 cells	 for	 20min	 and	 fixed.	 F-actin	 was	 stained	 with	 bodipy	 conjugated	 phallacidin	 (green),	nuclear	DNA	was	stained	with	DAPI	(blue)	and	anti-perforin	(grey)	was	used	to	visualize	cytotoxic	granules.	Polarization	of	perforin	to	the	IS	was	stated	as	percentage	of	all	evaluated	conjugates	where	accumulation	was	observed	at	the	synapse.	The	data	are	representative	of	or	summarize	three	experiments.	
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Figure	2.	The	formation	of	an	activating	synapse	between	unstimulated	pDCs	and	resting	NK	cells	
leads	to	the	increased	signaling	via	the	JAK-STAT	pathway	at	the	IS.		
(A)	pDCs	with	or	without	CpG	stimulation	overnight	were	 incubated	with	 resting	NK	cells	 for	20min	and	fixed.	F-actin	was	stained	with	bodipy	conjugated	phallacidin	(green),	nuclear	DNA	was	stained	with	DAPI	(blue),	 anti-phospho-STAT1	 (magenta)	 and	 anti-NKp46	 (grey)	 antibodies	were	 used	 for	 surface	markers.	(B)	The	 fluorescence	 intensity	of	 the	opposite	sides	 in	both	cells	was	summed	up	and	plotted	against	 the	fluorescence	intensity	at	the	synapse	to	plot	the	accumulation	of	f-actin	and	phospho-STAT1	at	the	synapse.	(C)	The	fluorescence	intensity	was	plotted	along	a	trajectory	through	both	cells	with	the	synapse	indicated	by	boxes.	The	data	are	representative	of	or	summarize	three	experiments. 	 		 	
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4.3.2	Interaction	with	pDCs	leads	to	phenotypic	activation	of	human	NK	
cells	 	It	has	been	demonstrated	that	monocyte-derived	DCs	are	capable	of	notably	increasing	surface	expression	of	the	activation	marker	CD69	on	NK	cells	(Brilot	et	al.,	2007;	Draghi	et	al.,	2007;	Vitale	et	al.,	2004).	Another	recognized	marker	for	NK	cell	activation	is	their	expression	 of	 HLA-DR	 upon	 stimulation	 (Bozzano	 et	 al.,	 2009;	 Ferlazzo	 et	 al.,	 2003;	Ingram	et	al.,	2009).	Therefore,	we	decided	to	monitor	 the	surface	expression	of	 these	markers	 as	 readout	 for	 NK	 cell	 activation	 by	 pDCs.	 Isolated	 NK	 cells	 were	 incubated	overnight	on	their	own	or	with	unstimulated	or	CpG-stimulated	autologous	pDCs	under	transwell	or	co-culture	conditions.	The	read	out	by	flow	cytometry	showed	that	HLA-DR	surface	 levels	 were	 evidently	 upregulated	 on	 NK	 cells	 in	 co-cultures	 of	 both	unstimulated	and	CpG-stimulated	conditions	(Fig.	3A).	However,	HLA-DR	molecules	on	NK	 cells	 were	 more	 detectable	 after	 co-culture	 with	 CpG-stimulated	 pDCs	 and	 could	result	 from	 expression	 by	 NK	 cells	 or	 trogocytosis	 from	 pDCs.	 Similarly,	 CD69	 on	NK	cells	 only	 showed	 a	 significantly	 increased	 expression	 in	 co-cultures	 between	 CpG-stimulated	 pDCs	 and	 NK	 cells.	 In	 contrast,	 pDCs	 did	 not	 upregulate	 these	 surface	molecules	 upon	 co-culture	with	 NK	 cells	 (Fig.	 3B).	 These	 findings	 indicate	 that	 pDCs,	especially	after	CpG	stimulation,	activate	NK	cells,	and	that	this	activation	occurs	more	efficiently	in	conjugates	of	pDCs	with	NK	cells.		 	
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Figure	3.	NK	cells	show	phenotypic	maturation	upon	co-culture	with	pDCs.  
Co-cultures	of	resting	NK	cells	and	pDCs	with	or	without	CpG	stimulation	were	set	up.	Cells	were	cultured	with	 direct	 cell-contact	 or	 in	 transwell	 plates.	 (A)	NK	 cells	were	 analysed	by	 staining	 of	 surface	markers	with	 anti-HLA-DR	and	 anti-CD69	 antibodies	 for	 expression	 and	upregulation.	 (B)	 pDCs	were	 analysed	by	staining	of	 surface	markers	with	 anti-HLA-DR	and	 anti-CD69	antibodies	 for	 expression	 and	upregulation.	The	data	are	representative	of	or	summarize	three	experiments. 
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4.3.3	pDCs	increase	NK	cell	cytotoxicity 	In	 addition	 to	 the	 phenotypic	NK	 cell	 activation	 during	 co-culture	with	 pDCs,	we	 also	addressed	 if	 NK	 cell	 cytotoxicity	 can	 be	 stimulated	 by	 pDCs.	 pDC	 induced	 NK	 cell	cytotoxicity	has	been	reported	to	be	cell-contact	 independent	(Gerosa	et	al.,	2005)	and	also	 in	 our	 experiments	 transwell	 separation	 did	 not	 alter	 the	 increased	 NK	 cell	cytotoxicity	 after	 co-culture	with	pDCs	 (data	not	 shown).	 Therefore,	we	 incubated	NK	cells	with	 different	 doses	 of	 pDC-derived	medium.	 After	 4	 days	 of	 incubation,	 the	 NK	cells	were	used	in	a	killing	assay	against	the	erythroleukemic	K562	cell	line	to	determine	NK	cell	cytotoxicity	against	these	target	cells	with	high	susceptibility	to	NK	cell	lysis.	We	observed	enhanced	cytotoxicity	of	NK	cells	that	were	conditioned	with	CpG-stimulated	pDC	 supernatant	 (Fig.	 3C).	We	 determined	 the	 IFN-α	 concentrations	 in	 the	 used	 pDC	supernatants	and	found	that	the	IFN-α	concentrations	in	these	correlated	with	specific	K562	lysis	by	supernatant	exposed	NK	cells	(Fig.	3D).	Furthermore,	a	threshold	value	of	1000pg	 IFN-α	 was	 necessary	 to	 enhance	 cytotoxic	 responses	 of	 NK	 cells	 significantly	(Fig.	3E).	These	experiments	 indicate,	 that	 soluble	 type	 I	 IFNs	secreted	 from	pDCs	are	able	to	stimulate	NK	cell	cytotoxicity.			 	
NK	cell	–	pDC	interactions	
	98	
	
Figure	3.	NK	cells	show	functional	maturation	upon	co-culture	with	pDCs.  
Co-cultures	of	resting	NK	cells	and	pDCs	with	or	without	CpG	stimulation	were	set	up.	Cells	were	cultured	with	 direct	 cell-contact	 or	 in	 transwell	 plates.	 (C)	 NK	 cells	 were	 incubated	 for	 4	 days	 with	 supernatant	derived	 from	pDCs	 cultured	overnight	with	 or	without	 CpG	 stimulation.	After	 stimulation	 of	 the	NK	 cells	they	were	incubated	for	6h	with	the	target	cell	line	K562,	pre-stained	with	PKH26.	NK	cell	cytotoxicity	was	assessed	 by	 quantification	 of	 dead	 cells	 using	 To-Pro-3-iodide.	 (D)	 Specific	 lysis	 was	 determined	 on	 the	basis	 of	 the	 spontaneous	 lysis	 of	 K562	 cells	 on	 their	 own	 and	 total	 lysis	 upon	 saponin	 incubation.	 (E)	Percent	of	specific	 lysis	shows	a	positive	correlation	to	the	amount	of	IFN-𝛼	present	in	the	supernatant	of	pDCs.	The	data	are	representative	of	or	summarize	three	experiments. 	
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4.3.4	pDCs	are	not	killed	by	NK	cells 	We	next	wanted	 to	analyze	 the	reciprocal	 interaction	 in	pDC	conjugates	with	NK	cells.	Accumulation	of	f-actin	at	the	cell-cell	contact	site	in	NK	cells	is	a	hallmark	of	cytotoxic	NK	cell	synapses	(Carpén	et	al.,	1983;	Katz	et	al.,	1982)	and	non-activated	conventional	DCs	 can	 be	 killed	 by	 NK	 cells	 (Ferlazzo	 et	 al.,	 2002;	 Jungraithmayr	 et	 al.,	 2013).	Therefore,	 we	 examined	 the	 impact	 of	 NK	 cell	 presence	 on	 pDC	 survival.	 pDCs	 were	cultured	overnight	alone,	 in	 transwell	or	 in	co-culture	with	autologous	NK	cells.	When	looking	 at	 the	 percent	 of	 surviving	 pDCs,	 a	 significant	 difference	 with	 increased	 pDC	survival	could	be	observed	between	unstimulated	pDCs	alone	and	those	that	had	been	cultured	 in	 the	 presence	 of	 NK	 cells.	 In	 the	 case	 where	 CpG	 was	 added	 to	 the	 cells,	survival	was	high	overall	since	this	agonist	acts	as	a	proliferation	and	survival	stimulus	for	pDCs	 (Fig.	4A).	 Since	direct	 cell-contact	was	not	a	 requirement	 for	pDC	survival	 in	the	co-cultures,	we	tested	the	influence	of	NK	cell	supernatant	on	the	survival	of	pDCs.	We	could	confirm	that	 in	 the	presence	of	soluble	stimuli	provided	by	 the	NK	cells,	 the	pDCs	 showed	 increased	 survival	 (Fig.	 4B).	 Also	 total	 cell	 counts	 of	 pDCs	 after	NK	 cell	supernatant	 transfer	 showed	a	 slightly	better	 survival	 of	 pDCs	 (Fig.	 4C).	However,	we	were	not	able	to	determine	the	NK	cell	secreted	factor	that	promotes	pDC	survival.	IL-3,	GM-CSF	and	Flt3-L	were	not	produced	by	NK	cells	at	significant	levels	under	our	culture	conditions	(Fig.	4D).		Instead,	 expression	 of	 TNF-α	 and	 IFN-γ	 could	 be	 detected	 from	 overnight	 co-cultures	 of	 NK	 cells	 with	 pDCs	 and	 pDC	 supernatants	 (Fig.	 4E).	 Further	 analysis	demonstrated,	however,	 that	the	bulk	TNF-α	originated	from	stimulated	pDCs.	Further	evidence	 for	 the	non-cytolytic	nature	of	 the	 IS	between	pDCs	 and	NK	 cells	 came	 from	ultrastructural	investigations	by	transmission	electron	microscopy	(TEM),	in	which	the	synaptic	cleft	between	these	innate	leucoytes	was	quantified.	Distances	ranged	between	90-160nm	(median	=	114nm,	Fig.	4F)	reminiscent	of	the	range	measured	for	regulatory	synapses	of	NK	cells	with	 conventional	DCs	 (Barreira	da	Silva	et	 al.,	 2011).	Therefore,	pDCs	 are	 not	 getting	 killed	 in	 the	 interaction	 with	 NK	 cells,	 although	 they	 form	 an	immunological	 synapse	 with	 these	 innate	 lymphocytes	 that	 has	 hallmarks	 of	 an	activating	NK	cell	synapse.	
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Figure	4.	NK	cells	aid	pDC	survival	in	absence	of	a	TLR	agonist.		
(A)	Unstimulated	and	CpG-stimulated	pDCs	were	incubated	overnight	alone	or	with	NK	cells	in	transwell	or	co-culture.	 The	 percent	 of	 BDCA2+	 HLA-DR+	 Aqua-	 cells	 was	 used	 as	 the	 readout	 for	 pDC	 survival.	 (B)	Supernatants	 from	allogeneic	NK	cells	were	used	 to	 stimulate	pDCs	overnight.	 Survival	was	quantified	as	fold	 increase	 compared	 to	pDCs	 incubated	with	plain	medium.	 (C)	 Supernatants	 from	allogeneic	NK	 cells	were	 used	 to	 stimulate	 pDCs	 overnight.	 Survival	 was	 evaluated	 by	 counting	 absolute	 cell	 numbers.	 (D)	ELISAs	for	IL-3,	GM-CSF	and	Flt3L	were	run	on	pDC,	co-culture	and	NK	cell	supernatants	to	find	the	cytokine	promoting	pDC	survival.	(E)	ELISAs	for	GM-CSF,	TNF-α	and	IFN-γ	were	run	on	supernatants	of	NK	cells	co-cultured	 with	 pDCs	 or	 pDC	 supernatants	 to	 determine	 the	 cytokine	 expression	 profile	 of	 NK	 cells.	 (F)	Overnight	 CpG	 stimulated	pDCs	were	 incubated	with	 resting	NK	 cells	 for	 20min,	 fixed	 and	processed	 for	TEM.	 The	 synaptic	 cleft	 between	 the	 two	 cells	 was	 quantified	 by	 measuring	 the	 interspace.	 Scale	 bars	represent	2μm	and	1μm	for	left	to	right.	The	presented	data	are	representative	of	or	summarize	a	minimum	of	two	experiments	with	exception	of	TEM	images.		 	
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4.4	CONCLUSIONS		pDCs	readily	form	immunological	synapses	with	NK	cells.	These	are	stabilized	by	f-actin	polymerization	from	the	NK	cell	side.	At	least	phenotypic	NK	cell	activation	is	facilitated	through	 this	 synapse,	while	 stimulation	of	NK	cell	 cytotoxicity	 is	also	 transferred	with	NK	 cell	 supernatant,	 presumably	 primarily	 via	 type	 I	 IFNs.	 Nevertheless,	 this	 IFN	signaling	 is	 optimized,	 especially	 under	 IFN	 limiting	 conditions	 at	 the	 synapse	 and,	accordingly,	STAT1	phosphorylation	can	be	observed	at	the	synapse.	This	optimized	IFN	signaling	might	be	especially	 important	 in	 tissues,	where	secreted	 type	 I	 IFN	might	be	easily	bound	and	consumed	by	neighboring	cells.	Thus	NK	cells	form	activating	synapses	with	 pDCs.	 However,	 pDCs	 are	 not	 killed	 in	 this	 interaction,	 but	 even	 survive	 slightly	better	 upon	 encountering	 NK	 cells.	 Thus	 it	 would	 be	 interesting	 if	 these	 two	 innate	leucocyte	 populations	 also	 support	 each	 other	 during	 early	 phases	 of	 infections	 with	pathogens	in	humans.	
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4.5	MATERIAL	AND	METHODS		
Antibodies	and	labeling	reagents	Directly	 labeled	 anti-CD56	 (clone	 B-159),	 -NKp46	 (9E27NKp46),	 -CD69	 (FN50)	 and	 -CD16	(3G8)	antibodies	were	purchased	from	BD	Bioscience.	Anti-HLA-DR	(L242),	anti-perforin	(dG9)	were	from	Biolegend	and	anti-BDCA2	(AC144)	was	from	Miltenyi	Biotec.	Rabbit	 anti-IFN-α/βR2	 was	 from	 Abcam	 and	 rabbit	 anti-Phospho-STAT1	 pTyr701	antibody	 (F.747.9)	was	 from	 Thermo	 Scientific,	 both	 unconjugated.	 Cells	 labeled	with	unconjugated	 antibodies	were	 stained	with	 Alexa	 Fluor	 555-	 conjugated	 donkey	 anti-rabbit	IgG	or	Alexa	Fluor	647-conjugated	goat	anti-mouse	IgG	from	Invitrogen.	Control	antibodies	 for	 stainings	 were	 normal	 rabbit	 IgG	 (Jackson	 Immunoresearch).	 Live	 and	dead	 cell	 staining	 in	 flow	 cytometry	 experiments	 was	 performed	 with	 an	 aqua	fluorescent	reactive	dye	from	Invitrogen.		
Plasmacytoid	DCs	and	NK	cells	Peripheral	blood	mononuclear	cells	(PBMCs)	were	isolated	from	leukocyte	concentrates	(Zürich	 Blood	 Center)	 by	 density-gradient	 centrifugation	 on	 Ficoll/Hypaque	 (GE	Healthcare).	BDCA4+	plasmacytoid	DCs	were	isolated	from	PBMCs	by	positive	magnetic	cells	 separation	 (Miltenyi	Biotec).	 Isolated	pDCs	were	 cultured	overnight	 in	R2	 (RPMI	1640	 (GIBCO)	 supplemented	 with	 2%	 heat-inactivated	 pooled	 human	 AB	 serum	(Invitrogen))	 and	 gentamicin	 (10mg/ml,	 Invitrogen),	 in	 the	 presence	 or	 absence	 of	CpG2216	 (10𝝻g/ml,	 Invivogen).	 NK	 cells	 were	 isolated	 from	 BDCA4-	 fractions	 by	negative	 selection	 using	 the	 NK	 cell	 isolation	 kit	 II	 (Miltenyi	 Biotec).	 If	 necessary	 NK	cells	 were	 frozen	 down	 or	 cultured	 in	 R5	 (RPMI	 1640	 supplemented	 with	 5%	 heat-inactivated	 pooled	 human	 AB	 serum)	 and	 gentamicin	 (10mg/ml).	 Activated	 NK	 cells	were	 stimulated	 with	 100U/ml	 of	 IL-2	 (Peprotech)	 for	 4	 days,	 when	 not	 specified	otherwise.		
Co-cultures	Isolated	pDCs	and	NK	cells	were	cultured	either	alone	or	in	the	presence	of	each	other	in	co-cultures	overnight.	For	the	transwell	conditions	a	HTS	Transwell	96	well	permeable	support,	pore	size	0.4	μm	from	Corning	Life	Science	was	used.	
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K562	cells	K562	 cells	 were	 maintained	 in	 RPMI	 1640	 medium	 supplemented	 with	 gentamicin	(10mg/ml)	 and	 10%	 FCS	 (Sigma).	 Cell	 cultures	 were	 kept	 in	 a	 water-saturated	atmosphere	with	5%	CO2	and	37°C.	
 
Human	plasmacytoid	DC	and	resting	NK	cells	conjugate	assays	Resting	 NK	 cells	 were	 mixed	 with	 unstimulated	 or	 CpG-stimulated	 autologous	plasmacytoid	DCs	at	a	ratio	of	2:1	 in	20μl	of	RPMI	1640	without	serum,	prior	to	being	pelleted	shortly	at	10’000g.	The	cells	were	allowed	to	conjugated	for	20min	at	37°C.	The	cells	 were	 resuspended	 in	 RPMI	 1640	 and	 centrifuged	 onto	 polylysine-coated	 1.5mm	coverslips	for	immunofluorescence	processing.	Alternatively	co-cultures	were	fixed	and	treated	for	TEM	analysis.			
Immunofluorescence	microscopy	and	analysis	Cells	 on	 slides	were	 fixed	 in	3%	PFA	 for	20min	at	4°C.	 Cells	were	permeabilized	with	0.01%Triton-X	 for	 1	 min	 at	 room	 temperature.	 Cells	 were	 then	 incubated	 with	 the	Image-iT	 FX	 signal	 enhancer	 (Invitrogen)	 and	 stained	 with	 the	 indicated	 antibodies	followed	 by	 the	 appropriate	 secondary	 reagent.	 All	 washes	 were	 performed	 in	 PBS	supplemented	 with	 1%	 fish	 skin	 gelatin	 (Sigma-Aldrich)	 and	 0.02%	 saponin	 (Sigma-Aldrich).	 After	 staining,	 slides	 were	 counterstained	 with	 DAPI	 and	 mounted	 with	Prolong	gold	anti-fade	reagent	 (Invitrogen).	Slides	were	visualized	 through	a	×100	1.4	NA	oil	 immersion	 lens	with	 an	 inverted	 Leica	 LX	microscope	 and	 a	 Leica	DFC	350	FX	camera	 or	 an	 inverse	 confocal	 CLSM	 Leica	 SP8	 gated	 STED	microscope.	 Serial	 optical	sections	(0.2μm	or	0.17μm;	17-64	sections)	were	acquired	for	all	labelings.	Images	were	deconvolved	using	Huygens	software	1.1.4	(Montpellier	RIO	Imaging).	Fold	enrichment	values	were	 determined	 by	 evaluation	 of	 conjugates	 in	 randomly	 selected	 fields	 in	 at	least	3	separate	experiments.	pDC/resting	NK	cell	conjugates	were	identified	using:	(a)	chromatin	density,	in	which	DAPI	staining	stains	brightly	condensed	and	round-shaped	nuclei	of	NK	cells	as	opposed	to	less	dense	pDC	nuclei;	(b)	staining	of	the	NK	cell	surface	marker	NKp46;	 and	 (c)	 f-actin	 staining,	 by	which	 cell-cell	 interaction	 can	 be	 properly	visualized,	 cytoplasm	can	be	 identified	and	 time	of	 interactions	can	be	selected	on	 the	basis	of	f-actin	polymerization	at	the	synapse.	Quantification	of	molecules	at	the	synapse	
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in	conjugates	was	done	after	image	analysis	with	Image	J	software	version	1.45s	(NIH).	We	 measured	 the	 enrichment	 of	 a	 molecule	 at	 the	 contact	 site	 of	 each	 conjugate	compared	with	the	distribution	of	the	same	molecule	in	the	area	opposite	to	the	contact	site	within	 the	 same	 cell.	 The	 fold	 enrichment	was	 calculated	 as	 the	 average	 intensity	per	 unit	 volume	 at	 the	 contact	 site	 or	 the	 sum	of	 the	 opposite	membranes	 across	 the	contact	 site	 divided	 by	 the	 average	 intensity	 per	 unit	 volume	 of	 the	 entire	 cell.	 The	values	obtained	at	opposite	sites	of	 the	cells	were	considered	as	baseline	for	statistics,	and	 data	 represent	 the	 ratio	 of	 relative	 enrichment	 at	 the	 contact	 site	 to	 relative	enrichment	at	the	membrane	across	the	contact	site	normalized	to	the	values	in	single	cells.	Fluorescence	intensity	of	different	markers	was	measured	across	cells	using	Image	J	plot	profile.	Z-stack	reconstruction	to	identify	the	distribution	of	molecules	in	pSMACs	and	cSMACs	was	performed	on	images	acquired	at	the	confocal	microscope	by	rotating	them	so	the	entire	contact	site	could	be	viewed.	Polarization	of	perforin	was	evaluated	by	visually	assessing	the	presence	of	granules	at	the	IS.	Images	represent	projections	of	acquired	z-planes	and	scale	bars	are	equivalent	to	10μm.	
 
Transmission	Electron	Microscopy	and	analysis	Samples	were	 process	 at	 the	 Center	 for	Microscopy	 and	 Image	 Analysis,	 UZH.	 Images	were	 acquired	 using	 TEM	 Zeiss	 Leo	 912	 Omega	 microscope.	 Original	 magnifications	were	 7’400x	 and	 17’500x	 from	 left	 to	 right.	 The	 synaptic	 cleft	 between	 NK	 cell-pDC	conjugates	was	determined	by	measuring	the	distance	between	two	cells	using	the	line	tool	and	ROI	manager	in	Image	J.		
 
K562	and	NK	cell	killing	assay	NK	cells	were	 left	untreated	or	 incubated	 for	4	days	with	supernatant	of	unstimulated	pDCs	 or	 different	 doses	 from	 CpG-stimulated	 pDCs.	 As	 positive	 control	 NK	 cells	were	incubated	with	100U/ml	of	 IL-2	 and	 as	 a	 negative	 just	with	plain	medium.	K562	 cells	were	prestained	with	the	PKH26	dye	(Sigma)	and	cultured	with	incubated	NK	cells	at	a	ratio	 of	 2:1	 for	 6h	 at	 37°C	 in	 R10	 (RPMI	 1640	 supplemented	 with	 10%	 FCS)	 and	gentamicin	 (10mg/ml).	 For	 assessing	 susceptibility	 of	 K562	 cells	 to	 NK	 cell-mediated	killing,	 K562	 single	 cultures	 or	K562/NK	 cell	 co-cultures	were	 stained	with	To-Pro-3-iodide	(Invitrogen).	
ELISA	
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After	 overnight	 culture	 plasmacytoid	 DCs	 were	 collected	 and	 IFN-α	 levels	 in	 the	supernatants	were	measured	by	ELISA	for	human	Interferon-α	MT1/2	(Mabtech).	After	overnight	 culture	NK	cells	were	 collected	and	GM-CSF	 (Mabtech),	 IL-3	 (abcam),	Flt-3L	(R&D	Systems),	TNF-α	(Mabtech)	and	IFN-γ	(Mabtech)	were	measured.		
 
Flow	Cytometry	Cells	were	acquired	on	a	FACSCanto	II	or	LSR	II	Fortessa	(BD	Biosciences)	and	all	flow	cytometry	analysis	were	performed	with	FlowJo	software	(Tristar).	
 
Statistics	Statistical	 analyses	were	 performed	with	 the	Mann	Whitney	 test,	 non-parametric	 and	bicaudal.	 P	 values	 lower	 than	 0.05	 were	 considered	 significant.	 Plotted	 data	 are	displayed	as	median	±	interquartile	ranges	or	means	±	SEMs.	
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PART	I	–	KIR	REPERTOIRE	AND	EDUCATION		
5.1	Novel	humanized	mouse	model	of	two	co-reconstituting	donors		Taking	 advantage	 of	 mixed	 CD34+	 hematopoietic	 progenitor	 cell	 reconstituted	 NSG	mice,	we	were	able	to	 investigate	the	influence	of	non-cognate	HLA	in	trans	on	the	NK	cell	compartment	of	the	engrafting	human	immune	system.		This	allowed	us	to	address	questions	of	KIR	 repertoire	 generation	 and	NK	 cell	 education,	which	 so	 far	have	been	very	difficult	to	experimentally	address.		To	the	best	of	our	knowledge,	this	is	the	first	work	studying	the	direct	influence	of	cells	from	two	engrafting	human	hematopoietic	systems	on	each	other.		In	the	clinical	setting	 of	 double-unit	 umbilical	 cord	 blood	 transplantations,	 only	 one	 donor	 prevails,	leading	essentially	to	single	unit	engraftment	(Gutman	et	al.,	2010;	Hashem	and	Lazarus,	2015).	This	single-unit	dominance	seems	to	be	mediated	by	co-transferred	T	cells	and	is	without	an	obvious	 influence	of	NK	cell	 interactions	(Gutman	et	al.,	2010;	Tarek	et	al.,	2015).	Data	 from	our	reconstitutions	show	that	mixed	reconstituted	huNSG	mice	were	 able	 to	 engraft	 all	 compartments	 of	 the	 immune	 system	 similar	 to	 single	reconstituted	mice	 (Strowig	 et	 al.,	 2009;	 2010).	 Furthermore,	we	 could	 demonstrate	that	 both	 donors	 were	 represented	 at	 equal	 frequencies	 with	 regard	 to	 the	 main	lymphocyte	 subsets.	 Thus,	we	 established	 a	model	where	 two	engrafted	donors	were	able	to	develop	and	persist	side-by-side.		
5.2	Skewing	of	KIR	repertoire	under	steady	state	and	EBV-induced	
inflammatory	conditions		Several	 studies	 have	 provided	 evidence	 that	 the	 KIR	 repertoire	 can	 be	 modulated	 to	some	extent	by	HLA	class	I	expression	(Shilling	et	al.,	2003).	Our	data	however	showed	that	the	KIR	repertoire	remained	diverse	after	NK	cell	development	in	single	as	well	as	mixed	 reconstituted	 huNSG	 mice	 during	 steady	 state,	 with	 frequencies	 representing	those	 found	 in	 the	donor	 fetal	 liver	 tissue.	 This	 suggests	 that	HLA	only	 influences	 the	repertoire	 marginally,	 in	 cis	 and/or	 trans,	 if	 at	 all.	 In	 addition,	 in	 HCMV-seropositive	patients,	 a	 history	 of	 HCMV	 infection	 was	 found	 to	 leave	 the	 KIR	 repertoire	 visibly	
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skewed	 in	 later	 life	 (Béziat	 et	 al.,	 2013;	 Gumá	 et	 al.,	 2004).	 Hence,	 exposure	 to	pathogens,	 in	 particular	 HCMV,	 is	 thought	 to	 be	 able	 to	 strongly	 influence	 the	 KIR	repertoire	 of	 NK	 cells.	 Contrary	 to	 HCMV,	 the	 KIR	 repertoire	 found	 in	 huNSG	 mice	remained	 unchanged	 during	 EBV-induced	 inflammatory	 conditions	 and	 continued	 to	resemble	 a	 repertoire	 as	 found	 throughout	 steady	 state.	 Therefore,	 it	 seems	 that	 only	the	 beta-herpesvirus	 CMV,	 but	 not	 other	 herpesviruses	 like	 EBV	 or	 HSV	{Bjorkstrom:2011hp},	is	adept	at	skewing	the	KIR	repertoire	in	humans.			
5.3	Education	and	disarming	of	huNSG	mouse			Studying	NK	cell	education	has	been	challenging	due	to	the	lack	of	phenotypic	markers.	Solely	upregulation	of	DNAM-1	and	decreased	expression	of	 self-specific	KIRs	seem	to	characterize	educated	NK	cells	(Enqvist	et	al.,	2015;	van	Bergen	et	al.,	2013)	whereas	NK	cell	differentiation	occurs	 independently	of	education	by	self-HLA	 ligands	 (Björkström	et	al.,	2010).	Thus,	readouts	are	restricted	to	assays	that	explore	the	functional	capacity	of	NK	cells	 in	order	to	determine	their	educational	status	(Höglund	and	Brodin,	2010).	Furthermore,	 the	precise	 cells	mediating	NK	 cell	 education,	whether	hematopoietic	or	stromal	in	nature,	have	not	been	conclusively	identified	(Bessoles	et	al.,	2013).	Although	both	 have	 been	 implicated	 in	 influencing	 education,	 recent	 studies	 mainly	 support	 a	favoring	 role	 of	 the	 hematopoietic	 system.	This	was	 exemplified	 in	 a	 study	where	 the	educating	 compartment	 was	 elucidated	 in	 more	 depth	 using	 a	 cohort	 of	 HLA-mismatched	 allogeneic	 hematopoietic	 cell	 donor	 transplants	 to	 identify	 the	 role	 of	stromal	versus	hematopoietic	cells.	Educated	donor	NK	cells	were	found	within	the	first	year	 after	 transplant	 and	 could	 be	 followed	 for	 three	 years	 thereafter.	 In	 HLA-mismatched	transplants,	education	of	NK	cells	was	determined	by	the	donor’s	HLA/KIR-ligands.	Hence,	suggesting	that	the	educator	was	of	hematopoietic	cell	origin	(Haas	et	al.,	2011).	Furthermore,	 in	mice	with	inducible	MHC	expression,	 it	has	clearly	been	shown	that	the	hematopoietic	compartment	had	a	much	bigger	impact	on	education	compared	to	the	stromal	cells	(Ebihara	et	al.,	2013).	In	addition,	it	has	been	reported	that	already	the	 presence	 of	 low	 amounts	 of	 MHC-negative	 host	 cells	 could	 induce	hyporesponsiveness	 in	NK	 cells	 (Johansson	et	 al.,	 1997).	Together,	 these	data	 indicate	that	the	hematopoietic	compartment	is	key	in	NK	cell	education	and	that	the	threshold	for	 downregulating	NK	 cell	 functionality	 in	 response	 to	 an	 educational	 signal	 is	much	more	sensitive	than	through	effector	induction.	In	accordance	with	that,	our	data	shows	
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that	 NK	 cells	 of	 single	 reconstituted	 mice	 are	 being	 educated	 in	 the	 presence	 of	 the	educating	HLA.	However,	in	mixed	reconstituted	mice,	we	find	that	NK	cell	education	is	abrogated	due	 to	 the	 absence	of	 cognate	HLA	 in	 trans.	 Therefore,	 in	 keeping	with	 the	findings	 mentioned	 above,	 our	 results	 from	 one	 as	 well	 as	 two	 engrafting	 donors	influencing	each	other	support	the	premise	that	the	hematopoietic	system	takes	the	lead	on	educating	engrafted	NK	cells.	Thus,	in	contrast	to	KIR	repertoire	formation,	which	we	found	was	independent	of	the	HLA	microenvironment,	education	of	NK	cells	is	markedly	influenced	by	the	presence	of	non-cognate	HLA	within	the	same	recipient.	Interestingly,	a	contamination	as	small	as	5%	with	cells	expressing	 the	non-cognate	 ligand,	as	 is	 the	case	 in	 some	mixed	 reconstituted	huNSG	mice,	was	 enough	 to	disrupt	 education.	This	phenomenon	is	also	observed	in	the	murine	system,	however	only	at	higher	frequencies,	which	suggests	that	the	human	system	may	be	more	sensitive	(Johansson	and	Höglund,	2004;	 Johansson	 et	 al.,	 1997).	 The	 process	 that	 abrogates	 education	 and	 leads	 to	reduced	responsiveness	toward	targets	is	commonly	referred	to	as	disarming.	Curiously,	the	disarming	effect	non-cognate	HLA-ligands	had	on	education	was	partially	rescued	in	the	 case	 of	 KIR2DL2/3-positive	 NK	 cells	 in	 mixed	 reconstituted	 mice.	 It	 therefore	appears	 that	 the	 presence	 of	 the	 low	 affinity	 binding	 ligand	 HLA-C2	 in	 trans	 was	sufficient	to	prevent	disarming	of	HLA-C1	donor	derived	KIR2DL2/3+	NK	cells	(Pende	et	al.,	2009).	 It	 currently	remains	 to	be	uncovered	which	 leukocyte	 populations	are	able	to	 manipulate	 education	 and	 mediate	 disarming	 of	 NK	 cells.	 Furthermore,	 additional	investigation	 is	required	to	resolve	 the	physiological	role	such	disarmed	NK	cells	play.	As	 observed	 in	 our	 study,	 non-educated	 NK	 cells	 maintained	 self-inhibition	 and	 a	dampened	response	towards	targets	expressing	specific	HLA-ligands,	which	might	assist	in	mediating	NK	cell	tolerance	in	mixed	reconstituted	huNSG	mice.		Intriguingly,	 it	 has	 been	 shown	 that	 hyporesponsive	 NK	 cells	 are	 unable	 to	counteract	 infiltration	 by	HLA-negative	 tumors,	 yet	 have	 proven	 efficient	 at	 resolving	murine	 CMV	 infection	 (Orr	 et	 al.,	 2010).	 Similarly,	 we	 found	 that	 in	 mixed	reconstituted	 huNSG	mice,	where	 the	majority	 of	NK	 cells	 present	 are	 uneducated,	viral	loads	upon	EBV	infection	were	reduced.	This	was	seen	both	in	blood	and	spleen	at	 endpoint	 as	 well	 as	 indirectly	 as	 a	 measure	 of	 protection	 by	 a	 decreased	accumulation	of	CD8+	T	cells,	i.e.	decreased	CD8+	T	cell	lymphocytosis.	We	were	able	to	show	that	the	improved	control	of	EBV	was	mediated	by	NK	cells	as	there	were	no	discernable	 differences	 in	 the	 composition	 of	 the	 CD8+	 T	 cell	 compartments	 (in	terms	 of	 effector	 and	 memory	 differentiation)	 between	 single	 and	 mixed	
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reconstituted	 animals	 but	 the	 depletion	 of	 NK	 cells	 decisively	 led	 to	 a	 loss	 of	protection	as	observed	before	in	mixed	reconstituted	huNSG	mice.			
5.4	NK	cells	in	hematopoietic	cell	transplant	settings		Our	 results	 pose	 the	 question	 of	 how	 co-reconstitution	 of	 different	 donors	 in	 the	setting	 of	 hematopoietic	 transplantation	 could	 influence	 disease	 outcome.	 Recent	studies	have	underlined	the	value	of	NK	cells	as	a	means	of	immunotherapy	in	allogeneic	hematopoietic	 cell	 transplantation.	 In	 haploidentical	 transplantation	 KIR-HLA	mismatching	 in	 the	graft-versus-host	direction	(i.e.	presence	of	HLA-C1,	 -C2	or	Bw4	 in	the	donor	but	missing	in	the	recipient)	lead	to	NK	cell-mediated	donor-versus-recipient	alloreactivity	 or	 so	 called	 graft-versus-leukemia	 (GvL)	 effects	 (Elliott	 and	 Yokoyama,	2011;	Ruggeri	 et	 al.,	 2002).	Mature	NK	 cells	 that	 have	developed	 from	engrafted	 cells	exhibit	a	NK	cell	 repertoire,	which	mirrors	 that	of	 the	original	donor.	Moreover,	 these	cells	 seem	 to	 be	 immediately	 educated,	 as	 they	 are	 able	 to	 mount	 an	 alloreactive	response	that	kills	recipient	leukemic	cells	(Velardi	et	al.,	2009).	This	is	likely	facilitated	by	 their	 development	 in	 the	 bone	 marrow	 where	 they	 are	 primarily	 exposed	 to	 a	microenvironment	 that	 is	 dominated	 by	 donor	 HLA	 from	 the	 transplanted	hematopoietic	 cells.	 Thus,	 the	 repertoire	of	 engrafting	NK	 cells	 is	 educated	 to	be	both	self-tolerant	as	well	as	recipient	alloreactive,	allowing	 them	to	react	 to	missing-self	on	recipient	targets.	When	looking	at	the	functional	capacity	of	reconstituting	NK	cells	after	unrelated	donor	or	umbilical	cord	transplant,	both	cytotoxicity	and	cytokine	production	could	be	observed	in	NK	cells	educated	by	donor	HLA	(Foley	et	al.,	2011).	Interestingly,	in	HLA-matched	transplant	patients	NK	cells	that	did	not	express	receptors	for	self-HLA	remained	 hypofunctional	 after	 reconstitution.	 This	 emphasized	 the	 advantage	 of	mismatched	 transplants,	where	 the	 breaking	 of	 NK	 cell	 tolerance	 results	 in	 beneficial	clinical	outcome	for	patients.	Furthermore,	 it	was	observed	that	NK	cell	differentiation	occurred	 independently	 of	 education	 by	 self-HLA	 ligands,	 as	 is	 the	 case	 in	 healthy	individuals	(Björkström	et	al.,	2010).	Acute	 myeloid	 leukemia	 (AML)	 is	 a	 condition,	 where	 in	 patients	 that	 have	undergone	 haploidentical	 hematopoietic	 cell	 transplantation,	 the	 involvement	 of	reconstituted	NK	cells	 is	key	in	controlling	the	outcome	of	disease	(Pietra	et	al.,	2015).	Alloreactive	 NK	 cells	 have	 been	 implicated	 in	 eradicating	 AML	 tumor	 cells,	 favoring	engraftment,	protecting	 from	graft-versus-host	disease	 (GvHD),	 lowering	 relapse	 rates	
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and	 greatly	 improving	 event-free	 survival,	 as	 demonstrated	 by	 data	 from	 multiple	clinical	 and	 preclinical	 studies	 (Velardi	 et	 al.,	 2009).	 Also,	 in	 children	 with	 acute	lymphoblastic	leukemia	(ALL),	NK	alloreactivity	was	shown	to	lower	the	risk	of	relapse	(Moretta	 et	 al.,	 2011).	 Protection	 from	 ALL	 could	 additionally	 be	 improved	 when	alloreactivity	was	exerted	by	NK	cells	of	maternal	donors	primed	by	exposure	 to	 fetal	antigens	 during	 pregnancy	 and	 thus	 able	 to	 cooperate	 with	memory	 T-cell	 immunity	against	the	paternal	HLA	haplotype	(Stern	et	al.,	2008).	Furthermore,	transplantation	of	hematopoietic	cells	from	unrelated	donors	was	not	improved	when	recipient	and	donors	were	KIR-ligand	mismatched	with	only	a	few	studies	 reporting	 improved	 GvL	 effects	 {Velardi:2008hv}.	 In	 contrast,	 KIR-ligand	mismatch	 in	 the	 graft-versus-host	 direction	 during	 single	 unit	 cord	 blood	 transplants	significantly	 reduced	 the	 incidence	 of	 relapse	 and	 improved	 leukemia-free	 survival	 in	AML	{Willemze:2009ib}.	However,	nowadays	common	practice	is	the	administration	of	double	 unit	 transplants	 of	 which	 one	 donors	 tends	 to	 prevail	 during	 engraftment	(Gutman	et	 al.,	 2010;	Hashem	and	Lazarus,	 2015).	When	KIR-ligand	mismatching	was	studied	 in	 the	 dominant	 engrafting	 unit,	 no	 beneficial	 effect	 could	 be	 documented	 on	GvHD,	transplantation-related	mortality,	relapse	or	survival	(Brunstein	et	al.,	2009). Interestingly,	 in	 the	 transplantation	 setting	 the	 role	 of	 T	 cells	 is	 only	 poorly	assessed,	 since	depletion	 or	 naivety	 of	 transplanted	T	 cells	 does	not	 allow	 for	 a	 rapid	contribution	 during	 engraftment.	 Therefore,	 transplantations	 combining	 adoptive	transfer	 of	 T	 regulatory	 and	 effectors	 cells	 are	 of	 great	 relevance.	 Add-back	 of	 T	 cells	was	 shown	 to	 enhance	 recovery	 of	 NK	 cells	 that	 were	 donor-versus-recipient	alloreactive	and	single	KIR	positive	(Di	Ianni	et	al.,	2011).	The	role	of	activating	KIRs	in	transplantation	 has	 also	 been	 the	 focus	 of	 several	 studies.	 Consistent	 with	 previous	evidence	 that	 NK	 cells	 may	 be	 instrumental	 in	 limiting	 GvHD,	 NK	 cells	 expressing	KIR2DS1	efficiently	kill	allogeneic	KIR-ligand-mismatched	T	cell	blasts	and	DCs	(Sivori	et	al.,	2011),	which	suggests	 that	 they	are	 important	 in	patients	receiving	a	KIR	 ligand	mismatched	haploidentical	 transplantation.	 In	addition,	data	 from	 large	cohort	 studies	indicated	that	the	presence	of	activating	KIRs	and	activating	KIR	genes	in	donors	could	support	 relapse	 protection	 and	 survival	 in	 AML	 (Cooley	 et	 al.,	 2010;	 Stringaris	 et	 al.,	2010).		These	interesting	findings	have	encouraged	trials	that	aim	to	eradicate	AML	by	administering	alloreactive	NK	cells.	One	 such	 strategy	 is	 the	 infusion	of	haploidentical	NK	 cells	 following	 lymphoablating	 immunotherapy.	 The	 adoptive	 transfer	 was	 well	
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tolerated	 and	 some	 patients	 showed	 long-term	 persistence	 of	 alloreactive	 NK	 cells	 in	peripheral	 blood	 and	 bone	 marrow.	 This	 course	 of	 anti-leukemic	 treatment	 could	 be	especially	 interesting	 for	 candidates	 who	 do	 not	 qualify	 for	 hematopoietic	 cell	transplantation	(Curti	et	al.,	2011;	Miller	et	al.,	2005;	Rubnitz	et	al.,	2010).	Another	trial	involves	administration	of	anti-KIR	antibodies,	which	block	the	recognition	of	self-HLA-C	by	inhibitory	KIRs.	In	mice,	this	approach	has	produced	encouraging	results,	leading	to	increased	 NK	 cell-mediated	 killing	 of	 targets,	 while	 maintaining	 self-tolerance	 and	allowing	 for	NK	cell	 education	 (Romagné	et	 al.,	 2009).	These	encouraging	 results	may	pave	the	way	for	in	vivo	therapies	using	antibodies	to	activate	endogenous	NK	cells	that	can	clear	leukemia	and	other	malignancies.	Lastly,	 the	 risk	 of	 CMV	 reactivation	 in	 hematopoietic	 cell	 transplantation	patients	 induced	 by	 conditioning	 regimens	 is	 still	 a	 great	 threat	 and	 a	major	 cause	 of	treatment	 related	mortality.	 To	 date,	 several	 studies	 have	 confirmed	 the	 existence	 of	long-lasting	memory-like	NK	cells	 in	CMV-seropositive	 individuals	 (Béziat	 et	 al.,	 2011;	Lopez-Vergès	et	al.,	2011).	Thus,	transfer	of	memory	NK	cells	from	seropositive	donors	may	help	to	keep	reactivation	at	bay,	as	data	from	mice	suggest	(Sun	and	Lanier,	2011).	In	conclusion,	NK	cells	are	becoming	attractive	therapy	tools,	since	unlike	T	cells,	 they	do	not	induce	GvHD	and	are	able	to	target	both	leukemic	malignancies	and	viral	diseases	(Elliott	and	Yokoyama,	2011;	Ruggeri	et	al.,	2002). Taking	into	account	all	this	knowledge,	it	is	highly	important	to	understand	the	interplay	 of	 KIR-ligands	 with	 their	 cognate	 receptors	 during	 engraftment	 to	 advance	current	 therapeutic	 approaches.	 In	 addition,	 sustainable	 co-reconstitution	 could	 be	assessed	 as	 a	 viable	 option	 to	 give	 patients	 an	 advantageous	 edge	 in	 controlling	herpesvirus	infections	such	as	EBV	and	possibly	HCMV.	While	the	mechanism	by	which	uneducated	 NK	 cells	 targets	 EBV	 is	 still	 elusive	 and	 warrants	 further	 investigation,	 a	potential	 explanation	 might	 be	 found	 in	 the	 mismatching	 of	 the	 donors,	 such	 that	mismatched	 EBV-transformed	 B	 cells	 might	 prove	more	 susceptible	 to	 NK	 cell	 lysis,	while	 the	 response	 to	 their	 matched	 counterpart	 would	 still	 be	 dampened	 by	 KIR	inhibition	(Yu	et	al.,	2007).	
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PART	II	–	INTERACTIONS	OF	NK	CELLS	WITH	PDCS		
5.1	NK	cells	enhance	pDC	survival	despite	cytotoxic	IS	phenotype		As	interactions	of	NK	cells	with	their	surroundings	are	vital	to	their	immune	response,	our	 second	 study	 involved	 the	 in-depth	 study	of	NK	 cell-pDC	 interactions.	 Curiously,	the	interactions	we	found	showed	hallmarks	of	a	cytotoxic	synapse,	as	accumulation	of	actin	at	the	IS	in	NK	cells	was	observed	(Orange,	2008).	However,	pDCs	were	not	found	to	be	killed	as	seen	by	the	lack	of	perforin	polarization	at	the	IS	and	the	distance	of	the	synaptic	 cleft	 that	was	 comparable	 to	 that	 found	 in	 regulatory	 synapses	(Barreira	da	Silva	 et	 al.,	 2011).	 In	 addition,	 pDCs	 even	 seemed	 to	 show	 enhanced	 survival	 in	 the	presence	of	NK	cells	when	lacking	other	persistence-boosting	agonists.	This	correlates	with	data	 from	a	previous	 study,	where	NK	 cells	were	 shown	 to	 functionally	mature	pDCs	with	no	 trace	of	 cell	 lysis	 to	be	 found	(Gerosa	et	al.,	2005).	 	Moreover,	NK	cells	also	 induce	a	positive	 feedback	 loop	 in	pDCs	 towards	oligodeoxynucleotides	 (ODNs),	making	them	better	responders	and	type	I	IFN	producers	(Gerosa	et	al.,	2005).		
5.2	Direct	cell-to-cell	contacts	facilitate	NK	cell-pDC	interactions		The	 accumulation	 of	 IFN	 signaling	 receptors	 and	 STAT	 signal	 transducers	 at	 the	synapse	suggest	that	the	observed	IS	could	aid	in	efficient	signal	transmission	during	infection.	 This	 would	 attribute	 similar	 functions	 to	 the	 IS	 of	 pDCs	 with	 NK	 cells	 as	reported	 for	 the	 one	with	 cDCs	 (Barreira	 da	 Silva	 et	 al.,	 2011).	 Indeed,	 results	 from	Gerosa	et	al.,	showing	that	as	little	as	0.2%	of	pDCs	were	sufficient	to	transfer	a	type	I	IFN	 signal	 suggest	 that	 a	 specific	 means	 of	 interaction	 between	 NK	 cells	 and	 pDCs	should	 exist	 to	 mediate	 such	 efficient	 cross-talk	 (Gerosa	 et	 al.,	 2005).	 Although	 no	immediate	role	of	the	NK-pDC	synapse	could	be	reported,	because	transwell	conditions	performed	comparable	with	respect	 to	NK	cell	activation	 to	conditions	allowing	direct	cell-to-cell	 contact	 (Gerosa	 et	 al.,	 2005),	 the	 accumulation	 of	 receptors	 as	 mentioned	above	strongly	hints	toward	a	functional	relevance	of	direct	cell	contact.	In	addition,	the	observation	that	low	levels	of	type	I	IFN	production	upon	poly(I:C)	stimulation	are	able	to	mediate	NK	cell	cytotoxicity	too,	might	be	explained	by	the	well-organized	capture	of	secreted	type	I	IFNs	via	the	IS	(Gerosa	et	al.,	2005).	Furthermore,	we	could	confirm	the	
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involvement	of	STAT1	signaling	during	pDC-mediated	NK	cell	induction	as	we	were	able	to	 show	 polarized	 accumulation	 of	 phosphorylated	 STAT1	 at	 the	 IS.	 	 As	 signaling	 via	STAT1	has	been	implicated	in	cytotoxicity	as	well	as	accumulation	and	proliferation	of	NK	cells	(Nguyen	et	al.,	2002),		the	enhanced	cytolytic	capacity	of	pDC-induced	NK	cells	fits	nicely	with	the	phosphorylated	STAT1	immunofluorescence	images.	Thus,	we	could	demonstrated	 the	 preferential	 accumulation	 of	 STAT1	 at	 the	 IS,	which	 could	 facilitate	the	 IFNα/β-STAT1-IL-15	 signaling	 cascade,	 enhancing	 both	 NK	 cell	 cytotoxicity	 and	survival	at	low	levels	of	immune	activation.		In	 keeping	 with	 data	 from	 Gerosa	 et	 al.	 that	 the	 HLA-DR-positive	 lymphocyte	population	induces	CD69	upregulation	on	NK	cells,	we	could	also	show	that	our	purified	pDCs	displayed	elevated	expression	 levels	of	HLA-DR	and	were	able	 to	phenotypically	and	functionally	mature	NK	cells	as	seen	by	upregulation	of	HLA-DR	and	CD69	(Gerosa	et	 al.,	 2005).	 Curiously,	 while	 we	 did	 see	 expression	 of	 TNFα	 in	 stimulated	 pDCs	 the	presence	of	NK	cells	markedly	reduced	the	detected	secretion	levels	possibly	indicating	an	uptake	by	the	present	NK	cells.		Thus,	in	microenvironments	where	IFNs	could	be	scavenged	by	other	cells,	the	formation	 of	 an	 IS	 between	 NK	 cells	 and	 pDCs	 might	 be	 important	 to	 ensure	 the	efficient	stimulation	and	response	of	NK	cells.	In	fact,	this	might	be	particularly	useful	in	non-productive	viral	infections	where	pDCs	are	only	recruited	in	small	numbers	and	therefore	 low	amounts	of	 type	I	 IFNs	are	secreted	and	need	to	be	directed	efficiently	toward	NK	cells	(Gerosa	et	al.,	2005).	Moreover,	as	NK	cell	memory	receives	growing	attention,	the	sufficient	activation	of	NK	cells	towards	vaccines	could	ensure	a	robust	response	toward	a	later	challenge.	In	addition,	targeting	of	NK	cells	through	cytokines	such	 as	 GM-CSF	 and	 IL-2	 is	 being	 tested	 as	 a	 means	 to	 eradicate	 EBV-induced	malignancies	(Baiocchi	et	al.,	2001).	Thus,	understanding	activation	of	NK	cells	through	IFNα/β	 could	 be	 important	 to	 design	 therapies	 taking	 advantage	 of	 host	 intrinsic	pathways.	
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